Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3009214	s-lh	U/l (u/l)	5433	7213	1.77%
3009214	s-lh	IU/l (u/l)	4224	5398	0.00%
3009214	p-lh	U/l (u/l)	3563	4700	0.00%
3009214	s-lh	— (—)	3444	4802	100.00%	Distribution not available
3009214	p-lh	— (—)	928	1129	100.00%	Distribution not available
3009214	s-lh	IU/l______ (u/l)	246	357	0.00%
3009214	p-lh	U/L (u/l)	15	17	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Benign neoplasm of other and unspecified endocrine glands

805

1337

6.82

307.65

2.0

1.3

8.07

11.11

u/l

6.80

661

1082

Endocrine, nutritional and metabolic diseases

3717

6643

2.96

307.65

1.7

1.3

8.57

9.17

u/l

1.65

2998

5351

Female infertility, cervical, vaginal, other or unspecified origin

1953

1607

8.83

307.65

1.2

1.3

8.31

14.01

u/l

31.36

1622

1275

Benign neoplasm: Pituitary gland, craniopharyngeal duct

708

654

15.61

307.65

2.2

1.4

7.30

9.60

u/l

3.26

577

530

Used for control exclusion in common control thyroid runs

3873

9629

2.09

307.65

1.6

1.4

8.48

9.15

u/l

2.19

3097

7715

Female infertility, associated with anovulation

1099

960

15.35

307.65

1.3

9.46

11.76

u/l

3.17

926

764

Medical treatment for female infertility

1575

4301

4.09

307.65

1.3

8.78

12.44

u/l

17.92

1381

3487

Polycystic ovarian syndrome, consortium definition

2984

5952

3.02

307.65

1.4

1.2

10.78

13.51

u/l

16.41

2460

4855

Exclusions for E4_PCOS_BROAD

2277

2656

11.41

307.65

2.1

1.4

7.65

9.43

u/l

6.16

1783

2061

Hypogonadotropic hypogonadism

780

524

37.22

307.65

2.3

1.4

3.53

5.14

u/l

6.05

591

425

Hypothyroidism, levothyroxine purchases

1617

2667

3.65

307.65

1.6

1.3

8.36

7.81

u/l

0.70

1296

2216

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2238

4353

5.75

307.65

2.0

1.4

8.21

11.28

u/l

17.06

1757

3457

Hypothyroidism and >3 levothyroxin purchases

1617

2667

3.65

307.65

1.6

1.3

8.36

7.81

u/l

0.70

1296

2216

Hypopituitarism

1411

1006

24.34

307.65

2.2

1.4

5.73

7.01

u/l

2.79

1077

750

Polycystic ovarian syndrome

806

1373

7.94

307.65

1.4

1.2

9.82

8.75

u/l

2.16

684

1132

Disorders of other endocrine glands

4013

6044

7.61

307.65

1.9

1.3

9.20

9.57

u/l

0.74

3200

4851

Testicular hypofunction

668

487

24.00

307.65

2.1

1.4

7.64

4.76

u/l

8.59

544

392

Hypothyroidism (congenital or acquired)

1628

2683

3.65

307.65

1.6

1.3

8.29

7.81

u/l

0.60

1305

2228

Amenorrhoea

889

738

16.01

307.65

1.8

1.4

8.34

11.07

u/l

4.49

706

581

Polycystic ovarian syndrome, broad definition

1408

2530

7.14

307.65

1.3

1.2

9.48

9.88

u/l

0.44

1191

2090

Ovarian dysfunction

1006

1714

7.70

307.65

1.5

1.2

13.01

9.10

u/l

8.79

837

1401

Irregular menses

2357

5790

3.25

307.65

1.5

1.2

10.42

13.23

u/l

14.96

1932

4726

Exclusions for E4_PCOS_CONSORTIUM

3297

8033

2.69

307.65

1.9

1.3

9.09

11.13

u/l

11.58

2605

6482

Female infertility

2319

1671

9.57

307.65

1.3

8.75

13.82

u/l

24.52

1957

1322

Testicular dysfunction

734

546

22.92

307.65

2.1

1.4

7.38

4.87

u/l

7.54

597

439

Noninflammatory disorders of female genital tract

1602

2061

4.11

307.65

1.4

9.70

13.01

u/l

11.91

1321

1613

Hyperfunction of pituitary gland

511

656

9.94

307.65

2.1

1.3

7.80

10.43

u/l

3.52

416

513

Hyperprolactinaemia

381

469

10.64

301.79

1.8

1.2

7.64

10.95

u/l

4.02

307

378

Depression

3366

11658

1.98

263.65

1.5

1.4

9.40

9.69

u/l

0.58

2613

9552

Recurrent or chronic depression

1558

4054

2.78

263.02

1.5

1.4

9.35

9.93

u/l

0.84

1228

3377

Hypothyroidism, other/unspecified

2978

9738

2.07

260.29

1.5

1.4

10.95

10.15

u/l

1.76

2386

7890

Mood [affective] disorders

3501

11792

1.95

259.61

1.5

1.4

9.45

9.69

u/l

0.45

2725

9648

Disorders of the thyroid gland

3171

10469

2.02

259.09

1.5

1.4

10.49

9.86

u/l

1.35

2542

8475

Mood disorders

3504

11795

1.95

258.84

1.5

1.4

9.46

9.68

u/l

0.42

2728

9650

Medical observation and evaluation for suspected diseases and conditions

2307

5227

2.32

251.08

1.6

1.3

8.77

9.03

u/l

0.41

1838

4185

Hypothyreosis and Thyroxine purchase for inclusion criteria

3022

10027

2.03

250.81

1.5

1.4

11.03

10.30

u/l

1.53

2426

8118

Mood disorders, excluding more controls

3081

9154

2.03

250.36

1.5

1.4

9.36

9.86

u/l

1.12

2400

7570

Procreative management

1623

5435

2.60

246.19

1.7

1.6

8.81

8.84

u/l

0.02

1235

4253

Anxiety disorders, excluding more controls

2818

8942

2.07

245.74

1.5

1.4

9.86

9.82

u/l

0.04

2199

7398

Genitourinary diseases

2146

4681

2.37

242.84

1.6

7.21

6.95

u/l

0.52

1699

3667

Neurotic, stress-related and somatoform disorders

3181

11555

1.95

238.29

1.5

1.4

9.68

9.67

u/l

0.02

2483

9437

Male infertility

446

835

6.52

236.79

1.9

1.6

6.43

4.38

u/l

8.65

343

686

Anxiety disorders

3192

11583

1.94

236.65

1.5

1.4

9.67

9.68

u/l

0.01

2491

9462

Oligomenorrhoea

259

269

11.32

229.00

1.5

1.3

8.98

12.08

u/l

2.20

211

200

Anxiety (asthma-related co-morbidities)

2483

9356

2.09

227.84

1.5

1.4

9.15

9.66

u/l

1.05

1914

7701

Depression or dysthymia

2016

4859

2.33

225.50

1.5

1.4

9.06

9.78

u/l

1.42

1590

3998

Other antidepressants

3241

8718

1.94

225.40

1.4

8.88

9.58

u/l

2.10

2554

7142

Oxycodone

1006

2868

3.09

220.49

1.4

13.46

11.07

u/l

4.19

814

2294

Behavioural syndromes associated with physiological disturbances and physical factors

3189

11751

1.88

215.23

1.5

1.4

8.76

9.84

u/l

4.80

2543

9496

All anxiety disorders

2574

10312

2.00

211.74

1.5

1.4

9.09

9.58

u/l

1.03

1984

8428

Sleep apnoea

2653

8561

2.00

211.21

1.5

1.4

8.86

11.15

u/l

11.64

2137

6907

Excessive, frequent and irregular menstruation

1129

2038

3.06

210.25

1.3

10.38

13.06

u/l

6.53

944

1600

Panhypopituitarism

216

214

14.33

203.34

2.4

1.5

4.93

9.04

u/l

3.27

144

168

Other nutritional deficiencies

2397

11339

1.99

200.59

1.5

1.4

8.73

10.43

u/l

10.29

1948

9165

Neoplasms

3167

9181

1.86

193.59

1.7

1.4

8.27

8.06

u/l

0.44

2543

7360

Sleep disorders (combined)

3338

9761

1.82

193.57

1.4

8.70

10.30

u/l

8.14

2687

7867

Depression medications

1409

2853

2.59

189.23

1.5

1.4

7.93

7.68

u/l

0.32

1122

2359

Pain and other conditions associated with female genital organs and menstrual cycle

743

1908

3.41

186.97

1.3

9.60

12.74

u/l

7.83

604

1499

Sleep apnoea, including avohilmo

2797

9305

1.86

177.60

1.5

1.4

9.18

10.85

u/l

6.83

2253

7517

Sleep disorders

2943

11447

1.81

177.06

1.4

8.92

9.92

u/l

3.89

2359

9310

Malignant neoplasm of testis, including Hilmo

218

266

11.17

175.21

3.2

1.5

7.80

4.15

u/l

6.46

176

218

Malignant neoplasm of testis

211

251

11.92

174.07

3.3

1.5

7.79

4.00

u/l

6.82

171

207

Obesity and other hyperalimentation

2223

11103

1.94

173.24

1.5

1.4

8.77

10.50

u/l

9.94

1810

8988

Obesity

2215

11080

1.94

172.64

1.5

1.4

8.77

10.50

u/l

9.92

1806

8969

Selective serotonin reuptake inhibitors

3013

8872

1.80

167.98

1.5

8.41

9.51

u/l

4.79

2378

7222

Use of cabergoline

188

203

13.60

167.51

2.0

1.3

6.15

9.19

u/l

2.09

151

167

Non-small cell lung cancer

300

509

6.13

167.02

1.3

14.35

8.66

u/l

7.20

252

395

Hypertrichosis

261

423

8.15

163.31

1.5

1.4

9.28

10.87

u/l

1.11

225

346

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

581

1651

3.54

162.96

1.6

1.3

16.45

10.21

u/l

13.33

481

1296

General symptoms and signs

3371

9955

1.73

162.35

1.5

1.4

9.83

9.20

u/l

1.70

2709

8024

Non-small cell lung cancer, including Hilmo

371

730

4.96

162.22

1.3

14.79

9.41

u/l

7.21

313

570

Other disorders of adrenal gland

274

461

6.78

159.82

1.8

1.4

14.70

9.29

u/l

4.14

216

338

Hirsutism in women

243

377

8.73

159.17

1.4

1.3

9.21

10.69

u/l

0.96

208

307

Insomnia

2891

11724

1.75

156.35

1.4

8.90

9.89

u/l

3.85

2325

9559

Other anxiety disorders

2005

9067

1.95

154.62

1.5

1.4

8.94

9.39

u/l

0.83

1539

7414

General examination and investigation of persons without complaint and reported diagnosis

1977

5227

2.01

152.61

1.5

1.3

9.67

9.03

u/l

1.20

1650

4185

Hypothyroidism, strict autoimmune

2160

7589

1.91

152.46

1.3

11.54

10.25

u/l

2.86

1747

6144

Lung cancer and mesothelioma

435

924

4.13

147.16

1.3

1.4

14.87

10.30

u/l

6.10

367

720

Opioids

3134

9691

1.70

143.80

1.4

9.33

9.29

u/l

0.06

2536

7867

Episodal and paroxysmal disorders

3365

10414

1.67

143.02

1.5

1.4

8.89

9.82

u/l

3.22

2728

8306

Adrenocortical insufficiency

215

316

7.79

142.85

1.7

1.3

15.78

9.80

u/l

3.86

182

243

Liquid cancers, including Hilmo

835

2821

2.68

142.72

1.9

1.4

13.75

8.94

u/l

13.30

668

2200

Malignant neoplasm of respiratory system and intrathoracic organs

462

1038

3.81

139.26

1.3

13.54

9.20

u/l

6.78

392

806

Headache

2163

9318

1.83

139.08

1.5

1.4

9.62

9.43

u/l

0.27

1760

7522

Obesity due to excess calories

1687

8857

1.97

138.45

1.5

1.4

8.95

10.52

u/l

6.14

1379

7164

Thyrotropin deficiency

150

158

14.04

136.20

1.8

1.3

9.51

10.70

u/l

0.36

130

129

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

500

1192

3.56

136.13

1.4

1.3

14.12

9.48

u/l

7.71

423

929

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

440

1258

3.66

130.07

1.8

1.4

15.78

8.77

u/l

12.86

359

988

Other endocrine disorders

333

772

4.69

126.71

2.4

1.6

6.68

7.07

u/l

0.22

213

541

Neurological diseases

2814

8530

1.69

124.67

1.5

1.4

8.72

9.41

u/l

1.67

2264

6799

Malignant neoplasm of bronchus and lung, including Hilmo

418

967

3.71

121.90

1.3

15.13

9.62

u/l

8.15

351

748

Malignant neoplasm of bronchus and lung

383

836

3.95

121.88

1.3

1.4

14.53

9.30

u/l

7.36

324

647

Diseases of male genital organs

1667

4373

1.97

120.58

1.7

1.6

5.56

5.32

u/l

0.85

1300

3464

Anaemias

922

2499

2.46

120.17

1.6

1.3

10.62

7.93

u/l

6.40

737

2052

Persons encountering health services in other circumstances, wide

3257

10616

1.60

118.80

1.5

1.4

9.63

9.51

u/l

0.17

2613

8495

Codeine

2835

9432

1.65

118.31

1.4

9.28

9.37

u/l

0.13

2299

7661

Acute upper respiratory infections of multiple and unspecified sites

2396

10549

1.69

115.02

1.5

1.4

9.70

9.98

u/l

0.43

1934

8451

Corticotropin deficiency

110

17.20

114.48

2.0

1.3

12.87

10.99

u/l

0.38

Any mental disorder

2959

9256

1.63

114.15

1.5

1.4

9.56

9.86

u/l

0.54

2327

7613

Other special examinations and investigations of persons without complaint or reported diagnosis

1875

5228

1.85

114.15

1.6

1.3

8.80

9.03

u/l

0.31

1531

4185

Endometriosis

749

1677

2.66

113.60

1.2

1.3

12.06

14.14

u/l

2.75

656

1334

GASTRO-related operations

2623

8013

1.67

112.38

1.6

1.4

9.52

8.33

u/l

4.52

2133

6391

Any gastric operation

2623

8013

1.67

112.38

1.6

1.4

9.52

8.33

u/l

4.52

2133

6391

Osteoporosis

466

1365

3.21

112.30

1.5

1.4

13.96

14.35

u/l

0.17

374

1101

Malignant melanoma

385

1112

3.60

111.83

1.4

1.3

13.54

9.85

u/l

4.60

314

878

Fever of other and unknown origin

1634

7819

1.85

110.52

1.6

1.4

11.05

9.47

u/l

4.01

1323

6299

Psychiatric diseases

2599

7936

1.67

110.37

1.5

1.4

9.23

9.94

u/l

1.79

2039

6516

L02BG Aromatase inhibitors

498

1667

3.02

109.91

1.5

1.3

15.31

19.68

u/l

6.67

422

1364

Malignant melanoma, including Hilmo

413

1278

3.35

107.47

1.4

1.3

13.62

10.20

u/l

4.29

338

1009

Obesity related asthma

995

4768

2.15

105.39

1.5

1.4

9.38

10.78

u/l

2.79

801

3832

Parasetamol

2463

7595

1.67

105.19

1.5

8.70

8.42

u/l

0.52

2026

6070

Primary ovarian failure

165

259

7.81

104.85

1.7

1.2

29.15

12.78

u/l

6.00

129

205

Malaise and fatigue

1345

5587

1.93

103.06

1.5

1.4

10.98

9.93

u/l

1.65

1078

4473

Neurological diseases, wide definition

1268

3195

2.06

102.30

1.6

1.5

7.95

8.46

u/l

0.78

1012

2461

Non-small cell lung cancer, adenocarcinoma

172

281

6.47

101.46

1.3

1.4

14.22

9.89

u/l

2.43

143

225

Complications associated with artificial fertilization

131

163

9.45

101.08

1.2

9.07

12.18

u/l

1.41

115

127

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3070

10612

1.56

101.04

1.5

1.4

9.91

9.51

u/l

0.75

2485

8492

Ovarian cyst

767

1812

2.48

100.65

1.3

12.30

13.76

u/l

1.68

636

1435

Malignant melanoma of skin, including Hilmo

355

1042

3.54

100.64

1.4

1.3

14.00

9.98

u/l

4.95

290

825

Examination and observation for other reasons

1658

5209

1.83

100.07

1.5

1.3

9.57

9.04

u/l

0.74

1313

4173

Dental caries

766

3171

2.35

99.93

1.7

1.4

10.24

9.00

u/l

1.57

603

2571

Benign neoplasms

3144

11257

1.54

99.29

1.6

1.4

8.65

8.98

u/l

0.73

2545

9062

Benzodiazepine use

2841

12494

1.56

97.55

1.4

10.34

9.71

u/l

1.47

2206

10200

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2892

12107

1.55

97.53

1.4

9.45

9.81

u/l

0.74

2323

9690

Seminoma of testis, including Hilmo

117

138

11.92

97.13

3.3

1.5

7.77

3.92

u/l

3.44

101

116

Tramadol

2011

7212

1.70

96.75

1.4

9.93

9.98

u/l

0.05

1587

5887

Codeine or tramadol medication

3173

11448

1.53

95.49

1.4

9.50

9.78

u/l

0.55

2579

9284

Special screening examination for infectious and parasitic diseases

1091

4043

2.04

93.53

1.4

1.3

7.75

8.28

u/l

0.81

811

3264

Malignant melanoma of skin

308

867

3.70

93.26

1.4

1.3

13.78

9.72

u/l

4.35

249

681

Medicines for HER+ breast cancer

620

2373

2.48

92.68

1.5

1.3

15.74

18.67

u/l

3.99

523

1938

Disorders of puberty

171

322

6.89

91.94

3.3

1.7

4.99

5.97

u/l

0.89

127

226

Hypothyroidism, strict autoimmune, 3 medication purchases required

2191

9171

1.63

91.23

1.3

11.92

10.68

u/l

2.69

1771

7447

Endometriosis of pelvic peritoneum

388

1151

3.17

90.30

1.2

1.3

12.34

15.69

u/l

3.59

341

908

Migraine

1741

8065

1.72

89.78

1.4

10.53

10.57

u/l

0.04

1428

6506

Seminoma of testis

101

109

13.10

89.60

3.4

1.4

7.65

3.99

u/l

2.60

Liquid cancers

596

2324

2.48

89.09

2.0

1.4

11.69

9.05

u/l

3.87

462

1810

Other medical care

1066

4603

1.98

89.06

1.7

1.4

13.27

10.07

u/l

8.12

850

3618

Impotence

247

623

4.31

88.95

1.6

1.4

5.93

5.66

u/l

0.22

195

515

First line medication for Crohn's disease

3254

11869

1.50

88.62

1.6

1.4

10.09

8.96

u/l

4.51

2609

9500

Caries of dentine

678

2874

2.35

88.55

1.6

1.5

10.13

8.83

u/l

1.65

542

2327

Personal history of malignant neoplasm

277

756

3.87

88.34

2.6

1.4

11.02

15.31

u/l

4.16

203

597

Non-seminoma of testis, including Hilmo

15.69

88.16

3.6

1.6

8.64

3.94

u/l

4.19

Pain in joint

1745

6343

1.72

87.37

1.5

9.60

8.91

u/l

1.33

1433

5057

Unspecified/other endometriosis

310

897

3.55

87.07

1.2

1.3

10.05

13.37

u/l

3.78

261

712

Any reimbursement code in KELA

2162

6724

1.65

86.75

1.5

1.3

9.19

8.30

u/l

1.92

1733

5471

Non-small cell lung cancer, adenocarcinoma, helper endpoint

172

330

5.50

85.74

1.3

14.22

10.73

u/l

1.78

143

262

Female infertility, tubal origin

170

329

5.51

84.23

1.2

1.3

8.44

17.72

u/l

10.91

138

256

Malignant neoplasm

2148

7923

1.61

83.23

1.8

1.4

13.42

9.46

u/l

22.15

1709

6359

Personality disorders, excluding more controls

985

5124

1.99

83.18

1.4

1.3

9.06

9.05

u/l

0.01

737

4294

Malignant neoplasm

2146

7920

1.61

82.94

1.8

1.4

13.45

9.47

u/l

22.43

1710

6361

Obesity, other/unspecified

1096

5917

1.91

82.76

1.4

1.3

8.98

11.18

u/l

8.07

881

4816

Symptoms and signs involving the circulatory and respiratory systems

3043

10320

1.50

82.52

1.5

1.4

9.42

9.38

u/l

0.06

2458

8288

Dysplasia of cervi uteri

540

1508

2.58

81.66

1.2

11.47

14.07

u/l

3.18

444

1198

Malignant neoplasm, including Hilmo

2240

8354

1.58

80.82

1.8

1.4

13.16

9.33

u/l

22.17

1791

6713

Disorders of puberty, all

202

493

5.32

80.72

3.5

1.8

5.16

6.84

u/l

1.98

154

341

Malignant neoplasm, wide definition

2234

8337

1.58

80.17

1.8

1.4

13.17

9.33

u/l

22.16

1782

6699

Endometriosis diagnosis and infertility diagnosis occurring together

438

1670

2.78

79.84

1.2

1.3

9.53

12.91

u/l

6.59

381

1373

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1360

6813

1.76

79.74

1.5

1.4

13.25

10.52

u/l

7.73

1106

5433

Factors influencing health status and contact with health services

755

1708

2.26

78.71

1.5

1.4

7.34

7.46

u/l

0.10

607

1383

Gender identity disorders

171

375

5.98

78.00

2.2

1.6

6.10

7.99

u/l

2.12

145

299

Endometriosis of ovary

343

1073

3.09

77.95

1.2

1.3

11.95

16.86

u/l

6.59

294

852

Asthma, excluding more controls

2091

6788

1.61

77.54

1.4

9.73

9.46

u/l

0.38

1675

5478

Persons encountering health services in other circumstances

1247

7056

1.79

77.30

1.5

1.4

10.08

9.47

u/l

0.81

1001

5644

Asthma

2110

6906

1.60

77.10

1.4

9.74

9.45

u/l

0.42

1693

5573

Bronchitis

2984

12323

1.47

76.80

1.5

1.4

9.98

9.87

u/l

0.15

2412

9883

Persons encountering health services for examination and investigation

1728

5228

1.68

76.68

1.5

1.3

8.91

9.03

u/l

0.13

1388

4185

Pain, not elsewhere classified

813

4081

2.05

75.98

1.5

1.4

10.74

9.83

u/l

0.94

666

3290

Disorders of adult personality and behaviour

1154

6521

1.83

75.90

1.5

1.4

8.37

9.00

u/l

1.00

879

5364

Persons encountering health services in circumstances related to reproduction

1754

7275

1.65

75.80

1.6

8.60

8.50

u/l

0.12

1351

5757

Dorsalgia

2911

10569

1.48

75.10

1.4

9.70

9.24

u/l

1.03

2363

8485

Asthma (mode)

2074

6959

1.59

74.05

1.4

9.81

9.45

u/l

0.56

1667

5618

Nonorganic sleeping disorders, excluding more controls

752

3720

2.09

73.88

1.4

8.76

9.48

u/l

0.88

575

3080

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

349

1220

2.94

73.50

1.5

1.3

19.14

9.92

u/l

13.43

304

959

Other reaction to severe stress, and adjustment disorders

1297

7626

1.75

73.25

1.5

1.4

10.64

9.76

u/l

1.42

1045

6263

Other soft tissue disorders, not elsewhere classified

2766

10768

1.48

72.92

1.4

1.5

10.22

9.15

u/l

3.50

2228

8596

Testicular dysfunction, other/unspecified

15.94

72.46

2.1

1.6

5.69

4.88

u/l

0.40

Abnormal findings on diagnostic imaging of lung

834

4049

1.98

71.97

1.3

1.4

14.13

10.73

u/l

7.22

681

3199

Other headache syndromes

1126

6375

1.80

71.36

1.4

10.09

11.39

u/l

2.44

901

5211

KRA_PSY_EATING, excluding more controls

516

2243

2.45

70.51

1.7

1.3

7.73

8.98

u/l

1.48

409

1869

Polyp of the female genital tract

486

1080

2.60

70.51

1.2

1.3

14.89

17.66

u/l

2.25

404

858

Habitual aborter

120

201

6.71

70.28

1.2

7.12

12.47

u/l

3.78

156

Primary_lymphoid and hematopoietic malignant neoplasms

514

2222

2.37

70.16

2.1

1.4

11.46

9.66

u/l

1.76

395

1752

Other menopausal disorders

429

881

2.77

69.82

1.3

1.2

18.92

19.31

u/l

0.13

335

708

Other dorsopathies, not elsewhere classified

2934

10622

1.45

69.00

1.4

9.28

9.22

u/l

0.08

2402

8521

Abdominal and pelvic pain

2734

9432

1.47

68.72

1.5

9.04

8.88

u/l

0.26

2215

7529

Solid cancers, including Hilmo

2087

7961

1.55

68.33

1.7

1.4

13.42

9.45

u/l

22.01

1674

6412

Solid cancers

1971

7476

1.57

68.08

1.7

1.4

13.82

9.69

u/l

21.63

1571

6012

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1196

3385

1.81

67.65

1.5

1.4

8.61

7.99

u/l

0.88

944

2742

Acromegaly and pituitary gigantism

15.31

67.28

2.7

1.1

7.66

7.52

u/l

0.03

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1363

7998

1.67

66.63

1.5

1.4

9.30

9.83

u/l

0.75

1077

6447

Intestinal infectious diseases

2614

13519

1.46

66.37

1.5

1.4

9.44

9.62

u/l

0.28

2108

10824

Non-selective monoamine reuptake inhibitors

651

3030

2.10

65.78

1.4

1.3

11.51

12.69

u/l

1.05

507

2501

Short stature, not elsewhere classified

188

458

4.54

65.09

2.7

1.9

3.93

5.99

u/l

4.19

112

288

Delayed puberty

149

8.80

64.30

3.2

1.8

4.88

5.73

u/l

0.48

116

Acute upper respiratory infections

2648

11049

1.45

64.28

1.4

10.24

10.14

u/l

0.13

2169

8817

Symptoms and signs involving the digestive system and abdomen

2709

9432

1.46

64.24

1.5

9.25

8.88

u/l

0.74

2182

7529

Malignant neoplasm of urinary organs, including Hilmo

242

742

3.37

64.14

1.5

1.4

16.22

8.07

u/l

8.22

186

575

Substance abuse, excluding more controls

1480

7742

1.62

63.15

1.5

1.4

9.33

8.99

u/l

0.44

1121

6394

Any event in cancer register

2452

9859

1.47

63.05

1.7

1.4

12.37

9.17

u/l

18.43

1954

7991

Uterine polyps

432

999

2.57

62.29

1.2

1.3

15.75

18.27

u/l

1.74

356

797

Disorders of skin appendages

1572

10113

1.58

60.33

1.5

1.4

9.81

9.60

u/l

0.25

1287

8170

Asthma (only as main-diagnosis)

1880

6906

1.54

60.14

1.4

10.01

9.45

u/l

0.93

1520

5573

Asthma (only as main-diagnosis), excluding more controls

1869

6788

1.54

59.79

1.4

9.97

9.46

u/l

0.84

1512

5478

Use of hypnotics and sedatives

2639

10623

1.44

59.69

1.4

9.85

10.06

u/l

0.31

2078

8627

Dentofacial anomalies [including malocclusion]

2121

11359

1.48

59.55

1.5

1.4

10.24

9.98

u/l

0.37

1712

9161

Intestinal infectious diseases, including avohilmo, including avohilmo

2973

11911

1.40

59.27

1.4

9.94

9.81

u/l

0.19

2398

9535

Endocrine disorders, other/unspecified

100

166

6.79

59.21

1.7

1.3

11.32

9.14

u/l

0.60

132

Abnormalities of breathing

2557

10270

1.44

59.04

1.5

1.4

9.89

9.40

u/l

0.97

2076

8251

Non-small cell lung cancer, squamous

108

190

5.92

59.01

1.3

15.38

8.17

u/l

4.86

152

Osteopathies and chondropathies

1261

7076

1.65

58.94

1.5

10.80

10.48

u/l

0.32

1014

5672

Autoimmune diseases

3130

11520

1.39

58.57

1.4

1.5

9.47

8.95

u/l

1.21

2527

9195

Malignant neoplasm of urinary organs

212

639

3.44

57.86

1.6

1.4

16.64

7.98

u/l

7.83

168

499

Type 2 diabetes

2478

10052

1.44

57.84

1.4

9.27

10.44

u/l

4.85

2010

8247

Routine general health check-up of defined subpopulation

123

253

5.40

57.73

2.6

1.3

7.55

10.74

u/l

1.65

206

Fentanyl

189

534

3.63

56.57

1.4

15.99

11.07

u/l

2.61

155

427

Soft tissue disorders

2948

10910

1.40

56.53

1.5

9.08

9.10

u/l

0.03

2410

8703

Pain (limb, back, neck, head abdominally)

1927

6434

1.52

56.45

1.5

8.76

8.81

u/l

0.06

1543

5106

Continuous positive airway pressure

419

1496

2.39

56.28

1.4

1.5

8.22

9.46

u/l

1.16

323

1157

Antihypertensive medication - note that there are other indications

2356

8587

1.46

56.08

1.5

8.41

8.91

u/l

1.14

1917

6883

Glucagon-like peptide-1 (GLP-1) analogues

736

3962

1.90

55.98

1.4

8.30

11.18

u/l

9.87

590

3219

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

736

3962

1.90

55.98

1.4

8.30

11.18

u/l

9.87

590

3219

Ovarian hyperstimulation (induction)

128

284

5.26

55.84

1.2

1.3

9.07

13.19

u/l

2.66

112

226

Dental pulpitis, including avohilmo

2715

12519

1.41

55.71

1.4

9.58

9.51

u/l

0.09

2188

10133

Dorsopathies

2930

10742

1.40

55.42

1.5

9.15

9.18

u/l

0.04

2388

8593

Oedema, not elsewhere classified

659

3343

1.96

55.32

1.4

1.3

12.51

10.48

u/l

2.61

525

2679

Primary amenorrhea

101

192

7.51

55.13

2.5

1.5

7.73

8.44

u/l

0.28

147

Type 2 diabetes, definitions combined, including avohilmo

2302

9291

1.45

54.85

1.4

9.28

10.78

u/l

6.96

1862

7620

Diabetes insipidus

10.03

54.15

2.5

1.1

7.66

8.75

u/l

0.28

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

211

663

3.29

53.86

1.6

1.4

15.57

7.89

u/l

6.45

163

517

Persons encountering health services for specific procedures and health care

2937

12676

1.38

53.78

1.6

1.4

11.24

9.17

u/l

10.60

2351

10181

Type 2 diabetes, definitions combined

2260

9185

1.45

53.73

1.4

9.15

10.82

u/l

8.71

1832

7532

Menorrhagia

556

1463

2.15

53.62

1.2

1.3

14.16

14.91

u/l

0.43

466

1161

Type 2 diabetes, strict (exclude DM1)

2265

9217

1.45

53.50

1.4

9.14

10.85

u/l

9.05

1838

7559

Adenomyosis (Endometriosis of uterus)

223

725

3.15

53.32

1.2

1.3

14.34

18.75

u/l

3.30

199

573

Bacterial infection, other or unspecified

1060

5376

1.69

53.06

1.6

1.4

11.91

10.21

u/l

2.83

797

4287

Malignant neoplasm of kidney, except renal pelvis

197

600

3.40

52.97

1.6

1.4

15.98

7.86

u/l

6.55

155

473

Disease of hard tissues of teeth, NOS

1148

3607

1.69

52.62

1.4

9.63

9.61

u/l

0.01

915

2928

Hyperkinetic disorders, excluding more controls

714

3648

1.92

52.49

1.6

1.4

6.71

7.98

u/l

2.91

532

2976

L01XE Protein kinase inhibitors

141

346

4.31

52.37

1.6

1.3

14.80

10.18

u/l

2.16

119

274

Other (not insulin) diabetes medications

2304

9561

1.43

51.33

1.4

8.78

10.81

u/l

14.06

1863

7828

Secondary uncertain malignant neoplasm

270

1001

2.77

51.19

1.7

1.4

14.41

8.67

u/l

5.52

211

790

Symptoms and signs involving the nervous and musculoskeletal systems

1341

8676

1.57

51.00

1.6

1.4

11.24

10.36

u/l

1.36

1114

6930

Bacterial infection, other or unspecified, including avohilmo

1197

6135

1.62

50.95

1.6

1.4

11.58

9.95

u/l

3.04

908

4903

Drug-induced adrenocortical insufficiency

174

6.15

50.91

1.6

1.4

15.39

10.71

u/l

1.42

142

Hypertrophy of breast in women and men

523

2596

2.07

50.85

1.5

1.3

11.02

13.81

u/l

4.31

422

2114

Abnormalities of heart beat

870

4915

1.75

50.34

1.4

10.66

10.42

u/l

0.18

717

4002

Symptoms and signs concerning food and fluid intake

299

1179

2.62

50.18

1.8

1.5

8.93

9.09

u/l

0.08

252

907

Care involving use of rehabilitation procedures

1484

8838

1.53

49.85

1.6

1.4

10.16

9.98

u/l

0.18

1209

7042

Caries of enamel

2563

12194

1.39

49.61

1.5

1.4

9.85

9.67

u/l

0.26

1988

9917

Coxibs

743

2099

1.89

49.39

1.4

1.5

7.81

8.92

u/l

1.67

611

1670

Complications of medical and surgical care

1647

10034

1.49

49.29

1.5

1.4

11.76

10.75

u/l

1.87

1324

8122

Other pulmonary diagnosis

2016

6984

1.46

49.22

1.5

1.4

9.78

9.48

u/l

0.44

1624

5633

Other noninflammatory disorders of vulva and perineum

209

689

3.13

49.19

1.2

1.3

12.80

15.40

u/l

1.20

167

532

Other functional intestinal disorders

1037

5766

1.66

49.16

1.5

10.86

10.55

u/l

0.28

824

4533

Personality disorders

985

6014

1.69

48.93

1.4

9.06

9.08

u/l

0.02

737

4955

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

928

5496

1.71

48.92

1.3

9.66

9.35

u/l

0.31

716

4586

Eating disorder

519

2636

2.10

48.88

1.7

1.4

7.72

9.15

u/l

1.89

410

2143

Low back pain

2128

10162

1.43

48.74

1.4

10.40

9.38

u/l

2.67

1741

8183

Anorexia (incl.atypical)

324

1365

2.55

48.74

1.8

1.4

6.25

9.23

u/l

7.33

253

1106

Rare circulating lymphoid malignancy, including Hilmo

121

282

4.67

48.58

3.0

1.6

7.50

7.33

u/l

0.06

215

Other diseases of intestines

2998

12455

1.36

48.03

1.4

1.5

9.98

9.25

u/l

2.05

2399

9993

Biguanides

2183

9363

1.42

47.64

1.4

8.70

10.96

u/l

16.66

1771

7654

ILD differential diagnosis

1999

6959

1.46

47.59

1.5

1.4

10.11

9.45

u/l

1.26

1604

5618

474

2333

2.10

47.53

1.6

1.4

10.79

9.53

u/l

0.98

369

1895

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1298

8300

1.55

47.43

1.5

1.4

11.61

11.10

u/l

0.58

1041

6701

COPD differential diagnosis

1999

6965

1.45

47.40

1.5

1.4

10.11

9.45

u/l

1.25

1605

5620

Excluding asthma or asthma-COPD overlap

2003

6984

1.45

47.29

1.5

1.4

10.05

9.48

u/l

1.02

1612

5633

Exposure to unspecified factor

2702

13600

1.37

47.11

1.5

1.4

9.15

9.71

u/l

1.39

2113

10959

Lower back pain or/and sciatica

2788

12871

1.36

46.72

1.4

10.40

9.63

u/l

2.09

2274

10396

Mouth breathing

971

5950

1.66

46.61

1.5

7.60

9.09

u/l

4.42

785

4671

Eating disorders

540

2824

2.01

46.34

1.7

1.4

7.75

9.14

u/l

1.86

424

2290

Specific personality disorders

864

5181

1.72

46.12

1.4

9.06

9.25

u/l

0.16

640

4259

Diarrhoea and gastroenteritis of presumed infectious origin

1961

12433

1.43

45.98

1.6

1.4

9.26

9.35

u/l

0.12

1585

9977

Chronic diseases of tonsils and adenoids

2192

9918

1.41

45.92

1.4

1.5

9.61

9.58

u/l

0.04

1789

7950

Non-small cell lung cancer, squamous, helper endpoint

108

238

4.71

45.79

1.3

15.38

8.95

u/l

4.01

188

Substance use, excluding alcohol

679

3815

1.84

45.66

1.5

8.98

8.07

u/l

0.99

491

3129

Isolated growth hormone deficiency

222

6.64

45.65

3.3

2.4

4.26

5.15

u/l

0.76

129

Supervision of high-risk pregnancy

701

2323

1.87

45.56

1.2

1.4

11.36

13.02

u/l

2.32

628

1820

ILD medications

3063

12452

1.34

45.13

1.5

1.4

10.09

9.14

u/l

3.20

2481

9942

Other diseases of blood and blood-forming organs, wide

500

2549

2.01

45.00

1.7

1.4

10.74

10.51

u/l

0.12

399

2020

Other joint disorders

2717

10501

1.37

44.98

1.5

8.94

9.13

u/l

0.34

2212

8386

Nausea and vomiting

679

3726

1.81

44.58

1.6

1.5

10.98

9.34

u/l

1.79

533

2872

Viral hepatitis, IBD co-morbidity

210

740

2.99

44.52

1.5

8.02

8.66

u/l

0.31

146

603

Other diseases of upper respiratory tract

2697

10411

1.36

44.41

1.5

9.85

9.64

u/l

0.32

2163

8313

Hodgkin lymphoma, hilmo

142

403

3.89

43.89

1.8

1.5

12.61

8.05

u/l

2.30

109

326

Hypothyroidism, drug reimbursement

383

1211

2.27

43.75

1.4

1.3

14.25

9.75

u/l

4.68

306

1014

Asthma, hospital admission 2, infections

1510

10086

1.48

43.58

1.5

9.53

9.85

u/l

0.43

1190

8093

Asthma-related infections

1510

10086

1.48

43.58

1.5

9.53

9.85

u/l

0.43

1190

8093

Migraine, single triptan purchase ok & required. ICD-code if available is included

2192

10774

1.40

43.55

1.4

1.5

10.56

9.72

u/l

2.01

1824

8656

Triptan medication for migraine, single purchase ok

2192

10774

1.40

43.55

1.4

1.5

10.56

9.72

u/l

2.01

1824

8656

Other abnormal uterine and vaginal bleeding

336

1035

2.37

43.46

1.3

14.74

16.97

u/l

1.31

268

820

Nonorganic sleeping disorders

752

4415

1.75

43.38

1.4

8.76

9.54

u/l

1.01

575

3583

Symptoms and signs involving the skin and subcutaneous tissue

1732

11494

1.44

43.32

1.4

10.96

10.34

u/l

1.06

1400

9239

Irritable bowel syndrome

730

4242

1.76

43.19

1.4

10.34

10.91

u/l

0.48

581

3442

Visual disturbances and blindness

1191

7791

1.55

43.08

1.6

1.4

10.23

10.35

u/l

0.10

927

6255

Disorders of parathyroid gland

270

1074

2.53

43.01

1.5

1.3

14.29

14.35

u/l

0.02

222

861

Sciatica+with lumbago

1201

6950

1.55

42.98

1.4

11.00

10.46

u/l

0.62

977

5650

Ovarian dysfunction, other/unspecified

9.73

42.79

1.5

1.2

19.91

8.99

u/l

4.20

Diseases of the musculoskeletal system and connective tissue

1793

6258

1.46

42.73

1.5

8.43

8.52

u/l

0.11

1444

4933

Cushing syndrome

8.04

42.66

2.6

1.3

11.61

11.15

u/l

0.07

1267

8373

1.53

42.46

1.5

9.39

9.54

u/l

0.15

1003

6715

Acute lymphocytic leukaemia

140

7.26

42.25

3.4

1.9

6.39

7.99

u/l

0.58

110

Acute lymphocytic leukaemia, helper endpoint

140

7.26

42.25

3.4

1.9

6.39

7.99

u/l

0.58

110

Acute lymphocytic leukaemia, including Hilmo

140

7.26

42.25

3.4

1.9

6.39

7.99

u/l

0.58

110

Diseases of the skin and subcutaneous tissue

2579

9591

1.36

42.17

1.5

1.4

9.02

9.41

u/l

0.83

2064

7699

Somatoform disorder

456

2312

2.03

41.96

1.4

10.28

10.56

u/l

0.16

356

1890

Polyuria

452

2280

2.02

41.84

1.4

8.60

9.73

u/l

1.40

351

1827

Diabetes mellitus

2651

11458

1.35

41.79

1.4

9.20

10.01

u/l

2.71

2139

9241

Diabetes, varying definitions

2631

11408

1.35

41.72

1.4

9.19

10.03

u/l

2.90

2123

9198

Other disorders of fluid, electrolyte and acid-base balance

529

2639

1.92

41.70

1.6

1.4

12.55

11.10

u/l

1.16

423

2125

Metabolic disorders

2179

9504

1.39

41.54

1.6

1.4

10.33

10.26

u/l

0.08

1719

7684

Certain infectious and parasitic diseases

2561

9537

1.36

41.08

1.5

1.4

10.02

9.48

u/l

1.19

2055

7691

Chronic rhinitis, nasopharyngitis and pharyngitis

837

5120

1.67

40.76

1.4

9.71

10.66

u/l

1.17

649

4097

Myalgia

655

3755

1.78

40.76

1.5

1.4

11.56

10.67

u/l

0.70

512

3023

Gastrointestinal diseases

1886

6702

1.43

40.60

1.5

1.4

9.13

8.75

u/l

0.63

1522

5351

Implicit viral Sepsis, including avohilmo

652

3722

1.78

40.57

1.5

1.4

9.73

9.94

u/l

0.15

508

2953

Persistent mood disorders

499

2642

1.94

40.30

1.4

10.25

9.98

u/l

0.16

389

2151

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1175

7762

1.53

40.22

1.5

1.4

11.45

11.27

u/l

0.15

946

6264

Pregnancy examination and test

645

2245

1.85

40.20

1.3

1.4

10.64

11.89

u/l

1.47

541

1772

Asthma, including avohilmo

3083

13037

1.31

40.17

1.4

9.34

9.60

u/l

0.50

2471

10462

Secondary and unspecified malignant neoplasm of lymph nodes

198

712

2.88

40.13

1.7

1.4

11.83

8.28

u/l

2.32

150

576

Complications of procedures, not elsewhere classified

1878

10891

1.40

39.98

1.5

1.4

11.17

10.15

u/l

2.36

1534

8824

Visual disturbances

1118

7345

1.54

39.96

1.6

1.4

10.42

10.34

u/l

0.06

871

5898

Non-seminoma of testis

17.24

39.95

3.2

1.5

6.68

4.25

u/l

1.60

Mycoses, including avohilmo

2406

13717

1.35

39.62

1.4

9.73

9.64

u/l

0.12

1908

11069

COPD/asthma related infections

2503

9342

1.35

39.53

1.4

10.34

10.00

u/l

0.55

2041

7482

COPD/asthma/ILD related infections

2503

9342

1.35

39.53

1.4

10.34

10.00

u/l

0.55

2041

7482

Hypoparathyroidism

206

4.76

39.44

1.5

1.3

14.49

11.89

u/l

0.58

160

Enlarged lymph nodes

413

2070

2.05

39.17

1.6

1.4

11.53

9.25

u/l

2.37

324

1634

Pain in throat and chest

2221

9688

1.37

39.02

1.5

1.4

9.80

9.50

u/l

0.47

1788

7792

Symptoms and signs involving the urinary system

1573

8312

1.44

38.68

1.4

10.44

9.91

u/l

0.74

1257

6657

Generalized anxiety disorder

690

4092

1.74

38.48

1.4

9.31

8.79

u/l

0.43

513

3368

Triptan medication for migraine, min. 3 purchases

1741

9314

1.42

38.40

1.3

1.4

11.31

10.66

u/l

1.06

1450

7563

Spondylosis

919

4516

1.61

38.05

1.4

12.47

11.58

u/l

0.85

727

3632

Dysphagia

468

2466

1.93

38.05

1.4

12.03

10.76

u/l

1.00

375

1971

Lumbar disc prolapse

1462

7513

1.46

37.91

1.4

9.78

10.05

u/l

0.31

1202

6105

Deviated nasal septum

754

4577

1.67

37.68

1.4

7.82

8.41

u/l

0.72

591

3671

Pain in limb

2196

10344

1.36

37.67

1.4

10.70

9.30

u/l

4.46

1773

8261

ILD medications: prednisolone, methylprednisolone, prednisone

2829

12047

1.32

37.65

1.5

1.4

10.47

9.21

u/l

4.75

2307

9650

Diabetes medication

2617

11604

1.33

37.52

1.4

9.00

10.10

u/l

4.88

2108

9361

Disorders of pituitary gland, other and/or unspecified

10.30

37.01

2.3

1.2

4.90

7.82

u/l

1.15

Hernia of abdominal wall, postoperative

368

1788

2.08

37.01

1.4

1.3

9.74

9.04

u/l

0.50

299

1417

Mental and behavioural disorders due to sedatives or hypnotics

263

1138

2.44

36.97

1.5

8.22

8.20

u/l

0.01

177

918

Infections of the skin and subcutaneous tissue

1630

11506

1.41

36.77

1.6

1.5

8.86

9.02

u/l

0.19

1304

9243

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2158

9342

1.36

36.59

1.5

1.4

10.49

10.00

u/l

0.82

1697

7482

2158

9342

1.36

36.59

1.5

1.4

10.49

10.00

u/l

0.82

1697

7482

Other specific joint derangements/joint disorders

2215

10297

1.36

36.51

1.4

10.08

9.18

u/l

2.42

1820

8244

Haemorrhage from respiratory passages

620

3169

1.75

36.50

1.5

10.82

9.71

u/l

1.12

470

2487

Infections, IBD-co-morbidities

373

1265

2.12

36.45

1.6

1.5

11.53

10.51

u/l

0.64

308

997

Inflammatory diseases of prostate (prostatitis)

305

1408

2.23

36.07

1.5

6.34

5.98

u/l

0.36

245

1127

Any operation in hilmo

133

177

3.96

36.04

1.6

1.3

6.58

6.02

u/l

0.24

106

134

Postprocedural endocrine and metabolic disorders, not elsewhere classified

328

1561

2.17

35.95

2.1

1.3

14.40

12.55

u/l

1.03

263

1288

Other diseases of hard tissues of teeth

1077

3623

1.56

35.89

1.4

9.22

9.66

u/l

0.48

860

2937

Bipolar affective disorders

617

3625

1.75

35.57

1.4

8.91

9.36

u/l

0.41

483

2983

Other metabolic disorders

352

1727

2.10

35.57

2.1

1.3

13.88

12.15

u/l

1.02

282

1407

2692

10440

1.32

35.50

1.4

10.45

10.08

u/l

0.62

2208

8333

Sexual dysfunction

107

291

4.11

35.45

1.6

1.4

6.48

6.94

u/l

0.19

243

Other intervertebral disc disorders

1896

8251

1.38

35.41

1.4

10.42

9.83

u/l

1.02

1551

6702

Other sleep disorders

297

1369

2.24

35.32

1.4

9.30

10.16

u/l

0.54

239

1090

Premenstrual syndrome

124

5.90

35.32

1.3

1.2

8.36

11.12

u/l

0.83

Panic disorder

584

3394

1.78

35.29

1.4

8.87

9.02

u/l

0.10

451

2801

Poisoning by drugs, medicaments and biological substances

789

4959

1.63

34.96

1.4

9.79

8.94

u/l

0.93

589

4033

Molar incisor enamel hypoplasia, with caries

262

4.93

34.88

3.7

2.4

4.89

4.53

u/l

0.16

136

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1880

12687

1.37

34.47

1.6

1.4

9.98

9.47

u/l

0.84

1501

10224

Other symptoms and signs involving the nervous and musculoskeletal systems

975

6428

1.54

34.40

1.5

1.4

11.54

10.17

u/l

2.03

819

5127

Gestational diabetes (for exclusion)

1320

6315

1.47

34.24

1.2

1.3

10.40

12.08

u/l

4.24

1107

5163

Other/unspecified dorsalgia

847

5350

1.59

34.15

1.4

11.23

10.39

u/l

0.87

671

4328

Exposure to other specified factors

2149

13937

1.34

34.07

1.4

8.70

9.68

u/l

3.50

1706

11217

Transport accidents

1326

7716

1.45

33.89

1.5

1.4

8.68

9.63

u/l

2.16

1067

6263

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1116

6646

1.51

33.65

1.6

1.5

7.03

7.92

u/l

2.46

840

5322

Acute sinusitis

1462

9498

1.42

33.45

1.5

1.4

9.52

9.92

u/l

0.57

1201

7640

Mental and behavioural disorders due to psychoactive substance use

1534

10122

1.41

33.44

1.4

1.5

9.36

8.45

u/l

1.98

1164

8240

Acetic acid derivatives and related substances

657

1985

1.74

33.43

1.4

8.27

9.05

u/l

0.87

541

1580

Cardiovascular diseases

2261

9071

1.34

33.40

1.5

1.4

8.71

8.69

u/l

0.02

1831

7266

Viral Sepsis

445

2412

1.88

33.36

1.5

1.4

9.34

9.45

u/l

0.06

353

1900

Hypo-osmolality and hyponatraemia

276

1248

2.23

33.35

1.6

1.4

13.13

10.84

u/l

1.36

219

993

Mental and behavioural disorders due to opioids

207

851

2.64

33.27

1.6

1.4

7.25

7.22

u/l

0.01

137

691

Implicit viral Sepsis

444

2409

1.88

33.18

1.5

1.4

9.33

9.43

u/l

0.06

352

1897

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2299

11802

1.32

33.04

1.6

1.4

11.26

9.80

u/l

4.57

1816

9508

Injuries to the wrist and hand

2608

13398

1.30

32.98

1.5

1.4

9.14

9.80

u/l

1.83

2098

10747

Other disorders of lacrimal gland

721

4487

1.63

32.74

1.5

1.4

13.58

12.05

u/l

1.44

558

3649

Nerve, nerve root and plexus disorders

2458

11333

1.31

32.69

1.4

10.73

9.88

u/l

2.22

2015

9217

Non-Hodgkin lymphoma, all, including Hilmo

216

896

2.46

32.65

1.7

1.4

10.97

8.73

u/l

1.70

180

701

Chronic sinusitis

972

6470

1.52

32.55

1.4

10.38

10.67

u/l

0.24

780

5263

Substance abuse

1480

9906

1.40

32.34

1.5

9.33

8.36

u/l

2.10

1121

8064

Disorders of thyroid, IBD co-morbidities

510

1953

1.82

32.33

1.5

1.3

11.83

9.71

u/l

2.53

411

1564

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

9.88

32.28

3.0

1.6

14.10

3.67

u/l

6.41

Other bacterial diseases

2077

10358

1.34

32.24

1.7

1.4

10.63

9.83

u/l

1.63

1614

8343

Disorders of lacrimal system

855

5460

1.56

32.20

1.5

1.4

13.12

12.02

u/l

1.05

671

4427

Cervical disc disorders

625

3767

1.68

32.16

1.4

11.11

11.43

u/l

0.21

503

3032

Certain infectious and parasitic diseases, including avohilmo

1748

6378

1.39

32.08

1.5

1.4

9.84

9.65

u/l

0.22

1392

5169

Injuries to the ankle and foot

2066

13381

1.33

32.00

1.4

1.5

9.55

9.45

u/l

0.12

1676

10743

Emotionally unstable personality disorder

518

3005

1.79

31.80

1.4

9.63

9.42

u/l

0.13

370

2470

Other eating disorders

292

1416

2.21

31.64

1.7

1.5

7.22

9.11

u/l

2.02

238

1136

Lymphoid leukaemia

143

493

3.03

31.58

2.8

1.6

8.43

8.26

u/l

0.06

104

380

Gastro-oesophageal reflux disease

1444

8746

1.41

31.57

1.5

1.4

10.70

10.57

u/l

0.13

1140

7038

Asthma, unspecified (mode)

1199

6001

1.46

31.14

1.4

10.92

9.97

u/l

1.39

947

4854

Vasomotor and allergic rhinitis

1127

7647

1.46

30.82

1.5

9.33

9.74

u/l

0.50

901

6100

Clear cell adenocarcinoma of kidney

105

305

3.59

30.72

1.4

1.3

15.04

7.09

u/l

4.54

246

Cough

883

5441

1.53

30.58

1.5

10.62

10.72

u/l

0.06

691

4331

Poisoning by medicine

712

4515

1.62

30.50

1.4

9.78

8.92

u/l

0.90

539

3658

Asthma, unspecified (mode), excluding more controls

1190

5926

1.45

30.33

1.4

10.91

9.96

u/l

1.40

941

4792

Hypoplasia of dental enamel

100

301

4.32

30.17

3.9

2.6

4.30

4.26

u/l

0.02

161

Dermatitis and eczema

2784

13001

1.28

30.00

1.5

1.4

9.99

9.57

u/l

0.85

2248

10421

Cervicalgia

429

2378

1.84

29.96

1.4

11.05

11.46

u/l

0.23

351

1915

Gingivitis and periodontal diseases

2268

8977

1.32

29.79

1.4

9.61

9.70

u/l

0.12

1799

7188

Other obstetric conditions, not elsewhere classified

1312

5895

1.44

29.70

1.2

1.3

10.28

11.31

u/l

1.95

1097

4820

Tonsillectomy and adenotomy

1989

10526

1.33

29.70

1.5

8.84

9.38

u/l

1.17

1648

8418

Asthma-related pneumonia

708

4477

1.60

29.63

1.5

9.93

10.12

u/l

0.13

547

3543

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1304

5853

1.44

29.42

1.2

1.3

10.19

11.18

u/l

1.82

1089

4786

Cystitis

1951

8759

1.34

29.37

1.3

1.4

11.97

10.65

u/l

3.20

1535

7107

Arthropathies

2661

10549

1.29

29.32

1.5

8.76

9.12

u/l

0.81

2167

8399

Asthma, hospital admissions 3, pneumonia

709

4500

1.59

29.21

1.5

9.96

10.10

u/l

0.10

548

3559

Asthma-related pneumonia or sepsis

709

4500

1.59

29.21

1.5

9.96

10.10

u/l

0.10

548

3559

Certain disorders involving the immune mechanism

436

2452

1.82

29.21

1.9

1.4

10.58

9.89

u/l

0.41

347

1950

Excessive attrition of teeth

1645

12147

1.36

29.17

1.4

10.13

9.85

u/l

0.35

1318

9812

Complications of surgical and medical care, not elsewhere classified

2292

11841

1.30

29.16

1.5

1.4

11.25

9.85

u/l

4.67

1871

9559

Constipation

1832

9324

1.34

29.07

1.4

11.12

10.74

u/l

0.47

1396

7472

Other disorders of male genital organs

151

565

2.83

28.97

2.0

1.6

5.85

5.08

u/l

0.84

123

459

Migraine without aura

720

4644

1.59

28.66

1.4

10.95

10.46

u/l

0.40

569

3754

Hyperhidrosis

135

482

2.98

28.37

1.5

1.4

10.86

9.44

u/l

0.62

109

401

Other maternal disorders predominantly related to pregnancy

1342

6026

1.41

28.35

1.3

12.65

13.28

u/l

0.77

1131

4876

Conjunctivitis (acute, non atopic), including avohilmo

2501

11848

1.28

28.32

1.4

9.71

9.44

u/l

0.45

2003

9552

Inflammatory bowel disease treatment related agents

2904

12846

1.26

28.25

1.5

1.4

10.48

9.29

u/l

4.50

2350

10290

Spinal stenosis

671

3093

1.61

28.24

1.4

12.35

11.87

u/l

0.32

542

2462

Aplastic and other anaemias

709

4148

1.58

28.22

1.6

1.4

13.54

10.46

u/l

4.80

568

3289

Diseases of the eye and adnexa

2426

9474

1.30

28.19

1.5

1.4

8.98

8.90

u/l

0.10

1939

7666

Precocious central puberty

112

6.21

28.17

3.7

1.5

6.33

7.88

u/l

0.63

Concussion

1320

7381

1.40

27.99

1.5

1.4

8.99

9.50

u/l

0.79

1032

5901

Other noninflammatory disorders of uterus, except cervix

208

581

2.42

27.98

1.2

1.3

14.49

22.89

u/l

9.41

173

463

Spontaneous abortion

1123

5256

1.45

27.95

1.2

1.3

11.41

12.63

u/l

2.06

931

4307

Diseases of the ear and mastoid process

2974

11910

1.26

27.94

1.5

1.4

9.37

9.69

u/l

0.64

2368

9606

Hypertensive diseases (excluding secondary)

1405

5927

1.40

27.58

1.5

1.4

9.81

9.89

u/l

0.08

1143

4793

Endometriosis of rectovaginal septum and vagina

125

430

2.98

27.49

1.2

1.3

11.64

16.54

u/l

2.88

106

336

Type 2 diabetes, wide definition

1379

6292

1.39

27.48

1.4

9.14

11.27

u/l

7.57

1070

5140

Disturbance of activity and attention

703

4466

1.59

27.48

1.6

6.57

7.86

u/l

3.20

522

3560

Fibromyalgia

251

1199

2.16

27.45

1.3

14.64

12.99

u/l

0.70

202

974

Benign neoplasm of colon, rectum, anus and anal canal

915

5249

1.49

27.21

1.4

1.3

11.63

11.49

u/l

0.10

738

4204

Other problems related to primary support group, including family circumstances

459

2619

1.77

27.04

2.0

1.5

9.23

9.07

u/l

0.10

349

2031

Other and unspecified anaemias

638

3784

1.60

26.87

1.5

1.4

13.82

10.59

u/l

4.51

504

3000

Influenza and pneumonia

2698

13271

1.26

26.86

1.5

1.4

9.93

9.53

u/l

0.76

2141

10673

Spondylopathies

1481

6424

1.37

26.86

1.4

11.43

10.44

u/l

1.62

1196

5186

Rotator cuff syndrome

1085

5225

1.44

26.74

1.4

10.69

10.99

u/l

0.29

918

4209

Other diseases of blood and blood-forming organs

164

662

2.57

26.66

1.6

1.4

8.52

9.09

u/l

0.24

123

542

Diseases of oral cavity, salivary glands and jaws

1027

3626

1.47

26.64

1.4

9.15

9.66

u/l

0.57

820

2940

Malignant neoplasm of skin, including Hilmo

705

3020

1.58

26.59

1.4

1.3

13.51

10.69

u/l

4.87

568

2377

Monoamine oxidase A inhibitors

223

1027

2.22

26.58

1.4

1.3

8.72

11.61

u/l

2.65

170

845

Atopic dermatitis

1780

10806

1.33

26.51

1.5

1.4

9.31

9.76

u/l

0.71

1415

8670

Psychotic depression

169

694

2.52

26.51

1.6

1.4

9.31

9.68

u/l

0.12

141

580

Secondary polycythaemia

245

3.76

26.30

1.8

1.4

6.22

7.79

u/l

0.76

197

Other anaemias

641

3814

1.59

26.29

1.6

1.4

13.78

10.58

u/l

4.49

507

3027

Dental operations

1089

3893

1.45

26.23

1.4

9.46

9.82

u/l

0.39

877

3132

Disorders of tooth development and eruption

475

2277

1.73

26.23

1.5

1.4

9.19

9.11

u/l

0.04

372

1839

Hyperkinetic disorders

732

4743

1.56

26.03

1.6

6.67

7.75

u/l

2.40

538

3759

Asthma, hospital admissions , main diagnosis only

2010

13589

1.30

25.98

1.5

1.4

9.85

9.79

u/l

0.08

1605

10900

Disturbances of skin sensation

733

4845

1.54

25.93

1.4

10.23

10.32

u/l

0.06

588

3917

Congenital malformations, deformations and chromosomal abnormalities

1706

12339

1.33

25.87

1.6

1.4

9.99

9.42

u/l

0.93

1355

9941

Covid-19 confirmed case

783

5236

1.51

25.80

1.5

1.4

11.26

9.57

u/l

2.26

623

4198

Polyneuropathies and other disorders of the peripheral nervous system

373

2080

1.82

25.60

1.6

1.4

12.21

9.75

u/l

1.99

280

1656

Drug-induced osteoporosis with pathological fracture

5.64

25.55

1.4

17.18

10.80

u/l

0.96

Osteoporosis with pathological fracture (FG)

232

3.65

25.55

1.4

1.3

21.45

20.95

u/l

0.06

184

Pain in thoracic spine

368

2052

1.83

25.43

1.4

10.17

10.91

u/l

0.49

303

1642

Other abnormal products of conception

1044

4819

1.45

25.33

1.2

1.3

10.76

11.96

u/l

1.99

889

3945

Other bacterial diseases, including avohilmo

2376

11742

1.27

25.15

1.6

1.4

10.42

9.76

u/l

1.37

1862

9460

Benign neoplasm: Colon

742

4620

1.52

25.08

1.4

11.64

11.51

u/l

0.08

595

3696

Vocal cord dysfunction

312

1449

1.93

25.03

1.4

13.01

11.08

u/l

1.17

248

1172

Pneumonia, organism unspecified

2165

11664

1.28

24.81

1.5

1.4

10.27

9.69

u/l

1.06

1690

9383

Weight loss

228

1091

2.15

24.81

1.7

1.6

9.75

9.55

u/l

0.08

194

852

Oxicams

423

1358

1.79

24.80

1.4

8.77

9.77

u/l

0.91

354

1102

Disorders of puberty, other/unspecified

7.57

24.77

3.9

1.9

4.93

6.09

u/l

0.36

Other septicaemia, including avohilmo

656

3993

1.56

24.76

1.9

1.4

11.46

9.88

u/l

1.79

508

3135

Shoulder lesions

1468

6538

1.36

24.62

1.4

10.75

10.41

u/l

0.40

1207

5286

Hypertension, essential

1685

7220

1.33

24.53

1.5

1.4

10.10

10.73

u/l

0.98

1368

5902

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2252

13895

1.27

24.50

1.5

1.4

9.61

9.66

u/l

0.07

1801

11153

Other septicaemia

635

3867

1.56

24.44

1.9

1.4

11.48

9.89

u/l

1.73

487

3043

Disorders of mineral metabolism

186

825

2.32

24.44

1.7

1.4

11.74

10.18

u/l

0.59

148

663

Transplanted organ and tissue status

259

1311

2.04

24.31

2.1

1.5

12.37

7.94

u/l

3.44

211

1010

Non-invasive ventilation

533

2850

1.64

24.30

1.5

1.4

9.56

10.08

u/l

0.38

471

2346

Convulsions, not elsewhere classified

629

4035

1.57

24.06

1.6

1.5

9.00

8.04

u/l

1.06

477

3204

Intracranial trauma

1492

7568

1.34

24.01

1.5

1.4

8.89

9.45

u/l

0.98

1173

6044

Malignant neoplasm of skin

634

2749

1.57

23.85

1.4

1.3

13.48

10.68

u/l

4.38

509

2161

Follow-up examination after treatment for malignant neoplasms

130

493

2.68

23.76

1.4

1.3

14.43

14.08

u/l

0.08

111

403

Inflammatory diseases of female pelvic organs

1448

7426

1.35

23.71

1.3

13.16

12.63

u/l

0.59

1178

6087

Follow-up examination after treatment for conditions other than malignant neoplasms

934

4328

1.45

23.70

1.3

11.79

9.80

u/l

3.64

756

3490

Diabetes mellitus in pregnancy

1156

5322

1.41

23.70

1.2

1.3

10.83

12.04

u/l

2.12

967

4301

Other and unspecified iron deficiency

660

4334

1.54

23.66

1.4

11.20

10.63

u/l

0.39

511

3459

Schizophrenia or delusion, excluding more controls

729

4842

1.51

23.59

1.4

8.47

8.87

u/l

0.42

536

4000

Thyroiditis, ILD-related definition

314

1712

1.89

23.57

1.6

1.4

12.94

11.36

u/l

0.86

247

1379

Redundant prepuce, phimosis and paraphimosis

541

3362

1.61

23.47

1.7

1.6

4.89

5.10

u/l

0.49

430

2688

Oral corticosteroids

2527

11898

1.25

23.45

1.5

1.4

11.17

9.47

u/l

6.97

2066

9598

Chromosomal abnormalities, not elsewhere classified

129

505

2.83

23.31

2.8

1.9

9.68

7.65

u/l

1.10

349

Iron deficiency anaemia

780

5223

1.48

23.22

1.4

11.69

10.85

u/l

0.74

608

4183

malignant neoplasm of female genital organs, including Hilmo

176

738

2.30

23.06

1.5

1.3

24.75

16.77

u/l

6.07

154

590

Malignant neoplasm of bladder, including Hilmo

154

634

2.44

23.02

1.4

1.3

12.68

8.03

u/l

4.09

126

497

Diseases of the respiratory system

1487

5583

1.35

23.00

1.5

1.4

10.00

9.82

u/l

0.18

1192

4473

Chronic lower respiratory diseases

3024

13050

1.23

22.82

1.4

9.58

9.53

u/l

0.06

2418

10493

Post-traumatic stress disorder

375

2191

1.78

22.67

1.4

9.38

9.15

u/l

0.13

296

1793

Other disorders of penis

252

1295

2.00

22.57

1.7

1.6

5.61

5.52

u/l

0.07

200

1005

Speech and linguistic disorders, excluding more controls

335

1773

1.84

22.55

2.1

1.6

7.30

7.62

u/l

0.20

239

1381

Other symptoms and signs involving the digestive system and abdomen

314

1729

1.85

22.55

1.6

1.4

13.13

12.08

u/l

0.57

250

1372

Carpal tunnel syndrome

1122

7094

1.38

22.52

1.4

1.3

11.76

11.55

u/l

0.18

947

5767

Use of pramipexole

327

1824

1.82

22.45

1.4

1.3

10.66

11.98

u/l

0.79

258

1478

Internal derangement of knee

832

5741

1.45

22.36

1.4

9.26

10.15

u/l

1.32

668

4637

Other extrapyramidal and movement disorders in other diseases

435

2632

1.68

22.35

1.5

1.4

10.54

11.24

u/l

0.46

345

2120

Hyperparathyroidism

190

871

2.18

22.12

1.5

1.3

14.75

14.60

u/l

0.04

159

693

Primary adrenocortical insufficiency

130

4.71

22.10

1.6

1.3

17.81

10.59

u/l

1.61

105

Hyperplasia of prostate

652

2400

1.55

21.89

1.4

6.16

6.23

u/l

0.10

512

1940

Haemorrhoids and perianal venous thrombosis

577

3724

1.55

21.83

1.4

10.56

10.46

u/l

0.06

485

2997

Unspecified haematuria

698

3825

1.50

21.75

1.4

11.61

9.27

u/l

3.84

566

3024

Radiculopathy

251

1301

1.96

21.72

1.4

1.3

12.45

11.87

u/l

0.24

200

1055

Unspecified mental disorder

1050

7668

1.39

21.68

1.4

8.93

8.96

u/l

0.03

813

6250

Chronic laryngitis and laryngotracheitis

259

1360

1.94

21.66

1.4

1.3

12.66

11.71

u/l

0.46

210

1116

Restless leg syndrome

287

1562

1.88

21.53

1.4

10.23

11.54

u/l

0.78

222

1275

Other and unspecified polyneuropathies, also in other diseases

308

1712

1.83

21.47

1.4

12.98

9.65

u/l

2.77

232

1368

Postmenopausal bleeding

222

547

2.14

21.46

1.2

1.3

28.31

25.04

u/l

1.27

185

438

Disorders of lipoprotein metabolism and other lipidaemias

1445

6659

1.33

21.31

1.5

1.4

9.34

10.73

u/l

3.29

1132

5424

Disorders of ocular muscles, binocular movement, accommodation and refraction

1285

9618

1.34

21.25

1.6

1.4

9.69

9.88

u/l

0.14

1010

7703

Other symptoms and signs involving cognitive functions and awareness

732

4441

1.47

21.19

1.4

10.38

10.92

u/l

0.48

568

3544

Migraine without aura and triptan purchases

589

3898

1.55

21.13

1.4

11.27

10.28

u/l

0.88

468

3158

Endometriosis of intestine

142

4.28

21.07

1.2

1.3

7.73

11.09

u/l

1.18

109

112

428

2.82

21.02

1.4

1.3

10.23

9.91

u/l

0.10

102

349

Viral infections characterized by skin and mucous membrane lesions

988

7174

1.39

21.00

1.6

1.5

8.80

9.35

u/l

0.68

796

5687

Persons with potential health hazards related to communicable diseases

1279

9598

1.34

20.99

1.5

8.72

8.93

u/l

0.26

1067

7673

Nutritional anaemias

852

5741

1.43

20.98

1.4

11.98

11.02

u/l

0.94

666

4591

Mixed and other personality disorders

264

1420

1.93

20.95

1.5

1.4

8.46

9.25

u/l

0.44

199

1171

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

534

3466

1.58

20.93

1.4

9.93

8.86

u/l

0.98

395

2818

Central nervous system disorder causing precocious puberty

7.44

20.93

4.3

2.1

5.22

7.13

u/l

0.70

Acne, including avohilmo

1040

6172

1.40

20.93

1.5

7.63

7.89

u/l

0.39

817

4990

Asthma (diagnoses ohter than nonallergic)

2081

13463

1.26

20.87

1.5

1.4

10.05

9.83

u/l

0.31

1649

10803

Septicaemia

709

4418

1.48

20.80

1.9

1.4

11.33

9.72

u/l

2.01

545

3457

Other diseases of urinary system

2291

10350

1.25

20.80

1.4

10.76

9.77

u/l

2.64

1812

8406

Pneumonias (Asthma/COPD co-morbidities)

2462

13086

1.24

20.66

1.5

1.4

10.00

9.58

u/l

0.76

1942

10530

Diseases of salivary glands

696

4769

1.48

20.63

1.4

11.49

10.61

u/l

0.81

563

3850

Visual field defects

167

762

2.25

20.57

2.1

1.4

9.78

10.03

u/l

0.08

125

620

Benign neoplasm of meninges

150

653

2.34

20.55

1.7

1.3

11.80

14.66

u/l

1.37

120

525

Anomalies of dental arch relationship, including avohilmo

659

4045

1.51

20.54

1.7

1.5

8.60

9.14

u/l

0.55

518

3210

Disorders of adrenal gland, other and/or unspecified

8.64

20.50

1.8

1.2

11.09

9.36

u/l

0.14

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

928

6719

1.41

20.48

1.3

1.4

9.66

9.34

u/l

0.32

716

5512

Missing teeth due to accident, extraction or parodontitis

996

6472

1.38

20.48

1.4

12.49

10.78

u/l

2.54

765

5222

Diseases of pulp and periapical tissues, including avohilmo

2557

10773

1.24

20.46

1.4

1.5

9.43

9.39

u/l

0.06

2045

8630

Other specified and unspecified personality disorders

285

1581

1.86

20.46

1.4

1.3

8.45

9.27

u/l

0.58

203

1292

Syncope and collapse

830

4884

1.43

20.41

1.5

1.4

10.23

9.35

u/l

1.14

663

3928

Phobic anxiety disorders

513

3314

1.59

20.40

1.5

8.58

8.41

u/l

0.11

383

2690

Temporomandibular joint disorders, including avohilmo

1284

9447

1.33

20.38

1.4

10.77

10.57

u/l

0.20

1032

7713

Diseases of middle ear and mastoid

1725

11088

1.28

20.38

1.5

1.4

8.70

8.87

u/l

0.23

1391

8899

Nonalcoholic fatty liver disease

249

1323

1.93

20.32

1.5

1.4

9.62

10.40

u/l

0.41

205

1056

Emotional disorders starting during childhood or adolecense, excluding more controls

241

1238

1.99

20.31

1.9

1.6

7.05

8.19

u/l

1.25

183

974

malignant neoplasm of female genital organs

145

609

2.36

20.28

1.5

1.3

24.52

17.22

u/l

4.21

127

487

Abnormal weight loss

194

945

2.11

20.23

1.7

1.6

10.29

9.29

u/l

0.48

166

742

DVT of lower extremities and pulmonary embolism

595

3942

1.52

20.19

1.5

1.4

12.93

10.91

u/l

2.39

495

3171

Dyspnoea

1896

10865

1.27

20.17

1.4

11.22

10.20

u/l

2.22

1545

8740

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

284

1587

1.87

20.14

1.6

1.5

7.05

7.15

u/l

0.06

192

1282

Other bacterial intestinal infections, including avohilmo

469

2971

1.60

20.09

1.4

11.07

9.86

u/l

1.02

370

2377

Candidiasis, including avohilmo

743

5186

1.45

20.06

1.4

11.44

10.43

u/l

0.92

567

4215

Implicit Sepsis

1472

8354

1.31

19.99

1.5

1.4

10.43

9.72

u/l

1.12

1155

6711

Cervical polyps

119

473

2.56

19.87

1.2

1.3

17.57

21.72

u/l

1.41

371

Malignant neoplasm of heart, mediastinum and pleura

5.34

19.83

1.6

1.3

8.94

7.30

u/l

0.39

Cardiovascular diseases (excluding rheumatic etc)

2109

9693

1.26

19.82

1.5

1.4

9.47

8.90

u/l

1.12

1716

7782

All pneumoniae

2474

13147

1.23

19.78

1.5

1.4

10.00

9.58

u/l

0.79

1954

10583

Agranulocytosis

219

1123

2.00

19.77

1.7

1.5

12.56

11.24

u/l

0.55

182

899

Benign neoplasm: Cerebral meninges

138

590

2.39

19.74

1.6

1.3

12.11

14.49

u/l

0.94

110

471

Other diseases of anus and rectum

506

3258

1.56

19.74

1.4

10.81

10.69

u/l

0.06

403

2579

Hypokalaemia

201

1000

2.05

19.66

1.5

1.4

11.70

11.42

u/l

0.09

161

801

Provisional assignment of new diseases of uncertain etiology

1259

9504

1.33

19.61

1.4

11.32

9.65

u/l

3.34

1002

7670

Codes for special purposes

1259

9513

1.32

19.46

1.4

11.32

9.65

u/l

3.35

1002

7677

Pulmonary embolism

409

2523

1.64

19.43

1.5

1.3

13.53

11.07

u/l

2.37

341

2037

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2368

12880

1.23

19.28

1.5

1.4

10.11

9.61

u/l

0.96

1863

10373

Pulmonary heart disease

409

2530

1.63

19.22

1.5

1.3

13.53

11.08

u/l

2.36

341

2043

Undetermined asthma

273

1518

1.83

19.08

1.5

1.4

11.34

10.04

u/l

0.70

213

1195

Other disorders starting during childhood or adolecense, excluding more controls

230

1167

1.98

19.07

1.8

1.6

5.90

7.76

u/l

4.00

163

886

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

206

1051

2.01

18.96

1.6

1.4

12.37

10.38

u/l

0.90

171

856

Problems related to lifestyle

318

1864

1.75

18.83

1.5

1.4

8.94

7.95

u/l

0.70

249

1499

Other diseases of liver

371

2259

1.67

18.80

1.5

1.4

10.80

10.61

u/l

0.08

300

1819

Implicit Sepsis, including avohilmo

1689

9531

1.27

18.78

1.5

1.4

10.32

9.74

u/l

0.93

1325

7691

Other diseases of lip and oral mucosa

841

6069

1.40

18.69

1.5

1.4

11.52

10.64

u/l

0.94

674

4870

Abnormal findings on examination of blood, without diagnosis

869

5691

1.39

18.65

1.5

1.4

9.38

9.29

u/l

0.07

704

4491

Localized swelling, mass and lump of skin and subcutaneous tissue

636

4371

1.47

18.59

1.5

1.4

11.05

10.22

u/l

0.78

510

3481

Other diseases of pleura

618

3649

1.48

18.59

1.4

11.51

10.21

u/l

1.38

476

2880

Paralytic ileus and intestinal obstruction

364

2205

1.67

18.56

1.5

1.4

12.08

10.95

u/l

0.76

297

1765

Disorders of calcium metabolism

126

534

2.42

18.51

1.6

1.4

14.78

10.88

u/l

1.45

100

433

Explicit Sepsis, including avohilmo

822

5349

1.41

18.49

1.8

1.4

11.15

9.74

u/l

1.95

643

4220

Other disorders of optic [2nd] nerve and visual pathways

171

826

2.14

18.45

2.1

1.5

11.37

9.47

u/l

0.65

133

636

Suicide or other Intentional self-harm

679

4744

1.46

18.41

1.4

9.71

9.24

u/l

0.40

505

3853

Hypertension

1731

7720

1.27

18.41

1.5

1.4

10.09

10.51

u/l

0.58

1410

6260

Disorders of psychological development

523

3227

1.55

18.38

2.0

1.6

7.09

7.20

u/l

0.09

389

2489

Undetermined asthma, excluding more controls

273

1537

1.81

18.33

1.5

1.4

11.34

10.15

u/l

0.62

213

1207

Explicit Sepsis

798

5201

1.41

18.30

1.8

1.4

11.17

9.78

u/l

1.83

622

4096

Renal cell carcinoma of kidney

138

3.96

18.26

1.3

22.46

8.32

u/l

3.36

108

Symptoms and signs involving speech and voice

563

3792

1.50

18.19

1.4

12.48

12.09

u/l

0.23

436

3060

Sequelae of external causes of morbidity and mortality

471

3057

1.56

18.19

1.4

11.02

10.41

u/l

0.40

369

2452

Hypertensive diseases

1731

7734

1.27

18.17

1.5

1.4

10.09

10.51

u/l

0.58

1410

6265

Diseases of liver

631

4354

1.47

18.05

1.5

1.4

10.39

10.14

u/l

0.16

499

3476

Venous thromboembolism

797

5510

1.40

18.01

1.5

1.4

12.54

11.17

u/l

1.68

652

4421

Thyrotoxicosis, other and/or unspecified

382

2371

1.64

17.90

1.4

1.3

13.20

11.78

u/l

0.96

304

1934

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

110

4.39

17.89

1.8

1.4

9.63

7.91

u/l

0.43

Voice disturbances

464

3014

1.56

17.85

1.3

1.4

12.78

12.39

u/l

0.21

362

2437

Other enthesopathies

557

3758

1.50

17.84

1.4

10.75

11.74

u/l

0.89

465

3018

Primary hyperparathyroidism

139

623

2.27

17.82

1.5

1.3

15.08

14.82

u/l

0.06

119

493

Other complications of surgical and medical care, not elsewhere classified

218

1159

1.93

17.77

1.5

1.4

11.58

10.83

u/l

0.31

184

924

Spondylolisthesis/Spondylolysis

295

1714

1.75

17.75

1.4

12.75

12.15

u/l

0.25

250

1387

Subjective visual disturbances

528

3536

1.51

17.67

1.5

1.4

10.95

10.33

u/l

0.43

412

2859

Abnormal findings on diagnostic imaging of central nervous system

145

669

2.25

17.66

1.6

1.4

9.30

9.61

u/l

0.11

120

526

Extrapyramidal and movement disorders

582

3969

1.48

17.64

1.4

10.31

11.11

u/l

0.73

461

3187

Other and unspecified nerve root and plexus disorders, also in other diseases

438

2821

1.58

17.60

1.5

1.4

10.52

10.23

u/l

0.17

361

2298

Functional dyspepsia

529

3546

1.51

17.58

1.3

1.4

11.96

11.11

u/l

0.64

435

2872

Pulmonary heart disease, diseases of pulmonary circulation

433

2775

1.58

17.57

1.5

1.4

13.76

10.96

u/l

3.08

358

2228

Constitutional tall stature

112

4.89

17.51

2.8

1.6

4.70

6.23

u/l

1.00

Melanocytic naevi

739

5295

1.41

17.30

1.4

9.97

10.28

u/l

0.24

593

4293

Fissure and fistula of anal and rectal regions

490

3246

1.53

17.27

1.4

10.03

9.93

u/l

0.05

392

2601

Implicit bacterial Sepsis

609

3590

1.47

17.26

1.5

1.4

10.94

9.93

u/l

0.94

469

2840

Acute bronchitis

849

6095

1.38

17.25

1.5

9.67

9.53

u/l

0.11

680

4823

Caries of dentine, including avohilmo

1582

6363

1.28

17.23

1.4

1.5

9.84

9.46

u/l

0.52

1267

5113

Precocious puberty

123

4.69

17.19

3.6

1.7

4.82

6.80

u/l

1.79

Other and unspecified drugs and medicaments

190

977

2.00

17.16

1.7

1.4

12.63

10.24

u/l

1.08

160

785

Pain associated with micturition

242

1344

1.84

17.14

1.4

1.5

10.89

10.82

u/l

0.03

191

1074

Abnormal results of function studies

213

1139

1.92

17.13

1.7

1.5

13.30

9.09

u/l

2.64

171

913

Pure hypercholesterolaemia

1203

5831

1.32

17.12

1.5

1.4

9.39

10.75

u/l

2.65

948

4755

Epilepsy

614

4245

1.46

17.12

1.5

10.38

9.61

u/l

0.64

484

3315

Postpartum care and examination

511

2124

1.55

17.11

1.2

1.4

10.80

11.64

u/l

0.71

449

1676

Other follicular disorders

233

1288

1.87

17.02

1.4

11.37

8.96

u/l

1.72

195

1065

Dental caries, including avohilmo

1383

5487

1.30

16.99

1.4

9.88

9.66

u/l

0.24

1102

4444

Brain meningioma

267

2.96

16.90

1.7

1.3

12.11

11.89

u/l

0.04

212

Falls/tendency to fall

2747

11507

1.20

16.88

1.4

9.56

9.49

u/l

0.09

2188

9261

Kela-code for severe mental illness

893

6628

1.36

16.81

1.4

8.83

8.84

u/l

0.01

682

5384

Dermatitis

1296

9887

1.29

16.79

1.5

1.4

10.71

10.51

u/l

0.21

1064

7925

Deforming dorsopathies

561

3841

1.48

16.75

1.5

11.93

10.57

u/l

1.19

454

3031

COPD (mode)

360

1726

1.64

16.71

1.4

10.59

9.56

u/l

0.75

266

1364

All influenza

569

3912

1.47

16.69

1.6

1.5

9.34

8.38

u/l

0.93

461

3111

Cerebral cysts

177

901

2.04

16.65

1.6

1.4

10.74

8.94

u/l

0.75

146

719

Disorders of vestibular function (Vertigo)

702

4874

1.41

16.65

1.4

11.33

12.34

u/l

1.12

565

3934

Brain meningioma, including Hilmo

282

2.87

16.46

1.7

1.3

12.54

11.90

u/l

0.13

225

Other arthrosis

874

4298

1.37

16.45

1.4

11.10

11.59

u/l

0.43

717

3458

Brachial plexus disorders

247

1402

1.81

16.43

1.4

1.3

11.32

11.22

u/l

0.03

211

1156

Elevated blood glucose level

197

1042

1.94

16.41

1.6

1.5

8.88

8.67

u/l

0.07

155

826

Other acute lower respiratory infections

1223

9046

1.30

16.40

1.6

1.5

9.12

9.00

u/l

0.12

977

7210

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

104

427

2.49

16.38

1.9

1.4

15.65

9.03

u/l

2.83

336

Rheumatism, unspecified

184

948

1.97

16.36

1.2

1.3

17.02

16.10

u/l

0.30

154

776

Cervicobrachial syndrome

415

2685

1.57

16.32

1.4

1.3

11.15

11.90

u/l

0.45

333

2168

Contact with and exposure to communicable diseases

1089

8331

1.32

16.30

1.4

1.5

8.86

8.87

u/l

0.01

933

6656

Intestinal stricture

440

2885

1.54

16.19

1.4

12.36

10.72

u/l

1.36

356

2308

Migraine with aura

729

5276

1.40

16.15

1.4

10.27

10.48

u/l

0.16

610

4291

Non-follicular lymphoma

145

691

2.14

16.06

1.7

1.4

10.74

9.68

u/l

0.47

124

556

Cutaneous abscess, furuncle and carbuncle

664

4736

1.42

16.05

1.5

1.4

9.24

8.96

u/l

0.22

541

3790

Allergic rhinitis

969

7244

1.34

16.05

1.5

8.75

9.30

u/l

0.73

768

5784

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1328

8092

1.29

16.03

1.3

12.07

11.90

u/l

0.14

1066

6628

Cluster headache, wide

114

497

2.39

15.95

1.4

1.3

11.36

10.10

u/l

0.42

408

Erosion of teeth , including avohilmo

790

5811

1.38

15.93

1.6

1.4

9.13

9.24

u/l

0.08

609

4697

Injury of muscle and tendon at shoulder and upper arm level

603

4227

1.44

15.91

1.4

8.08

9.26

u/l

1.89

493

3383

Bulimia nervosa (incl. atypical)

171

883

2.05

15.85

1.4

1.3

9.21

10.00

u/l

0.32

134

721

Conjunctivitis

1904

12552

1.23

15.74

1.5

1.4

10.25

9.83

u/l

0.53

1514

10063

Mycoses

585

4094

1.45

15.67

1.5

1.4

11.08

9.89

u/l

1.09

454

3276

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

113

484

2.33

15.67

1.3

14.57

9.93

u/l

2.27

375

Secondary hypertension

178

909

1.97

15.66

2.0

1.5

11.48

8.07

u/l

2.12

149

711

Hypoplasia of dental enamel , including avohilmo

201

1058

1.95

15.66

2.8

1.9

6.54

7.12

u/l

0.22

136

739

Immunodeficiencies

129

597

2.24

15.66

1.8

1.6

10.27

9.77

u/l

0.13

103

453

Benign thyroid growths and nodules

392

2339

1.57

15.65

1.3

15.19

14.73

u/l

0.19

320

1923

Obsessive-compulsive disorder

294

1784

1.71

15.63

1.6

1.5

7.37

7.92

u/l

0.54

229

1452

Molar incisor enamel hypoplasia

209

1107

1.92

15.62

2.8

1.9

6.62

7.19

u/l

0.22

139

774

Cervicocranial syndrome

210

1150

1.86

15.61

1.3

1.4

10.08

12.21

u/l

1.37

169

933

Allergic asthma (mode)

659

4601

1.42

15.60

1.5

1.4

9.08

9.35

u/l

0.22

531

3694

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2327

12243

1.21

15.59

1.6

1.4

10.85

9.69

u/l

3.26

1870

9834

Hernia of abdominal wall

837

6219

1.36

15.57

1.4

8.77

9.66

u/l

1.50

683

4992

Accidents

1950

7967

1.23

15.56

1.4

9.97

9.83

u/l

0.17

1563

6436

Abnormal involuntary movements

277

1646

1.71

15.55

1.5

1.4

10.35

9.70

u/l

0.39

230

1304

Impingement syndrome of shoulder

351

2209

1.61

15.54

1.4

1.3

11.68

11.67

u/l

0.01

289

1757

Benign paroxysmal vertigo

422

2769

1.54

15.52

1.3

11.48

12.58

u/l

0.84

339

2239

Malignant neoplasm of head and neck, including Hilmo

146

707

2.10

15.48

1.4

13.31

8.10

u/l

3.42

122

556

Cluster headache, strict

110

479

2.39

15.47

1.4

1.3

11.35

9.91

u/l

0.49

393

Crossbite

283

1565

1.73

15.46

2.1

1.9

7.57

7.26

u/l

0.19

206

1165

Disorders of refraction and accommodation

780

5729

1.38

15.43

1.6

1.5

9.28

9.58

u/l

0.24

598

4542

Malignant neoplasm of ovary, including Hilmo

264

2.86

15.41

1.9

1.3

21.55

17.09

u/l

1.38

208

Other external causes of accidental injury

1948

7967

1.23

15.40

1.4

9.92

9.83

u/l

0.10

1566

6436

Sequelae with surgical and medical care as external cause

338

2115

1.62

15.39

1.4

11.27

10.67

u/l

0.31

261

1713

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

136

644

2.16

15.39

2.3

1.5

7.47

8.07

u/l

0.25

107

506

Propionic acid derivatives

685

2437

1.43

15.37

1.5

1.7

7.51

8.43

u/l

1.37

554

1880

Other and unspecified dermatitis

1064

8194

1.31

15.36

1.5

1.4

10.77

10.78

u/l

0.01

871

6586

Diaphragmatic hernia

464

3113

1.50

15.32

1.4

1.3

11.63

12.32

u/l

0.46

376

2512

Dissociative [conversion] disorders

145

711

2.14

15.31

1.4

9.93

9.26

u/l

0.24

118

586

Viral hepatitis, including avohilmo

242

1401

1.78

15.22

1.5

1.4

8.16

7.83

u/l

0.18

171

1123

Injuries to the neck

629

4491

1.42

15.20

1.4

10.13

8.86

u/l

1.65

518

3648

Motor disorders, excluding more controls

325

2.75

15.15

2.9

2.1

4.42

6.17

u/l

2.16

210

malignant neoplasm of male genital organs

472

1887

1.52

15.15

2.3

1.4

7.58

6.04

u/l

3.30

375

1477

Allergic asthma (mode), excluding more controls

658

4617

1.41

15.13

1.5

1.4

9.08

9.35

u/l

0.23

531

3703

Infections with a predominantly sexual mode of transmission, including avohilmo

1324

9612

1.28

15.13

1.4

9.15

9.18

u/l

0.03

1034

7878

Other adrenocortical overactivity

110

4.45

15.11

2.3

1.6

10.37

7.63

u/l

0.49

Chronic gastritis

321

1990

1.63

15.08

1.4

12.03

12.00

u/l

0.01

252

1607

Anti-inflammatory and antirheumatic products, non-steroids

683

2438

1.42

15.05

1.6

1.7

7.46

8.43

u/l

1.54

549

1880

Drug-induced polyneuropathy

100

4.42

15.01

3.6

2.1

7.53

7.44

u/l

0.01

Tinnitus

411

2711

1.54

14.85

1.4

9.95

10.93

u/l

0.66

336

2210

Viral and other specified intestinal infections, including avohilmo

979

7223

1.32

14.85

1.6

1.5

7.82

7.96

u/l

0.17

794

5753

Malignant neoplasm of head and neck

124

574

2.20

14.80

1.3

1.4

13.86

7.66

u/l

3.87

105

459

Viral hepatitis

227

1301

1.80

14.80

1.5

1.4

8.11

7.91

u/l

0.09

159

1043

Other general symptoms and signs

156

786

2.03

14.70

1.6

1.5

9.85

9.19

u/l

0.21

115

595

Malignant neoplasm of mesothelium and soft tissue

239

2.92

14.65

1.9

1.3

14.25

7.97

u/l

2.49

187

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

909

6837

1.33

14.64

1.7

1.4

9.32

9.59

u/l

0.27

698

5493

malignant neoplasm of male genital organs, including Hilmo

485

1960

1.50

14.62

2.3

1.4

7.52

5.99

u/l

3.37

387

1540

Zoster [herpes zoster]

281

1703

1.67

14.55

1.8

1.4

10.64

11.39

u/l

0.37

232

1376

Sleep disorders, other/unspecified

134

651

2.15

14.52

1.4

1.5

9.98

10.32

u/l

0.10

517

Paracetamol or NSAID medication

474

1594

1.52

14.49

1.6

1.7

7.41

7.66

u/l

0.22

372

1194

Early onset COPD, excluding more controls

288

1756

1.66

14.47

1.4

9.75

9.31

u/l

0.23

213

1405

Other disorders involving the immune mechanism, not elsewhere classified

103

451

2.40

14.43

3.1

1.6

9.58

7.99

u/l

0.56

355

Other viral diseases, including avohilmo

1163

9062

1.29

14.41

1.5

9.17

9.02

u/l

0.15

946

7246

Cellulitis

499

3448

1.47

14.41

1.6

1.5

8.82

8.98

u/l

0.11

390

2737

Wide developmental disorders, excluding more controls

158

799

2.03

14.41

1.9

1.7

7.26

7.48

u/l

0.10

122

599

External causes of morbidity and mortality

1620

6548

1.25

14.41

1.4

9.76

9.65

u/l

0.12

1303

5285

Implicit bacterial Sepsis, including avohilmo

675

4063

1.39

14.40

1.5

1.4

11.02

9.77

u/l

1.38

512

3214

Dermatophytosis, including avohilmo

1514

12013

1.24

14.35

1.5

1.4

9.04

9.51

u/l

0.78

1222

9711

Any death

871

4571

1.34

14.35

1.4

13.76

9.90

u/l

9.55

694

3637

Undescended testicle

214

3.23

14.35

3.0

2.2

9.04

4.19

u/l

2.34

134

Other bacterial intestinal infections

308

1920

1.63

14.28

1.5

1.4

11.90

10.09

u/l

1.25

250

1533

Malignant neoplasm of corpus uteri, including Hilmo

193

3.09

14.28

1.3

1.2

26.65

21.41

u/l

1.16

147

Social phobias

339

2177

1.60

14.24

1.6

1.5

8.01

7.86

u/l

0.08

251

1761

Condition for Implicit Sepsis (Organ dysfunction codes)

1749

9916

1.23

14.22

1.5

1.4

10.22

9.76

u/l

0.70

1380

8017

L04AD Calcineurin inhibitors

276

1685

1.68

14.16

1.8

1.6

11.56

8.10

u/l

2.72

224

1301

Malignant neoplasm of endocrine gland, including Hilmo

151

772

2.00

13.92

2.0

1.5

13.26

10.82

u/l

0.90

108

622

Melanocytic naevi of trunk

295

1842

1.63

13.78

1.4

10.96

9.75

u/l

0.72

237

1494

Malignant neoplasm of corpus uteri

162

3.24

13.67

1.3

1.2

26.30

21.72

u/l

0.86

125

Assault

446

3061

1.49

13.62

1.5

8.13

7.57

u/l

0.50

333

2472

Bacterial Sepsis

725

4429

1.36

13.60

1.5

1.4

11.15

9.61

u/l

2.10

558

3503

Diverticular disease of intestine

994

4759

1.31

13.49

1.4

11.09

11.67

u/l

0.56

804

3862

Abnormalities of gait and mobility

189

1050

1.83

13.45

1.7

1.5

10.41

9.37

u/l

0.48

145

820

Bacterial intestinal infections, IBD co-morbidities

309

1958

1.60

13.42

1.5

1.4

11.75

10.40

u/l

0.82

254

1566

Fenamates

287

1198

1.65

13.40

1.4

1.3

10.03

10.04

u/l

0.01

232

978

Intracranial injury

1324

9921

1.25

13.35

1.5

8.89

9.25

u/l

0.54

1041

7929

Mental and behavioural disorders due to alcohol

1147

8647

1.27

13.35

1.4

1.5

9.27

8.16

u/l

2.38

875

7051

Disorders of conjunctiva

2022

13112

1.20

13.32

1.5

1.4

10.58

9.69

u/l

1.59

1617

10517

Gonarthrosis

1027

4481

1.30

13.32

1.4

1.3

10.52

11.70

u/l

1.79

834

3599

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

430

2.37

13.25

3.2

1.6

9.72

7.77

u/l

0.71

336

Malignant neoplasm of bladder

327

2.51

13.23

1.2

1.3

15.28

7.40

u/l

5.25

254

Orchitis and epididymitis

192

1079

1.82

13.23

1.7

1.5

6.15

5.85

u/l

0.26

159

861

Autism spe, excluding more controls

120

582

2.18

13.19

1.7

1.6

7.92

7.84

u/l

0.03

449

Other shoulder lesions

220

1289

1.74

13.14

1.4

10.62

10.39

u/l

0.08

175

1036

Other disorders of skin and subcutaneous tissue, not elsewhere classified

241

1446

1.69

13.08

1.4

11.18

10.38

u/l

0.40

193

1178

Diseases of pulp and periapical tissues and dental caries

1206

4878

1.28

13.05

1.4

9.76

9.65

u/l

0.10

954

3944

Disorders of optic nerve and visual pathways

236

1414

1.71

13.05

2.0

1.4

10.84

9.79

u/l

0.41

185

1122

Malignant neoplasm of brain, including Hilmo

107

494

2.23

13.05

2.5

1.5

6.37

7.47

u/l

0.64

393

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

371

2462

1.54

13.04

1.7

9.03

8.44

u/l

0.34

281

1896

Specific development disorders of scholastic skills

223

1301

1.76

13.03

2.4

1.8

6.44

6.83

u/l

0.25

161

961

Thyrotoxicosis

447

3083

1.47

13.02

1.4

1.3

13.60

12.16

u/l

1.09

356

2493

Other diseases of intestine

226

1336

1.71

12.93

1.4

10.33

10.98

u/l

0.27

168

1064

Oter anti-inflammatory and antirheumatic agents, non-steroids

256

835

1.70

12.81

1.4

9.92

11.52

u/l

0.98

197

679

Immunodeficiency with predominantly antibody defects

355

2.49

12.81

2.0

1.6

10.40

8.89

u/l

0.37

275

Diseases of the digestive system

786

5913

1.33

12.80

1.5

11.51

9.74

u/l

2.50

628

4654

Soft tissue disorders related to use, overuse and pressure

430

2955

1.47

12.73

1.4

10.53

11.29

u/l

0.52

347

2354

Disorders of continuity of bone

231

1385

1.70

12.70

1.6

1.5

9.55

10.41

u/l

0.42

193

1111

Mental and behavioural disorders due to alcohol, excluding acute intoxication

960

7424

1.29

12.69

1.4

9.40

8.05

u/l

2.76

722

6038

Lack of expected normal physiological development

124

540

2.15

12.67

2.6

1.8

5.43

6.52

u/l

0.99

378

Haemorrhage in early pregnancy

638

4570

1.37

12.64

1.2

1.3

11.32

13.13

u/l

2.80

547

3721

Other viral hepatitis, including avohilmo

219

1303

1.74

12.61

1.5

1.4

7.87

7.78

u/l

0.04

152

1047

Urinary track infection

1394

5627

1.25

12.60

1.3

12.73

12.33

u/l

0.40

1120

4619

Bilateral cryptorchidism (undescended testicles)

6.10

12.59

3.7

2.5

7.17

3.85

u/l

0.92

Other disorders of bladder

191

1089

1.78

12.50

1.4

8.35

8.87

u/l

0.26

154

878

Alcohol use disorder, Swedish definition

1175

8538

1.26

12.50

1.4

1.5

9.13

8.35

u/l

1.36

899

6929

Other noninfective gastroenteritis and colitis

525

3757

1.41

12.48

1.5

10.68

9.65

u/l

0.86

430

2910

Benign neoplasm: Sigmoid colon

242

1471

1.66

12.46

1.4

10.72

10.98

u/l

0.10

190

1192

Erysipelas

904

6029

1.30

12.41

1.4

9.28

9.57

u/l

0.31

717

4883

Candidiasis

305

1967

1.58

12.41

1.4

12.66

10.99

u/l

0.89

226

1604

Personal history of other diseases and conditions

381

2574

1.51

12.36

1.6

1.5

8.76

9.22

u/l

0.36

300

2005

Other noninflammatory disorders of vagina

103

477

2.19

12.35

1.3

13.33

16.84

u/l

1.18

356

Emotional disorders and disorders of social functioning with onset specific to childhood

269

1668

1.65

12.34

1.9

1.8

6.83

7.33

u/l

0.58

203

1279

Ectopic pregnancy

331

2176

1.54

12.32

1.2

1.3

14.17

14.03

u/l

0.05

282

1786

Other inflammation of eyelid

263

1640

1.63

12.31

1.4

11.59

11.15

u/l

0.14

191

1298

Benign neoplasm: Colon, unspecified

303

1949

1.57

12.31

1.4

11.35

10.96

u/l

0.18

245

1564

Gout

358

2039

1.52

12.30

1.5

1.4

9.23

9.10

u/l

0.07

272

1599

Misadventures to patients during surgical and medical care

252

1555

1.64

12.30

1.5

1.4

12.75

11.14

u/l

1.00

211

1265

Optic atrophy

214

2.92

12.30

2.7

1.6

6.57

8.77

u/l

0.68

165

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1974

11198

1.20

12.19

1.5

1.4

10.11

9.77

u/l

0.49

1557

9058

Other or unspecified ileus, impaction or obstruction

243

1486

1.65

12.19

1.4

11.80

10.65

u/l

0.62

206

1182

Other viral hepatitis

205

1210

1.75

12.18

1.5

1.4

7.81

7.73

u/l

0.03

141

976

Non-allergic asthma (mode)

353

2334

1.52

12.16

1.5

8.64

9.65

u/l

0.87

274

1832

Other hearing loss

322

2036

1.54

12.15

1.4

11.28

11.48

u/l

0.09

246

1648

Arthrosis

1334

5893

1.25

12.14

1.4

10.18

10.74

u/l

0.73

1098

4754

Pleural effusion

190

1090

1.76

12.12

1.4

13.18

9.95

u/l

2.02

152

869

Adrenogenital disorders

6.51

12.12

2.8

1.2

7.33

7.61

u/l

0.03

Other and unspecified follicular disorders

118

585

2.09

12.10

1.5

1.4

11.45

8.30

u/l

1.30

482

Non-allergic asthma (mode), excluding more controls

353

2337

1.51

12.09

1.5

8.64

9.73

u/l

0.96

274

1834

Malignant neoplasm of endocrine gland

132

678

1.99

12.08

1.8

1.4

14.01

10.65

u/l

1.26

550

Optic atrophy, wide definition

222

2.86

12.04

2.7

1.6

6.57

8.91

u/l

0.75

172

Anankastic personality disorder

129

663

2.02

12.03

1.5

1.3

8.86

9.85

u/l

0.33

106

541

Turner's syndrome

6.70

12.01

3.2

1.7

6.49

11.39

u/l

0.77

Congenital malformations and deformations of the musculoskeletal system

307

1996

1.57

12.00

1.8

1.7

8.55

8.20

u/l

0.18

225

1520

Other disorders of eye and adnexa

330

2185

1.54

11.95

1.6

1.5

12.84

10.22

u/l

0.96

245

1745

Diseases of oesophagus, stomach and duodenum

2346

11812

1.18

11.95

1.4

10.61

9.72

u/l

2.33

1883

9542

Colonic or urogenital fistula

512

3679

1.41

11.95

1.4

10.25

10.08

u/l

0.09

411

2963

Diagnoses used for exclusion with ILD

382

2600

1.48

11.93

1.4

11.98

10.19

u/l

1.30

310

2082

Implicit fungal Sepsis, including avohilmo

123

619

2.03

11.92

1.4

1.3

13.00

10.53

u/l

0.81

499

Inflammatory disease of uterus

370

2512

1.50

11.92

1.3

13.80

11.75

u/l

1.49

305

2067

Alcohol use disorder, ICD-based

891

6950

1.29

11.88

1.4

9.49

7.99

u/l

3.09

674

5659

Other and unspecified visual disturbances

205

1212

1.72

11.87

1.5

1.4

10.68

10.39

u/l

0.10

167

994

Drug-induced neutropenia

120

600

2.04

11.86

1.8

1.4

13.09

11.43

u/l

0.61

106

486

Umbilical hernia

562

4107

1.38

11.86

1.5

1.4

7.55

8.69

u/l

2.06

451

3322

Mixed hyperlipidaemia

322

2.46

11.85

1.6

1.3

8.36

7.88

u/l

0.16

261

Dislocation, sprain and strain of joints and ligaments at neck level

457

3234

1.44

11.85

1.4

10.56

8.97

u/l

1.71

379

2625

Injuries to the head

2629

13440

1.17

11.76

1.5

1.4

9.06

9.78

u/l

2.08

2096

10813

Zoster [herpes zoster], including avohilmo

825

6145

1.30

11.76

1.5

1.4

10.95

11.27

u/l

0.25

662

4949

Asthma and allergy

419

2883

1.46

11.75

1.5

8.56

9.06

u/l

0.37

334

2312

Diseases of external ear

699

5285

1.34

11.75

1.6

1.5

9.16

9.70

u/l

0.58

553

4154

Other symptoms and signs involving the urinary system

189

1097

1.75

11.69

1.7

1.5

8.43

8.50

u/l

0.03

164

883

Diseases of inner ear

805

5928

1.31

11.68

1.4

10.99

11.79

u/l

0.92

646

4788

Neuromuscular dysfunction of bladder

161

892

1.84

11.67

1.4

12.41

9.69

u/l

1.18

135

721

Postprocedural disorders of nervous system

219

1332

1.69

11.59

1.5

1.3

12.37

10.25

u/l

1.16

185

1087

Spermatocele

135

709

1.94

11.58

1.6

1.4

6.38

6.51

u/l

0.08

115

582

Hypermetropia

200

1186

1.73

11.56

2.0

1.7

9.36

8.27

u/l

0.62

151

886

ILD medications: immunosuppressive drugs

1431

10671

1.22

11.55

1.6

1.4

10.98

9.40

u/l

3.72

1180

8535

Lateral epicondylitis

244

1520

1.63

11.51

1.5

1.3

11.84

11.71

u/l

0.05

206

1228

Persons encountering health services for specific procedures, not carried out

228

1402

1.66

11.47

1.5

1.4

9.58

8.41

u/l

0.53

149

1131

Malignant neoplasm of oral cavity, including Hilmo

290

2.51

11.46

1.4

1.3

15.22

7.17

u/l

3.09

235

Asthma and allergy, excluding more controls

418

2891

1.45

11.44

1.5

8.56

9.02

u/l

0.34

334

2317

Later onset COPD, excluding more controls

162

678

1.83

11.39

1.3

11.58

10.77

u/l

0.32

120

519

1341

9554

1.23

11.37

1.4

1.5

9.10

8.41

u/l

1.23

1034

7759

Fracture of rib(s), sternum and thoracic spine

497

3583

1.40

11.35

1.4

9.68

9.08

u/l

0.45

389

2862

Volume depletion

142

763

1.89

11.31

1.5

11.39

8.76

u/l

1.39

112

604

Enthesopathies of lower limb, excluding foot

428

3012

1.44

11.27

1.5

1.4

9.53

11.20

u/l

1.92

335

2414

Malignant neoplasm of tongue, including Hilmo

178

2.96

11.26

1.3

14.73

6.40

u/l

2.78

142

Disorders of synovium and tendon

1119

7631

1.25

11.26

1.4

10.95

10.12

u/l

1.19

922

6180

Mental and behavioural disorders due to use of other stimulants, including caffeine

131

697

1.98

11.25

1.5

6.19

7.25

u/l

0.78

578

Speech and linguistic disorders

357

2343

1.50

11.20

2.2

1.7

7.11

7.05

u/l

0.04

256

1763

Other pleural conditions

126

653

1.96

11.19

1.3

1.5

14.37

9.95

u/l

1.89

521

Childhood asthma (age<16)

596

3464

1.37

11.17

1.5

8.11

7.72

u/l

0.36

456

2769

Special screening examination for other diseases and disorders

247

1554

1.61

11.16

1.4

9.85

9.19

u/l

0.34

203

1239

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1887

9433

1.19

11.14

1.4

1.5

9.16

10.49

u/l

4.57

1491

7594

Injuries to the abdomen, lower back, lumbar spine and pelvis

810

6201

1.30

11.13

1.4

1.5

9.90

9.30

u/l

0.63

633

4989

Other CVD

228

1407

1.63

11.08

1.4

12.44

10.35

u/l

1.18

184

1120

Childhood asthma (age<16), excluding more controls

596

3469

1.37

11.06

1.5

8.11

7.72

u/l

0.36

456

2771

Anosmia

111

3.45

11.05

1.3

11.02

12.45

u/l

0.20

Diffuse large B-cell lymphoma

277

2.51

11.05

1.7

1.3

10.77

8.52

u/l

0.67

223

Diffuse large B-cell lymphoma, including Hilmo

277

2.51

11.05

1.7

1.3

10.77

8.52

u/l

0.67

223

Diffuse large B-cell lymphoma, helper endpoint

277

2.51

11.05

1.7

1.3

10.77

8.52

u/l

0.67

223

Personal history of medical treatment

124

3.45

10.98

2.3

1.4

7.89

8.99

u/l

0.30

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1136

6745

1.25

10.95

1.2

1.3

12.52

12.84

u/l

0.27

927

5558

Systemic connective tissue disorders

530

3888

1.37

10.88

1.4

12.62

12.03

u/l

0.36

428

3142

Heart failure, not strict

1083

5828

1.25

10.88

1.5

1.4

12.14

10.43

u/l

3.00

864

4639

Migraine with aura and triptan purchases

509

3726

1.39

10.86

1.4

10.40

10.04

u/l

0.24

433

3026

Lesion of ulnar nerve

259

1662

1.58

10.82

1.4

10.50

9.66

u/l

0.42

222

1368

Other neurological diseases

1144

7169

1.24

10.81

1.5

1.4

11.31

10.65

u/l

0.76

901

5749

Other and unspecified mood [affective] disorders

248

1584

1.61

10.80

1.5

1.4

8.00

8.79

u/l

0.55

192

1286

Other disorders of skin and subcutaneous tissue

1266

8741

1.23

10.79

1.5

1.4

11.45

10.96

u/l

0.54

999

7044

Other and unspecified tonsillitis

1168

7897

1.24

10.77

1.6

1.4

7.56

7.80

u/l

0.31

956

6310

Atypical facial pain

100

486

2.11

10.76

1.4

1.3

11.25

12.37

u/l

0.29

410

Other disorders of patella

388

2710

1.45

10.76

1.5

1.4

9.64

10.76

u/l

0.91

308

2180

Collagenous colitis

165

945

1.78

10.75

1.4

12.34

11.02

u/l

0.47

134

758

Viral warts, including avohilmo

596

4473

1.35

10.73

1.5

8.52

8.87

u/l

0.30

477

3550

Autoimmune diseases related-to ILD

1906

13528

1.18

10.72

1.4

10.77

9.57

u/l

3.20

1529

10913

Complications of internal orthopaedic prosthetic devices, implants and grafts

244

1544

1.59

10.71

1.5

1.4

11.35

12.01

u/l

0.31

187

1232

Other disorders of eyelid

494

3381

1.39

10.71

1.3

12.99

13.44

u/l

0.24

380

2722

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

122

434

1.99

10.71

1.5

10.42

12.02

u/l

0.56

351

Premature rupture of membranes

709

3864

1.33

10.64

1.2

1.3

10.94

11.41

u/l

0.40

613

3070

Benign neoplasm of brain and other parts of central nervous system

128

683

1.92

10.57

2.1

1.5

7.99

9.74

u/l

0.89

545

Other CVD (FINNGEN)

169

736

1.77

10.56

1.4

10.92

10.17

u/l

0.26

138

590

Other skin changes

308

2061

1.51

10.56

1.4

12.79

10.96

u/l

1.29

262

1645

Retention of urine

476

2775

1.40

10.54

1.4

10.48

9.09

u/l

1.31

374

2193

Urticaria and erythema

845

6655

1.28

10.51

1.6

1.4

10.79

10.32

u/l

0.46

696

5308

Chronic apical periodontitis

2576

12535

1.16

10.46

1.4

10.41

9.59

u/l

2.07

2054

10174

Maternal care for other known or suspected fetal problems

849

4176

1.29

10.46

1.2

1.3

10.60

11.47

u/l

1.14

726

3324

Abnormal findings on diagnostic imaging of other body structures

219

1363

1.63

10.39

1.6

1.4

13.46

11.55

u/l

0.92

177

1106

Acne

461

3337

1.41

10.38

1.5

1.6

7.28

7.69

u/l

0.44

366

2692

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

198

1210

1.68

10.34

1.5

10.51

8.60

u/l

0.89

151

963

Malignant neoplasm of oral cavity

215

2.67

10.32

1.2

1.3

16.62

6.42

u/l

3.30

175

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

102

506

2.05

10.31

1.4

1.3

11.44

11.49

u/l

0.01

413

Dislocation, sprain and strain of joints and ligaments of knee

1536

11646

1.20

10.30

1.4

9.09

9.56

u/l

0.79

1264

9443

Other viral diseases, not elsewhere classified, including avohilmo

757

5866

1.30

10.30

1.6

1.5

8.57

9.10

u/l

0.64

626

4656

Coagulation defects, purpura and other haemorrhagic conditions

395

2791

1.43

10.27

1.5

1.4

11.05

9.78

u/l

0.92

309

2233

Other and unspecified trigeminal disorders

129

3.25

10.21

1.3

1.1

6.10

11.90

u/l

2.40

111

Other diseases of the digestive system

458

3318

1.39

10.18

1.4

11.25

9.38

u/l

1.92

374

2632

Benign neoplasm of mouth and pharynx

179

1065

1.71

10.18

1.4

11.83

9.94

u/l

0.87

148

860

Squamous cell neoplasms and carcinomas of the skin

388

2.18

10.16

1.2

1.3

13.19

9.79

u/l

1.29

299

Fall on same level

2812

13111

1.15

10.15

1.5

1.4

9.70

9.50

u/l

0.34

2222

10557

Sequelae of injuries, of poisoning and of other consequences of external causes

495

3642

1.37

10.12

1.4

9.16

9.25

u/l

0.05

393

2942

Noninfective enteritis and colitis

1028

8308

1.25

10.08

1.5

9.88

9.40

u/l

0.55

842

6600

Injuries to the knee and lower leg

2772

13107

1.15

10.01

1.4

9.94

9.65

u/l

0.53

2232

10514

Rash and other nonspecific skin eruption

177

1056

1.71

9.99

1.5

1.4

10.91

11.20

u/l

0.10

135

839

Chronic viral hepatitis

176

1056

1.72

9.97

1.5

1.4

6.67

7.77

u/l

0.90

118

848

Symptoms and signs involving cognition, perception, emotional state and behaviour

2073

11897

1.17

9.95

1.4

11.02

9.91

u/l

2.83

1674

9604

Sarcoidosis

225

1429

1.60

9.88

1.4

11.88

10.45

u/l

0.59

184

1156

Benign lipomatous neoplasm

452

3287

1.39

9.88

1.4

10.65

11.18

u/l

0.35

364

2659

Noninfectious colitis NAS

291

1957

1.51

9.86

1.4

1.5

10.45

9.78

u/l

0.32

242

1547

Urolithiasis

516

3836

1.36

9.80

1.4

9.57

9.28

u/l

0.22

426

3079

Hyperlipidaemia, other/unspecified

465

3047

1.38

9.78

1.4

11.05

10.44

u/l

0.41

359

2455

Diplopia

227

1449

1.59

9.75

1.4

11.60

10.28

u/l

0.56

176

1178

Bleeding

1437

8416

1.20

9.68

1.5

11.00

9.70

u/l

2.65

1132

6742

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

179

1081

1.68

9.67

1.6

1.4

12.35

10.30

u/l

0.89

143

882

Intestinal adhesions without obstruction

117

623

1.91

9.67

1.5

1.4

13.00

11.33

u/l

0.56

494

GI-bleeding

455

3325

1.38

9.61

1.4

11.42

9.26

u/l

2.45

376

2634

1254

9277

1.21

9.61

1.4

1.5

9.07

8.32

u/l

1.38

962

7537

Acne vulgaris

364

2579

1.45

9.59

1.5

1.6

7.17

7.45

u/l

0.25

298

2099

Pollen allergy

649

4947

1.31

9.58

1.6

1.5

8.20

8.67

u/l

0.49

506

3889

Endometriosis ASRM stages 3,4

424

3074

1.39

9.52

1.2

1.3

11.97

13.38

u/l

1.25

362

2514

Injury, poisoning and certain other consequences of external causes

1296

5360

1.22

9.51

1.4

9.91

9.70

u/l

0.20

1049

4279

Erysipelas, including avohilmo

1265

7756

1.21

9.50

1.5

1.4

9.17

9.92

u/l

1.37

1011

6299

Congenital malformations of genital organs

295

1999

1.50

9.50

1.7

1.5

10.55

10.01

u/l

0.26

226

1575

Hypotension

187

1144

1.65

9.49

1.4

11.66

9.96

u/l

0.80

152

909

Other and unspecified disorders of skin and subcutaneous tissue

108

566

1.95

9.43

1.4

12.23

10.55

u/l

0.59

461

Cerebral palsy and other paralytic syndromes

222

1423

1.59

9.42

1.8

1.5

10.22

9.60

u/l

0.30

168

1109

Dermatitis due to substances taken internally

125

689

1.86

9.40

1.6

1.5

11.86

9.43

u/l

1.12

105

546

Other disorders of bone

438

3202

1.39

9.39

1.5

8.98

9.59

u/l

0.48

348

2572

Injuries to the thorax

825

6562

1.26

9.38

1.4

1.5

9.37

9.01

u/l

0.36

635

5306

Other viral diseases

827

6576

1.27

9.36

1.6

1.5

9.60

8.71

u/l

1.12

663

5232

Drug-induced osteoporosis

3.53

9.34

1.3

13.49

10.46

u/l

0.40

Postviral fatigue syndrome

172

2.93

9.33

1.4

11.75

10.32

u/l

0.20

139

Seborrhoeic dermatitis

199

1247

1.62

9.31

1.6

1.4

9.69

8.64

u/l

0.52

165

989

Enterocolitis due to Clostridium difficile

149

864

1.75

9.31

1.4

13.92

10.29

u/l

1.66

122

698

Malignant neoplasm of ovary

197

2.63

9.28

2.1

1.3

18.29

15.77

u/l

0.49

155

Atrial fibrillation and flutter

502

2395

1.36

9.27

1.4

10.56

9.91

u/l

0.40

394

1956

Malignant neoplasm of bone and articular cartilage

3.55

9.26

2.1

1.9

9.63

7.03

u/l

0.42

Other disorders of breast

260

1734

1.52

9.20

1.3

13.89

13.55

u/l

0.12

219

1409

Cluster headache, wide,, including avohilmo

146

850

1.77

9.20

1.5

1.4

11.15

9.38

u/l

0.85

126

693

All influenza (not pneumonia)

339

2382

1.44

9.19

1.6

1.5

8.85

7.66

u/l

0.97

284

1883

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

766

6076

1.27

9.12

1.4

1.5

9.56

9.13

u/l

0.40

618

4895

Specific developmental disorder of motor function

424

2.16

9.10

2.9

2.2

4.42

5.70

u/l

1.57

268

Other and unspecified effects of external causes

715

5628

1.28

9.09

1.5

1.4

9.23

9.37

u/l

0.10

579

4506

Cardiac arrhythmias

1430

7697

1.20

9.09

1.4

10.59

9.90

u/l

0.99

1149

6234

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1020

4855

1.24

9.08

1.2

1.3

13.16

12.87

u/l

0.22

874

3873

Alcohol abuse, main dg, excluding more controls

320

2233

1.45

9.01

1.5

1.4

8.83

7.91

u/l

0.67

243

1839

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1287

10313

1.20

9.00

1.4

10.23

10.51

u/l

0.23

1030

8336

Drug-induced cataract

244

2.47

9.00

1.5

1.4

14.09

9.18

u/l

1.03

194

Malignant neoplasm of breast, HER-positive

276

1377

1.50

8.99

1.2

23.77

19.55

u/l

3.33

231

1092

Endometriosis ASRM stages 1,2

396

2871

1.40

8.99

1.2

1.3

12.57

12.80

u/l

0.12

348

2345

Emotional disorders starting during childhood or adolescence

246

1631

1.55

8.97

1.9

1.8

6.98

7.17

u/l

0.16

187

1230

Mental and behavioural disorders due to tobacco

178

1097

1.65

8.96

1.5

1.4

11.89

9.60

u/l

1.22

138

901

Calculus of kidney and ureter

484

3617

1.35

8.94

1.4

9.35

9.29

u/l

0.04

399

2900

Neuralgia and neuritis, unspecified

104

549

1.94

8.94

1.5

1.4

10.28

10.17

u/l

0.03

441

Unspecified misadventure during surgical and medical care

105

556

1.93

8.94

1.7

1.4

12.43

9.95

u/l

1.13

449

Allergic conjunctivitis

1348

10906

1.20

8.92

1.4

10.37

10.55

u/l

0.14

1081

8820

Astigmatism

188

1178

1.64

8.91

1.9

1.7

8.29

8.22

u/l

0.03

144

870

Cluster headache, strict, including avohilmo

142

829

1.76

8.89

1.5

1.4

11.14

9.28

u/l

0.89

123

675

Benign neoplasm of other and ill-defined parts of digestive system

227

1480

1.55

8.87

1.4

13.61

12.17

u/l

0.66

174

1201

Malignant neoplasm of breast, ER-positive, including Hilmo

276

1381

1.49

8.82

1.2

23.77

19.54

u/l

3.35

231

1096

Other peripheral vascular diseases

152

903

1.71

8.80

1.6

1.4

9.38

11.13

u/l

0.87

127

739

Injuries to the shoulder and upper arm

1752

11599

1.17

8.76

1.5

9.19

9.67

u/l

0.84

1433

9295

Benign neoplasm: Ascending colon

167

1016

1.66

8.75

1.4

12.10

11.01

u/l

0.40

129

825

Other systemic involvement of connective tissue

403

2938

1.38

8.73

1.3

13.23

12.43

u/l

0.45

336

2373

Postpartum haemorrhage

721

4701

1.28

8.71

1.2

1.3

10.76

12.24

u/l

2.54

633

3767

Failure and rejection of transplanted organs and tissues

177

2.75

8.69

1.6

1.4

13.67

8.47

u/l

0.87

137

Postpartum hemorraghe, parous women as controls

721

4769

1.28

8.68

1.2

10.76

12.54

u/l

3.39

633

3981

Female genital prolapse

247

895

1.54

8.68

1.2

1.3

16.33

19.54

u/l

1.95

193

711

Cramp and spasm

114

628

1.87

8.66

1.4

9.97

8.49

u/l

0.71

101

505

Benign neoplasm: Rectum, anus and anal canal

240

1593

1.52

8.63

1.5

1.4

11.74

10.94

u/l

0.37

197

1279

Benign neoplasm: Rectum

213

1379

1.56

8.60

1.5

1.4

11.05

10.79

u/l

0.10

176

1111

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

159

2.77

8.58

1.3

9.46

15.77

u/l

1.75

123

Delayed milestone in childhood

101

488

2.01

8.56

2.9

2.5

5.08

5.37

u/l

0.14

281

Nontoxic multinodular goitre

181

1129

1.62

8.55

1.3

16.13

15.40

u/l

0.18

142

926

Osteonecrosis

501

1.95

8.52

1.6

1.4

10.69

10.22

u/l

0.12

409

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

3.39

8.50

2.1

1.6

10.03

7.34

u/l

0.55

Other systemic involvement of connective tissue (FG)

391

2796

1.38

8.49

1.3

13.43

12.72

u/l

0.37

326

2264

Unspecified kidney failure

124

701

1.79

8.49

1.9

1.5

11.94

8.64

u/l

1.31

101

563

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

245

1621

1.53

8.48

1.8

6.54

7.43

u/l

0.75

171

1227

Dipeptidyl peptidase 4 (DPP-4) inhibitors

664

4071

1.28

8.47

1.4

9.65

11.27

u/l

2.84

498

3286

Open bite

209

1366

1.58

8.44

1.8

1.7

8.17

8.56

u/l

0.19

161

1047

Malignant neoplasm of bone and articular cartilage, including Hilmo

167

2.74

8.44

2.1

1.6

10.52

6.44

u/l

1.23

140

Ventral hernia

332

2357

1.42

8.44

1.4

10.30

11.29

u/l

0.72

271

1891

Other and unspecified types of non-Hodgkin lymphoma, hilmo

269

2.32

8.43

1.5

1.3

10.55

9.24

u/l

0.34

208

Other congenital malformations

257

1749

1.50

8.40

2.1

1.6

8.58

9.13

u/l

0.31

185

1329

Chronic periodontitis, complicated

873

6899

1.24

8.40

1.4

11.80

10.54

u/l

1.64

681

5610

Other and unspecified nonorganic psychotic disorders

543

4175

1.32

8.39

1.4

1.5

7.96

8.19

u/l

0.20

401

3407

Medial epicondylitis

368

2.12

8.37

1.6

1.4

13.83

10.22

u/l

1.00

303

Gout, FINNGEN

358

2560

1.40

8.36

1.5

1.4

9.23

8.44

u/l

0.59

272

2023

Insulin, intermediate and long-acting

998

7923

1.22

8.34

1.4

1.5

9.29

8.74

u/l

0.72

766

6325

Early lumbar disc prolapse, operated

301

2114

1.45

8.34

1.4

8.31

8.49

u/l

0.09

249

1712

Viral and other specified intestinal infections

716

5567

1.27

8.31

1.7

1.5

7.39

7.50

u/l

0.12

581

4418

Heart failure and antihypertensive medication

325

1479

1.44

8.30

1.4

10.61

9.75

u/l

0.46

255

1205

Smoking dependency

178

1119

1.62

8.30

1.5

1.4

11.89

9.57

u/l

1.25

138

918

Salpingitis and oophoritis

210

1367

1.55

8.30

1.2

14.93

17.64

u/l

1.45

162

1115

Ocular pain

199

1285

1.58

8.29

1.6

1.5

11.29

10.36

u/l

0.41

157

1043

Malignant neoplasm of tonsil and base of tongue

157

2.77

8.28

1.4

11.83

5.79

u/l

2.13

129

Blepharochalasis

270

1850

1.47

8.28

1.2

1.3

14.14

15.24

u/l

0.51

206

1492

Nephropathy related operations

220

1452

1.54

8.25

1.6

1.5

13.64

7.70

u/l

4.06

176

1138

Dialysis, with operation codes

221

1460

1.53

8.24

1.6

1.5

13.71

7.58

u/l

4.24

175

1145

Hypercalcemia

304

2.22

8.23

1.8

1.4

17.84

11.12

u/l

1.47

237

Short stature starting before birth

142

3.27

8.22

2.8

2.7

3.45

5.72

u/l

1.23

Urticaria

709

5645

1.27

8.21

1.6

1.4

10.69

10.13

u/l

0.52

586

4475

Trigeminal neuralgia

100

537

1.90

8.17

1.3

14.80

11.82

u/l

0.82

444

Diseases of the myoneural junction and muscle

193

1240

1.58

8.14

1.8

1.4

9.95

9.26

u/l

0.27

147

988

Assault by bodily force

255

1747

1.49

8.13

1.5

8.28

7.49

u/l

0.48

191

1387

Other benign neoplasms of skin

550

4247

1.30

8.08

1.5

1.4

11.71

11.37

u/l

0.20

427

3419

Malignant neoplasm of tongue

137

2.87

8.02

1.3

15.13

6.16

u/l

2.25

111

Abrasion of teeth

625

4913

1.28

8.01

1.4

1.3

11.72

11.96

u/l

0.14

501

3988

Disorders of eyelid, lacrimal system and orbit

1669

10530

1.17

7.97

1.5

1.4

12.21

10.49

u/l

3.95

1295

8505

Purpura and other haemorrhagic conditions

250

1706

1.48

7.96

1.5

11.45

9.32

u/l

1.42

194

1344

Melanoma in situ

289

2.22

7.94

1.3

10.92

11.15

u/l

0.05

227

Insulin medication

1114

7714

1.20

7.90

1.4

1.5

9.46

9.16

u/l

0.35

865

6152

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

127

2.92

7.89

1.3

16.94

6.23

u/l

2.69

102

Dizziness and giddiness

1361

8982

1.18

7.88

1.4

12.13

10.77

u/l

2.49

1103

7256

Malignant neoplasm of adrenal gland, including Hilmo

3.58

7.88

3.8

2.0

13.44

8.35

u/l

0.69

Malignant neoplasm of eye, brain and central nervous system

439

1.98

7.86

2.3

1.5

7.28

7.41

u/l

0.04

355

Malignant neoplasm of tonsil and base of tongue, including Hilmo

185

2.56

7.85

1.4

11.40

5.87

u/l

2.10

150

Statin medication

1567

7553

1.17

7.82

1.4

8.96

10.42

u/l

4.10

1268

6167

Papilloedema, unspecified

347

2.13

7.78

2.2

1.4

10.11

8.95

u/l

0.33

277

Fall on and from stairs and steps

485

3707

1.32

7.76

1.4

11.22

10.10

u/l

0.88

373

2962

Mental and behavioural disorders due to cannabinoids

130

776

1.75

7.73

1.5

1.6

6.45

6.66

u/l

0.10

637

Disorders of sclera, cornea, iris and ciliary body

1108

9289

1.20

7.73

1.5

1.4

10.43

9.91

u/l

0.54

903

7487

Benign neoplasm: Testis

4.64

7.71

2.1

1.5

7.31

5.36

u/l

0.41

Poisoning by narcotics and psychodysleptics [hallucinogens]

337

2.17

7.70

1.6

10.31

6.54

u/l

1.01

282

Torsion of testis

377

2.09

7.68

1.6

1.9

5.20

4.40

u/l

0.80

300

Acute renal failure

281

1972

1.44

7.67

1.4

11.37

8.87

u/l

1.87

201

1571

Stomatitis and related lesions

438

3310

1.34

7.66

1.5

10.53

9.56

u/l

0.73

335

2648

Artificial opening status

485

1.91

7.65

1.7

1.5

9.26

8.41

u/l

0.27

373

Cauda equina syndrome

136

2.85

7.62

1.6

1.2

9.54

8.56

u/l

0.21

104

Fracture of lumbar spine and pelvis

289

2036

1.43

7.60

1.4

11.55

10.28

u/l

0.76

222

1623

Respiratory insufficiency

427

1.96

7.60

1.6

1.5

11.63

9.31

u/l

0.88

327

ILD medications: azathioprine

342

2493

1.39

7.60

1.6

1.5

8.93

8.74

u/l

0.11

288

1978

Malignant neoplasm, without specification of site

135

2.79

7.58

1.6

1.3

19.10

8.23

u/l

2.14

108

Varicella [chickenpox]

144

884

1.68

7.58

1.9

1.6

5.33

6.52

u/l

1.38

120

681

Diffuse brain injury

362

2.06

7.57

1.6

1.3

8.43

8.05

u/l

0.12

306

Acute laryngitis and tracheitis

408

3017

1.35

7.54

1.8

1.6

7.35

7.81

u/l

0.42

332

2339

Diabetes, insulin treatment (Kela reimbursement)

1945

10101

1.15

7.51

1.4

1.5

9.06

10.44

u/l

5.12

1540

8147

Schizoaffective disorder

189

1238

1.56

7.47

1.3

1.4

8.62

9.11

u/l

0.23

136

1011

Acute pancreatitis

308

2210

1.41

7.45

1.5

1.4

9.71

9.32

u/l

0.20

242

1768

Recurrent aphthous stomatitis , including avohilmo

292

2079

1.42

7.45

1.6

1.5

10.75

9.75

u/l

0.56

224

1659

Pruritus

219

1477

1.50

7.44

1.4

10.09

11.72

u/l

1.02

185

1198

Meniscus derangement

900

4898

1.22

7.44

1.4

9.86

10.90

u/l

1.54

745

3939

Presbycusis

467

1.89

7.43

1.2

1.3

13.16

12.98

u/l

0.04

369

Invasive ventilation

131

785

1.70

7.43

1.6

1.5

8.90

8.43

u/l

0.13

603

Open wound of wrist and hand

1123

9141

1.19

7.42

1.4

1.5

8.30

8.28

u/l

0.02

903

7356

Other local infections of skin and subcutaneous tissue

205

1366

1.52

7.41

1.7

1.4

9.62

9.14

u/l

0.17

162

1081

6-mercaptopurine

117

684

1.77

7.41

2.2

1.5

8.44

7.68

u/l

0.29

541

Other and unspecified local infections of skin and subcutaneous tissue

196

1295

1.54

7.38

1.8

1.4

9.35

9.06

u/l

0.10

156

1028

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

4.60

7.38

2.1

1.4

10.74

6.57

u/l

0.47

Achilles tendinitis

169

1080

1.58

7.35

1.5

1.4

8.22

10.94

u/l

2.42

137

868

Otitis externa

479

3686

1.31

7.35

1.5

1.4

9.53

9.79

u/l

0.18

385

2920

Non-Hodgkin lymphoma, all

221

2.34

7.35

1.5

1.4

12.31

7.90

u/l

1.46

179

Trochanteric bursitis

171

1095

1.58

7.32

1.3

13.58

15.34

u/l

0.79

131

881

Acute pancreatitis (for exclusion)

308

2218

1.40

7.31

1.5

1.4

9.71

9.21

u/l

0.27

242

1781

Superficial injury of head

472

3624

1.31

7.27

1.5

10.00

9.40

u/l

0.43

366

2845

Galactorrhea

164

2.67

7.27

1.2

1.3

14.42

12.19

u/l

0.34

136

Vasomotor rhinitis (mode)

128

767

1.70

7.27

1.3

1.4

13.36

10.86

u/l

0.98

103

628

Any dementia

137

1530

0.62

7.23

1.3

1.4

12.20

12.37

u/l

0.04

106

1208

Other congenital malformations of male genital organs, including avohilmo

185

2.61

7.18

2.4

5.34

4.06

u/l

0.59

118

Vitamin deficiency, wide

496

1.87

7.18

1.7

1.5

9.26

9.10

u/l

0.04

390

Vitamin deficiency

496

1.87

7.18

1.7

1.5

9.26

9.10

u/l

0.04

390

Atopic dermatitis, strict definition with reimbursement

929

7424

1.21

7.16

1.6

1.4

9.24

9.40

u/l

0.14

731

5939

Varicose veins of other sites

137

840

1.66

7.16

1.8

1.5

7.62

6.64

u/l

0.38

117

668

Other diseases of the respiratory system

240

1658

1.46

7.16

1.5

9.97

9.84

u/l

0.05

181

1306

Other respiratory disorders and diseases

240

1658

1.46

7.16

1.5

9.97

9.84

u/l

0.05

181

1306

Herpesviral [herpes simplex] infections, including avohilmo

606

4822

1.27

7.15

1.4

11.19

10.47

u/l

0.56

477

3915

Malignant neoplasm, without specification of site, including Hilmo

211

2.35

7.15

1.5

1.3

16.82

8.50

u/l

2.03

170

Gonarthrosis [arthrosis of knee](FG)

1143

5527

1.19

7.14

1.4

10.70

11.68

u/l

1.48

926

4469

Malnutrition

232

2.32

7.13

2.5

1.9

8.38

8.45

u/l

0.01

160

Other heart diseases

1166

6400

1.19

7.12

1.5

10.54

9.52

u/l

1.39

922

5105

Faecal incontinence

546

1.81

7.12

1.2

1.3

13.01

14.27

u/l

0.36

442

Renal failure

593

3993

1.27

7.10

1.6

1.4

12.98

9.49

u/l

4.46

458

3131

Disorder of lipoprotein metabolism, unspecified

151

947

1.61

7.09

1.5

1.3

10.66

9.87

u/l

0.26

114

760

Thrombocytopenia, unspecified

121

719

1.71

7.09

1.6

1.5

12.84

8.83

u/l

1.83

581

Visual impairment including blindness (binocular or monocular)

107

614

1.77

7.08

2.2

1.5

7.88

9.58

u/l

0.91

488

Degenerative diseases of the nervous system

117

1403

0.60

7.08

1.3

11.03

12.17

u/l

0.37

1108

L02BA Anti-estrogens

175

1136

1.55

7.07

1.4

1.2

18.84

19.56

u/l

0.22

144

922

False labour

868

4433

1.23

7.05

1.2

1.3

11.45

12.10

u/l

0.68

755

3526

Kela reimbursement Agammaglobulinemia (D80-84)

120

2.95

7.04

2.2

1.8

12.44

8.47

u/l

0.61

Motor disorders

476

1.95

7.03

2.9

2.3

4.42

5.81

u/l

1.65

287

Bell's palsy

206

1390

1.50

7.01

1.4

11.53

9.90

u/l

0.91

159

1132

Azathioprine

342

2529

1.37

6.99

1.6

1.5

8.93

8.70

u/l

0.14

288

2005

Excessive vomiting in pregnancy

217

1485

1.49

6.99

1.2

1.3

13.63

11.21

u/l

1.42

176

1204

Protozoal diseases, including avohilmo

306

2.12

6.98

1.7

1.4

13.18

9.21

u/l

1.03

234

Alcohol dependence

482

3739

1.30

6.96

1.4

9.58

7.93

u/l

2.22

355

3043

Myeloid leukaemia

215

2.34

6.95

2.5

1.4

12.51

7.96

u/l

0.92

169

Hidradenitis suppurativa

115

682

1.74

6.94

1.3

1.4

11.71

9.54

u/l

0.99

568

Small fibre neuropathy

274

2.18

6.90

1.5

1.4

11.95

9.19

u/l

0.50

217

Fibroblastic disorders

292

2104

1.40

6.90

1.4

10.15

11.14

u/l

0.59

235

1680

Other and unspecified immunodeficiencies with predominantly antibody defects

162

2.61

6.88

2.5

1.7

10.92

9.04

u/l

0.26

120

Adjustment and management of implanted device

189

1255

1.52

6.88

1.4

12.02

9.23

u/l

1.48

135

974

Atrial fibrillation and flutter with reimbursement

327

1496

1.39

6.88

1.4

11.01

9.92

u/l

0.62

258

1220

Benign neoplasm: Tongue

229

2.29

6.86

1.3

1.4

13.60

10.26

u/l

0.75

180

Vitamin D deficiency

256

2.24

6.86

1.9

1.6

8.27

8.36

u/l

0.02

200

Ethmoidectomy

257

1818

1.43

6.86

1.4

11.02

9.63

u/l

0.79

212

1480

Paroxysmal tachycardia

442

2812

1.32

6.86

1.5

10.23

10.06

u/l

0.09

347

2235

Other disorders starting during childhood or adolescence

232

1606

1.48

6.84

1.8

1.9

5.90

7.21

u/l

2.42

163

1175

Benign neoplasm: Brain, supratentorial

199

2.42

6.84

2.7

1.4

7.71

9.18

u/l

0.31

150

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

132

810

1.65

6.83

1.4

12.38

10.15

u/l

0.81

656

Mixed specific developmental disorders

107

580

1.80

6.83

2.7

2.2

5.84

5.92

u/l

0.04

370

Striking against or struck by other objects

888

7382

1.21

6.82

1.5

8.43

7.97

u/l

0.52

693

5855

Other and unspecified disorders of white blood cells

406

1.94

6.77

1.7

1.5

9.89

9.11

u/l

0.19

324

Gingival hyperplasia

530

1.83

6.75

1.9

1.8

7.97

8.01

u/l

0.01

394

Other chronic obstructive pulmonary disease, including avohilmo

622

4083

1.26

6.75

1.4

11.13

10.56

u/l

0.47

468

3269

Torsion of ovary, ovarian pedicle and fallopian tube

156

2.56

6.75

1.3

11.19

13.61

u/l

0.54

120

Other/unspecified cytomegaloviral diseases

232

2.29

6.73

2.0

1.5

10.27

8.15

u/l

0.64

188

Adhesive capsulitis of shoulder

214

1466

1.47

6.72

1.5

1.3

11.15

12.32

u/l

0.55

165

1176

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

218

1501

1.47

6.71

1.4

11.70

11.04

u/l

0.26

178

1228

Rhabdomyosarcoma, including Hilmo

9.81

6.71

3.0

1.3

9.91

5.91

u/l

—

Schizophrenia, schizotypal and delusional disorders

731

5982

1.23

6.70

1.4

1.5

8.53

8.60

u/l

0.07

538

4864

Acute generalized exanthematous pustulosis

523

1.82

6.69

1.6

1.5

12.19

9.98

u/l

0.71

415

Other disorders of white blood cells

567

1.78

6.67

1.7

1.4

9.87

9.54

u/l

0.07

450

Somnolence, stupor and coma

458

1.87

6.66

1.4

12.59

8.02

u/l

1.15

369

Iron deficiency

119

723

1.71

6.63

1.5

1.4

6.90

10.02

u/l

3.75

579

Diseases of tongue

501

1.82

6.62

1.3

1.4

11.31

11.27

u/l

0.01

401

Skin changes due to chronic exposure to nonionizing radiation

306

2020

1.38

6.60

1.4

1.3

13.22

13.06

u/l

0.06

239

1604

Autism

122

749

1.70

6.60

1.7

7.82

6.98

u/l

0.39

100

579

Melanocytic naevi, other sites/unspecified

176

1167

1.53

6.59

1.4

10.45

10.06

u/l

0.15

148

950

Protozoal diseases

286

2.12

6.59

1.7

1.4

13.68

9.03

u/l

1.20

220

Insulin, combination of fast acting with intermediate-acting or long-acting

1114

8589

1.18

6.56

1.4

1.5

9.46

8.88

u/l

0.83

865

6860

Sequelae of other external causes

108

637

1.73

6.56

1.4

9.83

9.82

u/l

0.00

520

Other symptoms and signs involving the circulatory and respiratory systems

122

743

1.67

6.54

1.4

1.5

9.37

9.70

u/l

0.10

583

Schizophrenia or delusion

729

5981

1.23

6.53

1.4

1.5

8.47

8.60

u/l

0.12

536

4863

Anorexia

197

2.39

6.53

1.8

1.5

8.06

10.08

u/l

0.53

159

Traumatic subdural haemorrhage

131

756

1.63

6.52

1.4

1.3

8.41

9.93

u/l

1.01

101

608

FESS (DNB20)

249

1769

1.43

6.52

1.4

11.13

9.64

u/l

0.85

208

1438

Cytomegalovirus infection, IBD co-morbidity

268

2.16

6.51

2.0

1.5

10.52

8.56

u/l

0.61

220

Sudden idiopathic hearing loss

143

906

1.60

6.51

1.6

1.4

11.09

9.94

u/l

0.45

118

745

Cholecystectomy

1097

7907

1.18

6.51

1.4

1.3

12.09

12.28

u/l

0.16

880

6411

Strabismus

595

4766

1.26

6.51

1.7

1.5

9.35

9.68

u/l

0.23

471

3727

Raynaud syndrome

192

1301

1.50

6.49

1.7

1.3

9.60

10.60

u/l

0.45

157

1076

Maltreatment syndromes

174

1160

1.54

6.48

1.5

8.57

8.17

u/l

0.19

146

928

Heartburn

210

1448

1.47

6.45

1.4

10.10

9.60

u/l

0.21

170

1169

Maternal care for known or suspected abnormality of pelvic organs

711

3916

1.24

6.43

1.2

1.3

11.90

12.14

u/l

0.16

621

3121

Ganglion

405

3106

1.32

6.43

1.3

1.4

10.70

10.89

u/l

0.10

347

2505

Chronic kidney disease

366

2656

1.33

6.42

1.5

14.64

9.16

u/l

5.46

288

2077

Manic episode

422

1.90

6.41

1.3

1.4

9.40

8.77

u/l

0.19

350

Fungal Sepsis

364

1.96

6.41

1.5

1.3

11.90

9.45

u/l

0.63

294

Malignant neoplasm of thyroid gland

103

603

1.73

6.41

1.5

1.3

14.64

10.73

u/l

1.30

496

Nontoxic goitre/thyroid nodule

309

2276

1.37

6.40

1.2

1.3

14.90

15.07

u/l

0.05

247

1865

Wilms' tumor, including Hilmo

4.08

6.40

3.6

1.6

17.38

5.00

u/l

—

Explicit bacterial Sepsis, including avohilmo

179

1199

1.51

6.34

1.6

1.4

12.21

8.31

u/l

2.97

129

945

341

2290

1.34

6.34

1.4

1.3

13.00

12.85

u/l

0.06

268

1828

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

477

3749

1.29

6.34

1.3

10.85

10.95

u/l

0.05

379

3079

Effects of foreign body entering through natural orifice

553

4421

1.26

6.34

1.5

9.27

7.78

u/l

1.83

439

3511

Unknown and unspecified causes of morbidity

124

765

1.64

6.33

1.5

1.3

9.79

9.54

u/l

0.07

111

622

Flat foot [pes planus] (acquired)

138

873

1.60

6.33

1.4

12.77

13.75

u/l

0.26

117

700

Anogenital herpesviral [herpes simplex] infection, including avohilmo

375

2864

1.33

6.31

1.5

1.4

9.03

9.25

u/l

0.13

296

2355

Malignant neoplasm of thyroid gland, including Hilmo

110

659

1.69

6.29

1.5

1.3

13.98

11.01

u/l

0.93

540

Deep endometriosis

186

1261

1.50

6.28

1.2

1.3

10.51

12.60

u/l

1.42

157

1043

In situ neoplasms

572

4588

1.25

6.28

1.3

12.06

u/l

0.00

463

3750

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1112

9390

1.18

6.27

1.4

1.5

9.44

9.07

u/l

0.42

898

7522

Pure hyperglyceridaemia

213

2.27

6.23

1.7

1.3

7.38

7.86

u/l

0.12

175

Hypocalcemia

233

2.21

6.21

1.5

1.4

12.56

10.57

u/l

0.43

186

Generalized skin eruption due to drugs and medicaments

477

1.83

6.20

1.7

1.5

12.05

9.52

u/l

0.85

375

Viral infections of the central nervous system, including avohilmo

165

1096

1.53

6.17

1.6

1.4

9.24

9.41

u/l

0.05

133

879

Pneumonia due to other infectious organisms, not elsewhere classified

307

2.03

6.16

1.5

10.99

9.05

u/l

0.36

252

Varicella [chickenpox], including avohilmo

164

1092

1.54

6.14

1.9

1.7

5.54

6.41

u/l

0.90

129

801

AV-block

199

1164

1.47

6.14

1.4

1.5

10.91

9.05

u/l

1.00

156

941

Other diseases of stomach and duodenum

484

1.80

6.14

1.3

1.4

13.67

10.56

u/l

0.86

392

Postmenopausal osteoporosis with pathological fracture

127

2.62

6.13

1.5

1.3

27.75

24.82

u/l

0.35

COPD

489

3126

1.28

6.10

1.3

1.4

10.53

10.21

u/l

0.20

360

2505

Thyroiditis

132

836

1.61

6.10

1.6

1.3

14.08

11.92

u/l

0.79

107

680

Appendectomy

1447

12024

1.15

6.09

1.4

10.13

9.91

u/l

0.24

1203

9760

Melanocytic naevi of lower limb, including hip

584

1.73

6.08

1.4

10.65

9.87

u/l

0.19

467

Family history of malignant neoplasm

233

1658

1.42

6.08

1.4

1.3

15.68

12.05

u/l

2.62

205

1354

Suppurative and unspecified otitis media

1146

8720

1.17

6.07

1.6

1.5

8.79

8.23

u/l

0.82

915

6992

Other viral diseases, not elsewhere classified

450

3521

1.29

6.05

1.7

1.5

9.26

8.95

u/l

0.21

368

2715

Status epilepticus

309

2.01

6.04

1.7

1.6

9.68

8.68

u/l

0.19

239

Third [oculomotor] nerve palsy

141

2.56

6.03

2.1

1.4

6.04

9.72

u/l

1.56

106

Superficial injury of wrist and hand

550

4424

1.26

6.02

1.5

8.44

8.86

u/l

0.38

439

3509

Ischemic heart diseases

1262

6469

1.16

5.99

1.4

1.5

10.95

10.81

u/l

0.11

1034

5118

Wide developmental disorders

159

1059

1.55

5.99

1.9

7.26

6.76

u/l

0.26

122

772

Autism spe

120

754

1.66

5.98

1.7

7.92

6.90

u/l

0.49

584

Benign neoplasm of eye and adnexa

143

927

1.56

5.93

1.4

10.17

11.27

u/l

0.42

113

756

Other disorders of nervous system

572

1.72

5.91

1.6

1.4

12.20

9.82

u/l

0.79

463

Focal epilepsy, strict definition

363

2777

1.32

5.91

1.6

1.5

10.71

9.04

u/l

1.32

286

2151

Acute pharyngitis

493

3890

1.27

5.90

1.5

7.55

7.70

u/l

0.11

394

3066

Complications following infusion, transfusion and therapeutic injection

131

2.61

5.89

1.6

1.3

10.47

8.93

u/l

0.25

107

Other disorders of urethra and urinary system

1326

8001

1.16

5.88

1.3

1.4

13.09

11.03

u/l

4.33

1044

6547

Benign neoplasm of other and unspecified sites

299

2.02

5.87

1.6

1.3

11.91

10.46

u/l

0.28

239

Conjunctivitis (acute, non atopic)

648

5292

1.23

5.86

1.6

1.5

9.99

9.45

u/l

0.50

510

4177

Other specified disorders of external ear

355

1.93

5.86

1.9

1.4

8.03

8.64

u/l

0.15

283

Fitting and adjustment of other devices

378

2554

1.31

5.84

1.4

12.20

10.86

u/l

1.12

320

2014

Mental disorders, not otherwise specified

223

1590

1.43

5.84

1.4

9.44

9.19

u/l

0.10

177

1298

Keratitis

707

5850

1.22

5.84

1.5

1.4

10.08

9.52

u/l

0.49

579

4715

Viral infections of the central nervous system

150

989

1.54

5.84

1.5

1.4

9.65

9.52

u/l

0.04

121

795

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

608

4957

1.24

5.83

1.4

1.5

8.91

8.63

u/l

0.22

499

3990

Nontoxic single thyroid nodule

544

1.73

5.83

1.3

12.84

13.11

u/l

0.06

443

Hyperaldosteronism

206

2.24

5.82

2.0

1.2

9.43

9.16

u/l

0.05

162

Cytomegaloviral disease

301

2.03

5.82

1.9

1.5

10.19

9.10

u/l

0.29

245

Embedded and impacted teeth

1046

7270

1.18

5.82

1.5

8.10

7.81

u/l

0.24

857

5835

Hepatocellular carcinoma, including Hilmo

174

2.34

5.81

1.4

11.17

6.45

u/l

1.13

139

Gout, idiopatic and unspecified

296

2203

1.35

5.80

1.4

8.95

8.24

u/l

0.43

224

1752

Agoraphobia

109

671

1.67

5.80

1.5

1.4

8.94

8.54

u/l

0.11

549

Unspecified fall

975

8146

1.18

5.79

1.6

1.5

9.81

9.39

u/l

0.44

755

6468

Autoimmune hepatitis, wide definition

487

1.78

5.78

1.7

1.5

9.22

8.72

u/l

0.14

384

Explicit bacterial Sepsis

172

1167

1.49

5.77

1.6

1.4

12.45

8.29

u/l

3.16

125

920

Budesonide

297

2219

1.35

5.75

1.5

1.4

9.38

9.45

u/l

0.04

242

1800

Nasal polyp

296

2208

1.35

5.75

1.4

9.53

9.17

u/l

0.19

250

1781

Intestinal malabsorption

571

1.72

5.74

1.5

11.19

8.10

u/l

1.01

460

Other inflammation of eyelid, including avohilmo

1080

9286

1.17

5.73

1.5

1.4

10.04

10.02

u/l

0.02

852

7522

Vulvovaginal ulceration/inflammation in other diseases

188

1305

1.47

5.72

1.3

10.74

11.28

u/l

0.16

148

1073

Actinic keratosis

286

1924

1.36

5.72

1.4

1.3

13.49

13.01

u/l

0.21

224

1522

Other bursopathies

179

1226

1.47

5.71

1.4

11.01

10.34

u/l

0.27

152

981

Hypertrophic disorders of skin

142

931

1.56

5.71

1.5

1.4

9.86

9.89

u/l

0.01

113

750

Iron deficiency anaemia secondary to blood loss (chronic)

194

1349

1.45

5.71

1.4

12.56

11.35

u/l

0.48

154

1094

Fracture of lower leg, including ankle

1030

8656

1.17

5.70

1.5

10.33

9.93

u/l

0.41

836

6961

Car occupant injured in other and unspecified transport accidents

474

3777

1.27

5.67

1.4

8.58

8.93

u/l

0.29

384

3080

Conduction disorders

387

2394

1.30

5.67

1.4

1.5

10.87

9.72

u/l

0.82

302

1891

Ptosis of eyelid

128

818

1.58

5.66

1.4

9.60

11.86

u/l

1.26

651

Alzheimer disease, including avohilmo

113

1242

0.63

5.65

1.4

1.3

11.57

13.02

u/l

0.48

977

Other and unspecified myopathies

122

772

1.60

5.65

1.6

1.4

9.68

8.57

u/l

0.35

621

Malignant neoplasm of other connective and soft tissue, including Hilmo

289

2.01

5.64

1.7

1.3

10.90

8.61

u/l

0.62

227

Insulin, fast-acting

717

5958

1.21

5.64

1.4

1.5

9.61

8.34

u/l

1.91

556

4742

Trigger finger

211

1494

1.42

5.64

1.3

13.66

12.02

u/l

0.65

165

1204

Use of disulfiram, acamprosate or naltrexone

200

1407

1.44

5.64

1.4

7.68

7.34

u/l

0.19

149

1136

Malignant neoplasm of oropharynx

116

2.67

5.63

1.5

1.3

14.48

6.06

u/l

2.49

Ehlers-Danlos syndrome, including avohilmo

245

2.15

5.63

1.5

1.4

9.41

10.66

u/l

0.30

198

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

100

605

1.69

5.61

1.4

9.89

9.01

u/l

0.29

497

Otitis externa, unspecified

252

1847

1.38

5.57

1.5

9.67

9.35

u/l

0.15

211

1469

313

1.97

5.56

1.5

1.4

10.48

9.61

u/l

0.21

257

395

1.84

5.55

2.0

1.4

8.72

9.23

u/l

0.12

314

Gout, unspecified

242

1759

1.39

5.54

1.4

9.31

8.07

u/l

0.74

181

1395

Single delivery by caesarean section

587

2720

1.25

5.54

1.3

1.4

11.69

10.79

u/l

0.50

516

2109

Other congenital malformations, including avohilmo

340

2608

1.32

5.53

1.9

1.5

8.63

9.34

u/l

0.48

256

2030

Other and unspecified disorders of autonomic nervous system

3.48

5.53

1.6

1.5

9.35

10.31

u/l

0.12

Benign neoplasm: Stomach

104

636

1.65

5.52

1.4

1.3

12.71

12.59

u/l

0.03

511

Thyrotoxicosis with diffuse goitre

233

1686

1.40

5.52

1.4

1.3

11.65

12.21

u/l

0.23

191

1376

Other and unspecified diseases of blood and blood-forming organs

231

2.13

5.52

1.6

1.4

9.33

9.32

u/l

0.00

186

Autonomic disorders

272

2.04

5.52

1.7

1.4

10.04

8.81

u/l

0.23

223

Carbimazole or st.post thyroidectomy, condition for graves disease

354

2730

1.31

5.47

1.4

1.3

12.67

12.26

u/l

0.18

282

2212

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

5.06

5.45

2.6

1.4

6.47

6.48

u/l

—

Antenatal screening

556

2512

1.25

5.45

1.2

1.4

12.96

12.70

u/l

0.15

469

1983

Other specified/unspecified inflammatory spondylopathies

108

672

1.64

5.45

1.3

1.4

13.51

9.89

u/l

1.38

546

Pilonidal cyst

252

1858

1.38

5.44

1.6

1.5

6.33

7.35

u/l

1.25

213

1488

Cytomegaloviral disease, including avohilmo

309

1.97

5.43

1.9

1.6

10.19

8.99

u/l

0.33

253

Malignant neoplasm of brain

372

1.87

5.42

2.4

1.5

6.44

7.43

u/l

0.39

303

Hypertrophic scar

132

863

1.56

5.41

1.5

1.4

9.66

9.93

u/l

0.08

105

690

Olecranon bursitis

103

634

1.65

5.39

1.3

1.4

7.85

6.83

u/l

0.53

503

Malignant neoplasm of breast, HER-negative

130

808

1.55

5.38

1.2

21.87

18.61

u/l

1.13

117

643

Implicit fungal Sepsis

337

1.90

5.37

1.5

1.3

12.53

9.60

u/l

0.74

271

Other enthesopathy of foot (+metatarsalgia)

174

1202

1.46

5.37

1.3

1.4

9.71

11.72

u/l

1.21

144

961

Otitis media, unspecified

362

2589

1.31

5.37

1.8

1.6

7.52

8.18

u/l

0.67

288

1994

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

312

1.98

5.36

2.5

2.0

6.37

8.49

u/l

0.92

213

Alzheimer disease

1053

0.60

5.35

1.3

11.50

12.95

u/l

0.44

825

Other congenital malformations of male genital organs

172

2.41

5.34

2.4

4.89

4.02

u/l

0.42

107

Sequelae of injuries of head

116

739

1.60

5.32

1.3

1.4

8.00

7.53

u/l

0.19

601

Fracture of foot, except ankle

571

4677

1.23

5.31

1.5

9.79

9.10

u/l

0.59

465

3726

Mental retardation, excluding more controls

103

616

1.65

5.30

2.9

1.7

6.90

7.34

u/l

0.18

440

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

359

1.86

5.30

1.3

1.4

11.85

7.44

u/l

1.69

285

Other chronic obstructive pulmonary disease

456

2969

1.26

5.29

1.3

1.4

10.54

10.13

u/l

0.27

337

2370

Nail disorders

171

1183

1.47

5.28

1.5

10.75

8.78

u/l

1.03

144

959

Motor neuron disease (with DMD)

2.88

5.28

2.3

1.3

7.17

9.01

u/l

0.37

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

317

1.92

5.28

1.3

13.62

15.29

u/l

0.27

258

Malignant neoplasm of other connective and soft tissue

157

2.34

5.24

1.5

1.3

11.06

8.20

u/l

0.66

120

Fracture of skull and facial bones

451

3606

1.26

5.24

1.6

1.5

8.25

8.26

u/l

0.01

360

2892

Gastric ulcer

184

1289

1.44

5.22

1.3

1.4

13.03

10.41

u/l

1.26

147

1021

Artrosis, including avohilmo

1638

7939

1.13

5.22

1.4

9.65

10.23

u/l

1.00

1339

6457

834

0.49

5.21

1.5

1.4

8.33

7.14

u/l

0.28

667

Disorders of vitreous body

565

4394

1.23

5.21

1.3

12.96

13.00

u/l

0.02

437

3550

Disorders of endocrine glands in diseases classified elsewhere

7.09

5.20

3.0

2.0

5.44

8.55

u/l

0.46

Other and unspecified disorders of adult personality and behaviour

2.84

5.19

1.4

7.04

9.61

u/l

0.61

Unspecific neurodegenerative disorder

160

1590

0.69

5.19

1.4

1.3

10.63

12.97

u/l

1.49

120

1256

Hydrocele

170

1178

1.46

5.16

1.6

1.5

6.70

6.16

u/l

0.35

125

949

Any dementia, excluding more controls

130

1346

0.66

5.15

1.3

1.4

12.22

12.79

u/l

0.15

101

1068

Benign neoplasm: Adrenal gland

610

1.64

5.15

1.6

1.3

11.58

11.52

u/l

0.01

494

Other strabismus

514

4164

1.24

5.14

1.7

1.5

9.37

9.38

u/l

0.01

409

3266

Diabetic retinopathy, excluding more controls

329

2385

0.77

5.12

1.3

1.4

11.41

8.74

u/l

2.45

256

1951

Gonarthrosis,primary

1156

6040

1.16

5.12

1.4

1.3

10.83

12.51

u/l

3.61

937

4867

Other specified/unspecified dorsopathies

286

1.96

5.11

1.7

1.4

13.19

10.32

u/l

0.58

236

Disorders of muscles

188

1331

1.43

5.11

1.6

1.4

10.29

9.58

u/l

0.30

149

1068

Hepatocellular carcinoma

128

2.47

5.09

1.4

1.3

12.28

6.63

u/l

1.10

104

Hypoglycaemia, other or unspecified

141

947

1.51

5.08

1.6

11.29

8.31

u/l

1.30

105

741

Adverse effects, not elsewhere classified

450

3613

1.26

5.08

1.5

1.4

9.83

10.04

u/l

0.11

360

2885

Vestibular neuronitis

126

825

1.55

5.08

1.4

11.00

10.65

u/l

0.09

670

Diabetic retinopathy

379

2988

0.78

5.07

1.3

1.4

11.72

8.91

u/l

2.90

287

2419

Disturbances of smell and taste

351

1.86

5.07

1.3

1.4

10.28

11.46

u/l

0.28

285

Deep bite

319

2155

1.32

5.06

1.9

1.7

8.02

8.32

u/l

0.17

244

1625

Heterophoria

198

1420

1.42

5.06

1.5

1.6

10.16

9.09

u/l

0.48

162

1110

Malignant neoplasm of oropharynx, including Hilmo

141

2.40

5.05

1.5

1.3

13.63

6.17

u/l

2.29

115

Coronary revascularization (ANGIO or CABG)

1136

5981

1.16

5.03

1.4

1.5

10.49

10.59

u/l

0.07

932

4725

Barrett oesophagus

425

1.77

5.03

1.6

1.4

7.17

8.33

u/l

0.54

346

Dependence on enabling machines and devices, not elsewhere classified

148

2.39

5.02

2.2

1.9

4.57

6.34

u/l

0.81

Other blood glucose lowering drugs, excl. Insulins

155

1060

1.47

5.02

1.2

1.4

8.73

11.21

u/l

2.11

126

859

Preterm labour and delivery

415

3302

1.27

5.02

1.3

12.66

14.69

u/l

1.94

357

2687

Nonhereditary hypogammaglobulinemia

124

2.53

5.01

1.6

1.4

11.70

9.40

u/l

0.30

101

Algoneurodystrophy

427

1.78

5.00

1.5

1.4

11.30

10.39

u/l

0.19

346

Percutaneous Coronary Intervention

1133

5975

1.16

5.00

1.4

1.5

10.50

10.59

u/l

0.07

929

4720

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

274

1.96

4.99

1.4

1.5

10.50

7.09

u/l

0.93

218

Focal epilepsy

399

3163

1.27

4.99

1.5

10.46

9.12

u/l

1.07

317

2463

Other and unspecified nail disorders

234

2.06

4.98

1.5

1.4

9.29

9.81

u/l

0.12

193

Insulin, fast-acting or short human

717

6038

1.19

4.94

1.4

1.5

9.61

8.36

u/l

1.87

556

4805

Hypermobility syndrome

149

1021

1.49

4.94

1.4

11.68

10.84

u/l

0.24

120

831

Benign neoplasm of male genital organs

208

2.13

4.94

1.7

1.4

7.95

5.85

u/l

0.51

166

Other otitis externa (chronic)

123

808

1.55

4.93

1.6

1.4

9.89

9.65

u/l

0.08

653

Follicular cysts of skin and subcutaneous tissue

323

2500

1.30

4.92

1.5

1.4

11.25

9.50

u/l

1.16

266

2024

Metatarsalgia

156

1075

1.47

4.92

1.3

1.4

10.07

11.91

u/l

0.94

127

861

Malignant neoplasm of breast, ER-negative, including Hilmo

148

940

1.48

4.91

1.2

21.86

18.15

u/l

1.55

134

752

Other disorders of glucose regulation and pancreatic internal secretion

167

1168

1.45

4.90

1.6

1.5

11.38

8.41

u/l

1.54

126

915

Sequelae of injuries of neck and trunk

371

1.82

4.89

1.3

1.4

9.18

8.12

u/l

0.32

305

Osteonecrosis due to drugs

107

2.60

4.87

1.8

1.3

17.54

8.70

u/l

1.63

Certain conditions originating in the perinatal period

321

2212

1.31

4.86

2.0

1.8

7.16

7.49

u/l

0.22

249

1667

Early onset COPD

288

2197

1.32

4.86

1.4

9.75

9.50

u/l

0.12

213

1754

Pregnancy with abortive outcome

1287

5873

1.15

4.86

1.2

1.3

12.52

12.33

u/l

0.17

1073

4785

Combinations of oral blood glucose lowering drugs

349

2730

1.29

4.85

1.5

1.4

7.73

9.70

u/l

4.09

276

2190

Ehlers-Danlos syndrome

198

2.19

4.85

1.5

1.4

8.57

10.82

u/l

0.59

162

Special screening examination for neoplasms

444

1.73

4.84

1.5

1.3

11.94

10.06

u/l

0.54

357

Pervasive developmental disorders excl. Autism + Asperger

357

1.87

4.83

2.2

6.71

6.21

u/l

0.18

227

Acute myeloid leukaemia and myelodysplastic syndromes

113

2.52

4.83

2.7

1.3

17.30

8.18

u/l

1.03

Follow-up care involving plastic surgery

357

1.83

4.82

1.1

1.2

18.17

12.50

u/l

1.72

285

Autoimmune thyroiditis

231

2.05

4.80

1.6

1.3

14.55

10.93

u/l

0.65

182

Other disorders of kidney and ureter

174

1229

1.43

4.80

1.6

1.4

11.61

9.59

u/l

1.06

142

979

Extreme obesity with alveolar hypoventilation

343

1.84

4.80

1.3

10.30

9.73

u/l

0.13

278

Amblyopia ex anopsia

114

744

1.57

4.79

1.9

1.8

8.61

7.75

u/l

0.29

562

Maternal care for known or suspected fetal abnormality and damage

495

3422

1.24

4.79

1.2

1.3

9.98

11.03

u/l

1.00

401

2726

Other necrotizing vasculopathies (FG)

394

1.77

4.78

1.4

12.79

11.08

u/l

0.36

317

Event of undetermined intent

165

1160

1.45

4.77

1.5

8.26

7.98

u/l

0.11

119

918

Lesion of lateral popliteal nerve

508

1.68

4.77

1.5

1.3

10.93

8.84

u/l

0.68

420

Haemorrhage, not elsewhere classified

272

1.94

4.76

1.8

1.5

12.08

7.93

u/l

0.85

220

Alzheimer’s disease, strict definition

836

0.56

4.76

1.3

11.59

13.10

u/l

0.36

650

Focal epilepsy, mode (most common among epilepsy diagnosis)

339

2653

1.29

4.74

1.5

10.76

9.12

u/l

1.21

272

2060

Abscess of anal and rectal regions

181

1293

1.42

4.74

1.5

9.61

7.91

u/l

0.90

146

1034

Intentional self-harm by unspecified means

276

1.98

4.73

1.4

1.6

6.17

8.71

u/l

1.91

228

Dermatophytosis

218

1606

1.37

4.70

1.6

1.5

9.27

8.99

u/l

0.13

180

1278

Viral meningitis, including avohilmo

613

1.62

4.69

1.7

1.4

10.70

8.97

u/l

0.52

500

Other surgical follow-up care

504

1.68

4.69

1.3

1.5

9.86

8.80

u/l

0.30

403

Acute posthaemorrhagic anaemia

225

2.03

4.69

1.4

1.3

12.15

9.61

u/l

0.66

176

Paralytic strabismus

101

642

1.59

4.68

2.0

1.4

8.89

9.24

u/l

0.10

511

Postmenopausal atrophic vaginitis

165

619

1.46

4.68

1.2

1.3

23.18

23.59

u/l

0.09

136

489

Presence of other devices

260

1934

1.33

4.66

1.2

1.3

11.53

11.59

u/l

0.02

227

1536

Viral warts

234

1750

1.36

4.64

1.6

1.5

8.08

9.08

u/l

0.59

192

1391

Other erythematous conditions

333

1.84

4.62

1.5

11.77

9.94

u/l

0.39

257

Acute suppurative otitis media

901

7257

1.17

4.61

1.6

1.5

8.79

7.96

u/l

1.19

707

5819

Streptococcal septicaemia, including avohilmo

131

884

1.50

4.61

1.7

1.5

11.87

8.71

u/l

1.79

702

Other and unspecified coagulation defects

116

766

1.54

4.60

1.4

10.29

10.04

u/l

0.07

615

Arthropathies in other diseases classified elsewhere

348

1.82

4.60

1.4

13.89

10.00

u/l

0.74

275

Other gastritis (incl. Duodenitis)

280

2145

1.31

4.60

1.3

1.4

11.65

10.35

u/l

0.85

214

1739

Familial hypercholesterolemia

151

1047

1.45

4.60

1.4

10.46

9.90

u/l

0.18

122

840

DVT of lower extremities

233

1739

1.35

4.59

1.5

1.4

12.48

10.52

u/l

1.05

196

1410

Sensorineural hearing loss

1015

5866

1.16

4.59

1.5

1.4

10.81

11.17

u/l

0.32

796

4699

Disorders of vitreous body and globe

577

4532

1.21

4.59

1.3

1.4

12.78

12.90

u/l

0.06

446

3661

Other and unspecified erythematous conditions

305

1.87

4.58

1.5

10.96

9.99

u/l

0.18

238

Pneumocystosis

161

2.24

4.57

1.8

1.4

12.56

8.05

u/l

0.74

122

Pneumocystosis, including avohilmo

161

2.24

4.57

1.8

1.4

12.56

8.05

u/l

0.74

122

Atopic dermatitis, strict definition

891

7530

1.17

4.56

1.6

1.5

9.20

9.18

u/l

0.02

697

6025

Atrophic disorders of skin

223

1656

1.36

4.56

1.6

1.4

12.09

12.99

u/l

0.37

175

1345

Other disorders of pigmentation

393

1.76

4.56

1.3

1.4

12.97

10.25

u/l

0.80

310

Abnormal blood-pressure reading, without diagnosis

476

1.69

4.56

1.6

1.5

10.31

9.73

u/l

0.15

375

Exclusion endpoint for clefts

457

1.73

4.55

2.6

2.0

6.10

7.58

u/l

0.95

333

Second line medication for Crohn's disease

1123

9845

1.14

4.55

1.6

1.4

10.92

10.20

u/l

0.92

923

7885

Examination and encounter for administrative purposes

108

702

1.55

4.53

1.5

1.4

8.24

9.01

u/l

0.29

567

Other epidermal thickening

477

1.68

4.53

1.6

1.4

10.93

8.56

u/l

0.66

373

Ménière disease

107

694

1.56

4.53

1.5

1.3

11.93

12.31

u/l

0.11

563

Other and unspecified urticaria

428

3466

1.25

4.52

1.5

10.51

10.13

u/l

0.24

360

2744

Other specified/unspecified spondylopathies

123

2.40

4.52

1.3

11.87

8.82

u/l

0.59

Malignant neoplasm of breast, HER2-negative

391

2003

1.26

4.52

1.2

22.83

18.00

u/l

5.52

335

1607

Infections with a predominantly sexual mode of transmission

848

7293

1.17

4.51

1.4

9.46

9.42

u/l

0.03

656

6006

Contraceptive management

877

5274

1.17

4.51

1.4

1.5

10.82

9.25

u/l

2.69

725

4226

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

4.55

4.50

1.2

1.4

17.16

5.37

u/l

—

Sequelae of injuries of upper limb

186

1348

1.40

4.49

1.4

9.87

9.02

u/l

0.33

157

1086

Emergency coronary revascularization (for ACS)

1184

6269

1.14

4.48

1.4

1.5

10.50

10.68

u/l

0.15

968

4957

COPD-related respiratory insufficiency

113

744

1.53

4.46

1.2

1.4

9.42

10.08

u/l

0.23

597

Separation of retinal layers (serosa)

472

1.68

4.46

1.5

1.4

7.06

7.08

u/l

0.01

382

L04AA Selective immunosuppressants

413

3338

1.25

4.43

1.6

1.5

11.79

10.08

u/l

1.48

338

2649

Gastroduodenal ulcer

266

2027

1.31

4.43

1.3

1.4

12.77

10.07

u/l

1.86

212

1621

Complications predominantly related to the puerperium

587

4916

1.20

4.43

1.2

1.3

11.98

11.76

u/l

0.13

489

4061

Congenital malformations of the nervous system

484

1.69

4.42

1.6

1.9

7.61

8.42

u/l

0.27

351

Malignant neoplasm of breast

391

2008

1.26

4.42

1.2

22.85

17.99

u/l

5.59

335

1611

Seborrhoeic keratosis

258

1966

1.32

4.41

1.5

1.3

12.53

12.80

u/l

0.11

219

1585

Other abnormal findings of blood chemistry

535

1.63

4.41

1.5

1.4

10.70

9.24

u/l

0.36

433

Other specified congenital malformation syndromes affecting multiple systems

394

1.78

4.41

2.5

2.0

6.02

7.39

u/l

0.73

280

Campylobacter enteritis

339

1.81

4.41

1.5

1.4

9.67

8.99

u/l

0.13

278

Lesion of radial nerve

368

1.77

4.40

1.5

1.3

10.89

9.42

u/l

0.33

307

Acute bronchiolitis

220

1486

1.36

4.39

2.2

2.0

6.75

6.81

u/l

0.03

160

1065

Early lumbar disc prolapse operation

310

2432

1.29

4.39

1.5

1.4

8.35

8.69

u/l

0.20

257

1983

Plantar fascial fibromatosis

142

985

1.46

4.37

1.4

1.3

11.31

12.84

u/l

0.56

116

807

Need for other prophylactic measures

112

743

1.53

4.35

1.6

1.7

6.80

8.03

u/l

0.58

573

Social disorders starting during childhood or adolecense, excluding more controls

194

2.15

4.35

2.2

1.9

4.92

6.88

u/l

1.20

138

Other specified/unspecified soft tissue disorders

340

1.79

4.31

1.3

12.45

10.75

u/l

0.36

275

Postprocedural musculoskeletal disorders, not elsewhere classified

483

1.65

4.30

1.5

1.3

11.53

10.93

u/l

0.15

392

Obstructive hydrocephalus

159

2.21

4.30

3.7

1.7

4.09

7.57

u/l

3.73

117

Malignant neoplasm of liver and intrahepatic bile ducts

178

2.11

4.30

1.4

11.29

6.88

u/l

0.96

143

Superficial injury of abdomen, lower back and pelvis

344

2736

1.27

4.29

1.5

8.66

8.89

u/l

0.14

267

2198

Fall on same level involving ice and snow

1067

9368

1.14

4.28

1.4

10.34

10.32

u/l

0.01

873

7549

Nontoxic diffuse goitre

185

2.09

4.28

1.3

1.2

15.54

14.19

u/l

0.23

151

Specific development disorders of speech and language

187

1322

1.39

4.27

2.1

1.8

7.28

6.92

u/l

0.17

128

965

Diseases of arteries, arterioles and capillaries (FINNGEN)

327

1770

1.28

4.27

1.3

1.4

10.67

9.45

u/l

0.76

256

1444

Malignant neoplasm of breast, HER2-negative, including Hilmo

408

2102

1.25

4.25

1.2

22.81

17.63

u/l

6.53

351

1692

Corns and callosities

100

650

1.56

4.25

1.5

1.4

11.29

9.76

u/l

0.40

529

Carrier of infectious disease

366

1.77

4.24

1.4

7.50

8.82

u/l

0.52

293

Sicca syndrome [Sjögren]

642

1.56

4.23

1.3

16.02

14.56

u/l

0.37

522

Rosacea

221

1662

1.34

4.22

1.4

9.65

11.89

u/l

1.76

176

1378

Streptococcal septicaemia

126

861

1.48

4.21

1.7

1.5

12.11

8.67

u/l

1.96

683

Cholecystitis

162

1159

1.41

4.19

1.3

1.4

11.53

10.50

u/l

0.43

130

933

Dementia

200

1839

0.74

4.18

1.4

11.23

12.41

u/l

0.55

151

1456

Other specified/unspecified disorders of bone/cartilage

286

1.86

4.17

1.4

7.66

8.56

u/l

0.27

230

Hernia

1751

10503

1.11

4.16

1.5

1.4

9.39

10.17

u/l

1.65

1412

8455

Benign neoplasm of ovary

156

1110

1.41

4.16

1.2

1.3

17.85

17.91

u/l

0.01

127

900

Malignant neoplasm of breast, including Hilmo

407

2102

1.24

4.16

1.2

22.86

17.63

u/l

6.62

350

1692

Long labour

618

4427

1.19

4.15

1.2

1.3

13.01

12.30

u/l

0.35

518

3549

Other disorders of bone density and structure

331

1.80

4.14

1.7

1.4

9.84

9.47

u/l

0.08

266

Other female pelvic inflammatory diseases

221

1666

1.34

4.14

1.3

15.59

14.43

u/l

0.42

187

1361

Pacemaker

349

2587

1.26

4.14

1.5

1.4

12.18

9.86

u/l

2.03

271

2035

Lichen simplex chronicus and prurigo

567

1.59

4.13

1.7

1.4

13.35

10.27

u/l

1.00

453

Undescended testis, unilateral

191

2.12

4.13

3.2

2.3

10.16

4.51

u/l

1.65

118

Impacted teeth

812

6033

1.17

4.12

1.5

7.78

7.74

u/l

0.05

664

4845

Panniculitis affecting regions of neck and back

338

1.77

4.12

1.4

10.05

10.13

u/l

0.01

276

Superficial injury of forearm

243

1862

1.32

4.12

1.5

9.51

8.75

u/l

0.39

204

1495

Care involving dialysis

126

866

1.47

4.11

1.7

1.5

13.98

7.96

u/l

2.50

107

666

L04AX Other immunosuppressants

1057

9303

1.14

4.11

1.6

1.4

11.05

10.30

u/l

0.93

873

7455

Other hereditary haemolytic anaemias

2.82

4.11

1.5

1.6

13.27

7.37

u/l

0.72

Other facial nerve disorders

273

1.87

4.10

1.3

1.2

8.16

10.90

u/l

0.92

225

Erosion and ectropion of cervix uteri

2.48

4.07

1.1

1.4

12.63

19.89

u/l

0.98

Artificial joint re-operation

346

1.75

4.06

1.4

1.3

12.89

12.10

u/l

0.13

272

Acute tubulo-interstitial nephritis

1124

8380

1.14

4.06

1.4

11.24

10.74

u/l

0.51

895

6698

Alzheimer’s disease (Late onset)

708

0.56

4.06

1.3

13.03

13.84

u/l

0.14

545

Hallux rigidus

132

916

1.45

4.06

1.3

14.10

14.29

u/l

0.04

734

Slow fetal growth and fetal malnutrition

193

2.15

4.05

3.0

2.7

4.48

5.50

u/l

0.64

109

Pleural plaque

522

1.60

4.05

1.3

1.4

11.09

8.52

u/l

1.31

410

Mixed disorders of conduct and emotions, excluding more controls

583

1.60

4.04

1.6

5.86

6.80

u/l

0.83

453

Thyrotoxicosis with toxic multinodular goitre

332

1.77

4.04

1.3

1.2

18.89

14.24

u/l

1.14

260

Disorders of synovium and tendon in diseases classified elsewhere

197

2.03

4.03

1.5

1.4

9.07

8.19

u/l

0.20

163

Benign neoplasm: Skin of ear and external auricular canal

296

1.82

4.03

1.3

8.62

9.98

u/l

0.37

230

Dislocation, sprain and strain of joint and ligaments of hip

311

1.80

4.02

1.5

1.4

8.37

8.77

u/l

0.07

247

Periapical abscess

884

7710

1.15

4.01

1.4

1.5

9.81

9.72

u/l

0.07

707

6200

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

111

748

1.50

4.00

1.3

13.48

11.48

u/l

0.66

603

Gout, strict definition

203

1519

1.34

4.00

1.4

8.79

7.89

u/l

0.48

155

1206

Other ill-defined and unspecified causes of mortality

571

1.57

4.00

1.5

1.4

10.23

8.23

u/l

0.87

458

Benign lipomatous neoplasm of other sites/unspecified

627

1.55

3.99

1.4

8.98

10.88

u/l

0.79

509

Ulcer of vagina/vulva

365

1.74

3.99

1.1

1.3

12.77

11.16

u/l

0.28

294

Other and/or unspecified nontoxic goitre

462

1.64

3.99

1.2

16.03

15.63

u/l

0.05

373

Maternal care for cervical incompetence

480

1.64

3.97

1.3

9.85

11.73

u/l

1.00

387

Superficial injury of lower leg

552

4647

1.20

3.96

1.4

1.5

9.36

9.67

u/l

0.21

430

3686

Leukaemia of unspecified cell type

2.66

3.96

2.8

1.9

10.10

7.86

u/l

0.42

Benign neoplasm: Caecum

108

725

1.50

3.95

1.3

1.4

12.51

11.22

u/l

0.38

585

COPD, early/later onset

460

3185

1.22

3.94

1.3

1.4

10.51

10.35

u/l

0.09

340

2528

Hemiplegia

488

1.62

3.93

1.9

1.4

11.75

10.35

u/l

0.37

391

Other complications of labour and delivery, not elsewhere classified

464

3415

1.22

3.93

1.3

8.97

9.18

u/l

0.15

392

2733

Vitreous haemorrhage

140

990

1.43

3.93

1.3

1.4

12.46

8.94

u/l

1.38

104

799

Myocarditis

575

1.57

3.92

1.7

1.5

10.89

7.70

u/l

0.95

460

Malignant neoplasm of adrenal gland

3.04

3.92

2.8

2.2

16.85

8.05

u/l

—

Postzoster neuralgia

2.55

3.92

1.3

1.2

9.95

11.71

u/l

0.25

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

262

1.85

3.91

1.3

12.45

7.15

u/l

1.64

207

Congenital deformities of feet, including avohilmo

109

739

1.51

3.91

1.5

1.6

8.00

8.29

u/l

0.08

582

Other diseases of pericardium

404

1.68

3.91

1.4

1.5

10.40

8.60

u/l

0.55

328

Other necrotizing vasculopathies

496

1.61

3.91

1.4

14.10

10.32

u/l

0.99

400

Antepartum haemorrhage, not elsewhere classified

241

1862

1.31

3.90

1.2

1.3

12.43

11.31

u/l

0.54

203

1492

Lung diseases due to external agents

156

1125

1.40

3.89

1.4

11.88

8.97

u/l

1.67

124

907

Tobacco use

114

780

1.49

3.87

1.4

8.57

9.01

u/l

0.14

635

Hyperkalaemia

359

1.72

3.87

1.5

1.4

13.98

9.29

u/l

1.17

288

Superficial injury of ankle and foot, unspecified

2.61

3.86

1.4

1.7

9.38

8.06

u/l

0.16

Tongue abnormality

498

1.61

3.86

1.3

1.4

12.16

10.97

u/l

0.28

392

Lichen planus

138

976

1.42

3.86

1.3

1.4

12.37

12.57

u/l

0.05

115

785

Meralgia paraesthetica

323

1.76

3.85

1.3

10.68

10.19

u/l

0.09

270

Congenital malformations of uterus and cervix

432

1.67

3.85

1.1

1.3

7.99

11.02

u/l

2.21

346

Behavioural disorders, excluding more controls

446

1.66

3.85

1.5

1.6

8.73

7.73

u/l

0.30

345

Other heart diseases, wide

2090

11561

1.10

3.85

1.5

10.57

9.59

u/l

2.30

1667

9317

COPD, hospital admissions

454

3160

1.21

3.84

1.3

1.4

10.40

10.38

u/l

0.01

336

2513

Other/unspecified synovitis and tenosynovitis

185

1376

1.36

3.84

1.3

1.4

11.69

10.48

u/l

0.49

151

1108

Other specified/unspecified bacterial intestinal infections

650

1.53

3.84

1.5

10.44

9.66

u/l

0.25

523

All chronic kidney diseases

852

5914

1.15

3.83

1.5

12.78

9.41

u/l

6.31

688

4653

Cerebrovascular diseases (FINNGEN)

486

2830

1.21

3.82

1.4

11.27

10.94

u/l

0.18

385

2303

Other disorders of the genitourinary system

105

706

1.50

3.81

1.3

18.14

16.55

u/l

0.37

568

Chronic ulcer of skin, not elsewhere classified

539

1.57

3.80

1.4

11.15

9.19

u/l

0.61

428

Other nonscarring hair loss

141

2.21

3.80

1.1

1.3

7.54

10.66

u/l

1.08

120

Congenital deformities of feet

472

1.63

3.79

1.5

1.7

9.14

8.40

u/l

0.15

375

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

342

1.76

3.79

1.6

1.5

9.12

10.66

u/l

0.44

272

Glomerular diseases

287

2270

1.27

3.79

1.5

12.09

8.57

u/l

3.06

228

1803

COPD related to multimorbidity

375

2573

1.24

3.78

1.3

1.4

10.83

10.40

u/l

0.23

275

2040

Symptoms and signs involving emotional state

495

1.61

3.78

1.5

1.6

9.54

8.49

u/l

0.27

395

COPD, hospital admission 2, with asthma infections

319

2191

1.26

3.78

1.3

1.4

10.64

10.08

u/l

0.31

240

1741

Lichen ruber planus, wide definition including periferal and oral lichen planus

269

2110

1.28

3.78

1.3

1.4

11.85

12.18

u/l

0.14

220

1704

Congenital malformations of breast

358

1.74

3.77

1.5

1.4

10.11

10.21

u/l

0.02

295

Cirrhosis of liver, NAS

439

1.64

3.77

1.5

12.77

8.49

u/l

0.99

348

Pneumothorax

100

669

1.51

3.76

1.3

1.4

10.72

7.76

u/l

1.42

550

Presence of other functional implants

645

3763

1.18

3.76

1.5

1.4

12.73

11.67

u/l

0.83

524

3001

Calcific tendinitis of shoulder

486

1.60

3.75

1.2

1.4

13.15

12.87

u/l

0.05

401

Autoimmune diseases excluding thyroid diseases

2295

11422

1.09

3.75

1.5

10.15

8.94

u/l

4.10

1859

9119

Papulosquamous disorders

616

5258

1.18

3.75

1.4

10.27

10.53

u/l

0.18

489

4216

Nonsuppurative otitis media, including avohilmo

952

7249

1.14

3.74

1.6

1.5

8.16

8.54

u/l

0.54

748

5798

Superficial injury of ankle and foot

339

2742

1.25

3.74

1.6

1.5

9.62

8.50

u/l

0.97

277

2152

Pleural plaque with presence of asbestos

416

1.65

3.74

1.3

10.29

8.57

u/l

0.72

324

Focal brain injury

557

1.56

3.74

1.4

8.58

8.30

u/l

0.07

452

Familial hypercholesterolemia, with ischemic heart disease

541

1.56

3.73

1.3

1.4

8.84

8.87

u/l

0.01

426

Injury of muscle and tendon at hip and thigh level

185

1384

1.35

3.72

1.5

1.4

8.77

9.24

u/l

0.21

146

1116

Other and unspecified vasculitis limited to skin

203

1.96

3.72

1.4

13.23

8.81

u/l

0.96

160

Subacute thyroiditis

319

1.75

3.72

1.9

1.3

11.05

11.97

u/l

0.19

255

Macular pucker

133

941

1.42

3.71

1.3

14.73

11.68

u/l

0.85

103

749

Extracorporeal dialysis

656

1.51

3.70

1.7

1.5

14.16

7.65

u/l

2.34

511

Other and unspecified disorders of vitreous body

408

3282

1.22

3.70

1.3

12.85

14.33

u/l

1.06

313

2645

Other noninflammatory disorders of cervix uteri

175

2.02

3.69

1.1

1.3

19.41

22.07

u/l

0.32

133

Other and unspecified nonscarring hair loss

104

2.41

3.69

1.2

1.3

7.89

11.26

u/l

0.88

Disorders of speech understanding and production

127

880

1.45

3.69

2.1

1.9

7.70

6.88

u/l

0.29

610

Polyarthrosis

160

1050

1.38

3.69

1.3

16.52

17.21

u/l

0.16

131

837

Complications of labour and delivery

1133

5583

1.13

3.68

1.2

1.3

12.96

13.21

u/l

0.21

969

4485

Lagophthalmos

2.54

3.68

1.3

5.81

10.14

u/l

2.04

Malignant neoplasm of tonsil

110

2.33

3.67

1.6

1.3

13.76

6.16

u/l

1.75

Convalescence

529

1.57

3.66

1.3

1.4

10.80

10.99

u/l

0.04

432

Benign neoplasm: Lip

156

2.09

3.66

1.9

1.3

11.82

9.65

u/l

0.22

120

Diabetic maculopathy, excluding more controls

185

1388

1.35

3.65

1.4

9.71

8.27

u/l

0.73

144

1114

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

107

731

1.48

3.64

1.4

11.76

11.34

u/l

0.12

587

Disorders of orbit

436

1.63

3.63

1.5

1.4

12.50

10.58

u/l

0.43

357

Recurrent dislocation of patella

164

1214

1.38

3.63

1.4

10.14

9.26

u/l

0.32

124

978

Other inflammatory liver diseases

104

708

1.49

3.62

1.7

1.4

8.58

9.41

u/l

0.31

563

Papillary adenocarcinoma of thyroid gland

444

1.62

3.62

1.5

1.3

14.06

10.53

u/l

1.00

364

Nummular dermatitis

124

873

1.44

3.61

1.7

1.5

10.90

8.93

u/l

0.87

103

699

Viral meningitis

581

1.55

3.60

1.6

1.4

11.20

8.91

u/l

0.67

473

Localized skin eruption due to drugs and medicaments

131

2.21

3.59

1.5

1.4

12.00

9.53

u/l

0.36

104

Malignant neoplasm of tonsil, including Hilmo

124

2.23

3.59

1.5

1.3

13.24

5.95

u/l

1.75

102

Major coronary heart disease event

1184

6310

1.12

3.59

1.4

1.5

10.76

10.72

u/l

0.03

972

4990

Other osteochondrodysplasias

159

2.12

3.59

1.6

1.5

13.29

8.28

u/l

0.74

114

Other specified/unspecified arthritis

446

3719

1.21

3.58

1.4

10.85

10.78

u/l

0.03

361

2953

Acute alcohol intoxication

474

3976

1.20

3.58

1.4

1.5

9.18

8.03

u/l

1.35

358

3222

Scissor bite

114

790

1.48

3.58

2.1

2.2

6.11

6.23

u/l

0.04

560

Haemolytic anaemias

384

1.67

3.58

1.6

1.5

9.57

8.72

u/l

0.21

306

Open wound of lower leg

284

2262

1.27

3.57

1.6

1.5

9.68

8.70

u/l

0.58

231

1779

Disorders in reading

459

1.64

3.56

2.3

2.0

5.00

6.65

u/l

1.78

340

Other papulosquamous disorders

112

2.30

3.55

1.8

1.5

10.61

9.21

u/l

0.12

Other disorders of the musculoskeletal system and connective tissue

189

1428

1.33

3.55

1.3

1.4

11.60

10.92

u/l

0.28

151

1169

Spontaneous rupture of synovium and tendon

662

1.49

3.53

1.3

1.4

12.20

11.27

u/l

0.28

536

Ulcerative enterocolitis

433

1.63

3.52

1.3

8.01

8.34

u/l

0.09

352

Congenital malformations of the musculoskeletal system, not elsewhere classified

282

1.80

3.52

1.7

1.6

8.38

10.49

u/l

0.63

228

Major anomalies of jaw size

403

1.65

3.50

1.8

1.6

11.18

8.69

u/l

0.61

327

Other and unspecified papulosquamous disorders

2.88

3.49

1.4

1.8

13.66

7.48

u/l

—

Viral pneumonia

220

1703

1.30

3.49

1.5

8.83

8.61

u/l

0.09

168

1336

Other symptoms and signs involving general sensations and perceptions

449

1.61

3.48

1.5

1.6

7.35

7.95

u/l

0.22

344

Dementia in Alzheimer disease

536

0.53

3.48

1.4

1.3

14.66

13.21

u/l

0.23

416

severe traumatic brain injury, does not include concussion

272

2160

1.27

3.48

1.4

8.17

8.73

u/l

0.39

216

1714

Intussusception

180

1.98

3.48

1.5

1.3

13.33

13.37

u/l

0.01

138

Crohn disease

294

2362

1.26

3.47

1.5

8.83

8.88

u/l

0.02

247

1883

Other and unspecified rosacea

138

998

1.40

3.46

1.4

9.50

12.10

u/l

1.49

113

834

Ischaemic heart disease, wide definition

968

5258

1.14

3.46

1.4

10.62

u/l

0.00

783

4229

Muscular dystrophy

101

2.38

3.46

2.6

1.8

7.22

8.16

u/l

0.14

Other coagulation defects

145

1059

1.39

3.45

1.5

1.4

10.68

10.06

u/l

0.19

115

850

Other specified/unspecified hearing loss

102

698

1.47

3.45

1.3

1.4

9.44

10.31

u/l

0.27

567

D07AA Corticosteroids, weak (group I)

385

3179

1.22

3.45

1.5

9.05

9.24

u/l

0.12

295

2488

Other arrhythmias

1181

7894

1.12

3.43

1.4

10.67

10.41

u/l

0.26

959

6415

Dystonia

570

1.53

3.43

1.3

1.4

10.23

10.80

u/l

0.14

465

Hypoplasia of dental enamel, prenatal

3.11

3.42

3.5

2.6

3.77

3.31

u/l

—

Thiazolidinediones

114

798

1.44

3.42

1.4

9.34

9.88

u/l

0.21

632

Abnormal findings in nipple discharge synovial fluid wound secretions

175

2.00

3.41

1.4

9.74

9.89

u/l

0.02

143

Benign neoplasm: Rectosigmoid junction

260

1.79

3.41

1.4

1.3

12.84

9.69

u/l

0.57

206

Other embolism and thrombosis

168

1256

1.35

3.41

1.6

1.4

9.22

10.74

u/l

0.92

134

1024

Complications of other internal prosthetic devices, implants and grafts

320

1.71

3.40

2.1

1.3

8.35

10.52

u/l

0.85

254

Other abnormal auditory perceptions

148

2.10

3.39

1.4

1.5

6.50

11.10

u/l

2.05

120

Injuries involving multiple body regions

565

1.53

3.38

1.3

1.4

10.74

7.91

u/l

1.04

455

Scoliosis

192

1468

1.32

3.38

1.7

1.5

11.96

8.84

u/l

1.67

144

1139

Fracture at wrist and hand level

765

6675

1.15

3.38

1.6

1.5

8.08

8.29

u/l

0.20

617

5310

Other puerperal infections

261

2081

1.27

3.37

1.2

1.3

10.13

9.99

u/l

0.06

208

1704

ILD, hospital admission 2, with pulmonary infections

644

1.49

3.37

1.5

1.4

9.77

9.11

u/l

0.24

506

Benign neoplasm: Other/unspecified site

121

2.20

3.37

1.7

1.3

12.55

10.66

u/l

0.24

Failed induction of labour

213

1658

1.31

3.36

1.2

1.3

8.94

9.57

u/l

0.47

187

1339

Supplementary factors related to causes of morbidity and mortality classified elsewhere

635

5489

1.16

3.36

1.4

1.5

10.10

8.99

u/l

1.33

514

4410

Sacrococcygeal disorders, not elsewhere classified

345

1.68

3.35

1.3

1.4

10.50

10.84

u/l

0.07

284

Hypothyroidism, autoimmune, DX-based

2.77

3.34

1.1

1.6

14.09

10.42

u/l

0.25

Hypertensive heart and/or renal disease

245

1403

1.28

3.34

1.4

9.73

10.09

u/l

0.15

182

1109

Other osteochondrodysplasias, including avohilmo

177

1.99

3.34

1.6

1.5

14.19

8.35

u/l

0.94

129

Disorder of the sleep-wake schedule

332

1.71

3.33

1.6

1.7

7.20

7.75

u/l

0.14

271

Spinal instabilities

248

1.81

3.32

1.5

1.3

12.45

10.33

u/l

0.32

203

Abnormal serum enzyme levels

418

3368

1.20

3.31

1.4

8.51

8.34

u/l

0.11

336

2668

Vasculitis limited to skin, not elsewhere classified

219

1.86

3.31

1.4

13.54

8.78

u/l

1.11

173

Other specified and unspecified disorders of eye and adnexa

369

1.65

3.31

1.5

1.4

12.62

9.82

u/l

0.60

295

Stenosis and insufficiency of lacrimal passages

116

821

1.42

3.30

1.6

1.5

12.47

12.04

u/l

0.10

653

Congenital malformations of spine and bony thorax

124

2.24

3.30

1.7

2.1

7.77

8.89

u/l

0.18

Benign neoplasm: Transverse colon

117

830

1.42

3.28

1.4

10.93

10.09

u/l

0.28

677

Other peripheral vertigo

107

747

1.44

3.28

1.4

1.3

10.46

11.92

u/l

0.54

609

Other keratitis

236

1864

1.28

3.25

1.6

1.4

9.46

9.10

u/l

0.15

196

1500

Traumatic subarachnoid haemorrhage

242

1.80

3.24

1.4

9.10

8.20

u/l

0.28

195

Cysts of oral region, not elsewhere classified

111

784

1.44

3.24

1.5

10.86

8.36

u/l

0.98

626

Other neurotic disorders

402

1.61

3.24

1.5

1.3

11.98

9.36

u/l

0.65

332

Urethritis and urethral syndrome

243

1.81

3.24

1.4

10.74

9.35

u/l

0.34

198

Other disorders of ear

1630

9607

1.10

3.24

1.5

1.4

10.20

10.55

u/l

0.45

1284

7701

Cyst of kidney

537

1.52

3.23

1.4

1.3

10.00

9.70

u/l

0.07

430

Conductive and sensorineural hearing loss

1123

6674

1.12

3.23

1.5

1.4

10.59

11.01

u/l

0.44

885

5352

Unspecified urinary incontinence

618

1.48

3.22

1.4

15.30

13.13

u/l

0.45

490

Scar conditions and fibrosis of skin

547

1.52

3.22

1.9

1.4

11.34

10.58

u/l

0.15

441

Carcinoma in situ of other and unspecified sites

258

1.77

3.20

1.4

1.3

8.89

7.77

u/l

0.39

203

Other diseases of pancreas

103

718

1.45

3.20

1.2

1.4

10.08

9.20

u/l

0.30

580

Hydrocephalus

514

1.53

3.19

2.7

1.6

9.22

9.88

u/l

0.14

396

Type1 diabetes, definitions combined, early onset

151

1991

0.74

3.19

1.6

1.7

7.58

7.08

u/l

0.19

113

1505

Bicipital tendinitis

451

1.57

3.19

1.6

1.4

8.62

9.10

u/l

0.13

364

Outcome of delivery

413

2115

1.21

3.19

1.2

1.3

11.56

12.72

u/l

0.77

325

1659

Myeloproliferative diseases

604

1.49

3.17

1.6

1.3

12.57

9.98

u/l

1.06

485

Crohn's disease of small intestine

158

1188

1.35

3.17

1.4

1.5

8.04

8.62

u/l

0.27

134

950

Injury of muscle and tendon at wrist and hand level

250

1995

1.26

3.15

1.5

1.4

9.73

8.30

u/l

1.03

204

1601

Foreign body on external eye

324

2661

1.23

3.15

1.4

1.5

7.55

6.56

u/l

0.93

255

2141

Appendicitis, broad definition

1554

12736

1.10

3.15

1.4

9.44

9.81

u/l

0.52

1274

10338

Palmar fascial fibromatosis [Dupuytren]

147

1091

1.35

3.14

1.4

9.11

9.09

u/l

0.01

117

872

N06DA Anticholinesterases

121

1288

0.72

3.14

1.4

1.3

10.94

12.65

u/l

0.74

1014

Use of anticholinesterases

121

1288

0.72

3.14

1.4

1.3

10.94

12.65

u/l

0.74

1014

Acute appendicitis

1477

12498

1.10

3.13

1.4

9.36

9.79

u/l

0.62

1213

10153

Unspecified event, undetermined intent

384

1.63

3.13

1.3

1.5

7.96

8.23

u/l

0.06

313

Total colectomy operation

543

1.52

3.12

1.5

1.4

10.31

7.86

u/l

0.65

439

Total colectomy

543

1.52

3.12

1.5

1.4

10.31

7.86

u/l

0.65

439

Phlebitis and thrombophlebitis (not including DVT)

310

2535

1.23

3.10

1.5

1.3

12.23

10.99

u/l

0.70

252

2063

Hypertensive Heart Disease

218

1292

1.28

3.10

1.4

9.27

10.00

u/l

0.37

160

1017

Inflammatory diseases of the central nervous system

145

1079

1.36

3.10

1.8

1.4

10.10

9.31

u/l

0.27

118

867

Cardiodefibrillation

356

2941

1.21

3.10

1.4

9.36

9.23

u/l

0.06

275

2338

Benign neoplasm: Peripheral nerves and autonomic nervous system

153

2.01

3.10

1.6

1.3

8.24

9.68

u/l

0.26

124

Other/unspecified enthesopathies of lower limb, excluding foot

123

892

1.39

3.09

1.5

1.4

9.57

10.77

u/l

0.51

720

Diseases of appendix

1560

12755

1.10

3.08

1.5

1.4

9.45

9.82

u/l

0.52

1278

10351

Type 1 diabetes, wide definition, subgroup 1

481

4098

1.18

3.08

1.4

1.6

9.02

8.05

u/l

0.89

377

3240

Type of accident

573

4952

1.16

3.08

1.4

1.5

9.94

9.08

u/l

0.93

465

3963

Ill-defined and unknown causes of mortality

657

1.46

3.08

1.5

1.4

10.01

8.24

u/l

0.77

528

Disorders of iron metabolism

189

1.90

3.07

1.8

1.3

3.65

7.08

u/l

4.94

157

Herpesviral [herpes simplex] infections

205

1603

1.29

3.07

1.5

1.4

11.71

10.91

u/l

0.32

156

1308

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

178

1369

1.32

3.06

1.3

1.2

11.58

13.33

u/l

0.84

152

1120

Spirochaetal infections, other/unspecified

123

893

1.39

3.06

1.7

1.5

11.17

11.01

u/l

0.04

730

Acute lymphadenitis

134

989

1.37

3.06

1.7

1.5

9.36

8.55

u/l

0.29

103

778

Other and unspecified mononeuropathies, also in other diseases

225

1.80

3.06

1.2

1.4

13.77

10.46

u/l

0.47

189

Hard cardiovascular diseases

1293

6909

1.11

3.05

1.4

1.5

10.78

10.89

u/l

0.09

1049

5465

Other cataract

498

3153

1.18

3.05

1.5

1.4

11.79

11.44

u/l

0.19

392

2517

Congenital malformations of breast, including avohilmo

388

1.62

3.05

1.4

9.94

10.33

u/l

0.09

319

Fracture of shoulder and upper arm

568

4900

1.16

3.04

1.6

1.5

10.29

9.46

u/l

0.75

461

3871

Myopia

339

2809

1.22

3.04

1.5

9.67

9.29

u/l

0.18

270

2253

LeFortI or BSSO operation

102

721

1.44

3.03

1.3

1.4

11.03

10.15

u/l

0.26

593

Monosomies and deletions from the autosomes, not elsewhere classified

2.61

3.02

3.2

2.7

8.39

4.71

u/l

0.49

Acute nasopharyngitis (common cold)

268

2151

1.25

3.02

1.4

1.5

6.58

6.36

u/l

0.17

236

1699

Otalgia

159

1205

1.33

3.01

1.6

10.09

10.34

u/l

0.09

116

923

Family history of certain disabilities and chronic diseases leading to disablement

138

1027

1.37

3.01

1.5

1.4

9.86

9.05

u/l

0.35

127

828

Other diseases of oesophagus

116

836

1.40

3.01

1.5

1.4

10.26

9.33

u/l

0.29

675

Other superficial mycoses, including avohilmo

277

2253

1.24

3.00

1.4

8.16

8.70

u/l

0.40

215

1815

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

2.90

3.00

2.6

2.3

10.48

5.58

u/l

—

Bacterial pneumonia (organism specified)

669

5295

1.15

2.99

1.5

10.15

9.42

u/l

0.78

544

4230

Osteosarcoma, including Hilmo

2.88

2.99

2.2

2.1

7.75

4.83

u/l

—

Early complications of trauma

573

1.49

2.98

1.5

7.52

7.80

u/l

0.08

464

!Aliquae complicationes praecoces traumatis

573

1.49

2.98

1.5

7.52

7.80

u/l

0.08

464

Congenital malformations of spine and bony thorax, including avohilmo

136

2.10

2.98

1.7

2.1

8.52

8.77

u/l

0.04

Other infective otitis externa

106

755

1.42

2.98

1.3

1.4

10.88

9.36

u/l

0.54

605

Other mycoses, not elsewhere classified/unspecified, including avohilmo

228

1.80

2.97

1.5

7.82

9.02

u/l

0.20

179

Other congenital malformations, not elsewhere classified

164

1.98

2.97

2.5

2.1

11.08

6.57

u/l

0.60

117

Early syphilis, including avohilmo

214

1.84

2.97

1.5

1.6

7.84

6.18

u/l

0.39

181

Basal cell carcinoma

365

2067

1.21

2.95

1.4

1.3

13.19

10.69

u/l

2.33

290

1609

Other mental disorders due to brain damage and dysfunction and to physical disease

116

839

1.39

2.95

1.5

1.4

9.95

10.05

u/l

0.03

677

Oesophageal varices

350

1.62

2.93

1.4

1.5

12.64

7.61

u/l

0.92

271

Labour and delivery complicated by fetal stress [distress]

771

4429

1.14

2.93

1.2

1.3

10.73

11.26

u/l

0.53

673

3548

Acute and transient psychotic disorders

225

1792

1.27

2.93

1.4

9.72

9.20

u/l

0.24

157

1460

Type 1 diabetes

547

4726

1.16

2.92

1.4

1.6

8.76

8.13

u/l

0.57

431

3740

572

1.50

2.92

1.7

7.57

7.40

u/l

0.06

431

Basal cell carcinoma, including Hilmo

390

2209

1.20

2.92

1.3

13.01

10.69

u/l

2.19

308

1724

Iridocyclitis

369

3091

1.20

2.92

1.4

11.02

9.96

u/l

0.70

298

2475

Single spontaneous delivery

532

3263

0.86

2.92

1.2

1.4

11.96

11.66

u/l

0.19

432

2537

Angina pectoris

601

3456

1.16

2.91

1.4

9.62

10.29

u/l

0.58

476

2746

Chronic periodontitis, including avohilmo

1871

11014

1.09

2.90

1.4

11.29

10.01

u/l

3.25

1519

8953

ILD, hospital admissions 3, with pneumonia sepsis

526

1.49

2.89

1.5

1.4

10.25

9.57

u/l

0.22

422

Coronary atherosclerosis

745

4133

1.14

2.89

1.4

10.11

10.05

u/l

0.04

598

3312

Lichen planus, including avohilmo

216

1713

1.27

2.88

1.3

1.4

11.63

11.92

u/l

0.10

177

1375

All kidney diseases

2085

12951

1.08

2.87

1.5

1.4

11.18

9.64

u/l

4.68

1688

10419

Bacterial pneumoniae

624

4781

1.15

2.87

1.5

1.4

10.00

9.30

u/l

0.73

510

3833

Postpartum hemorraghe, all women as controls

721

6214

1.14

2.86

1.2

1.3

10.76

11.40

u/l

0.73

633

5074

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

120

884

1.39

2.85

1.7

7.07

7.93

u/l

0.41

643

Open wound of abdomen, lower back and pelvis

531

1.50

2.84

1.5

1.6

8.28

7.31

u/l

0.29

431

Left bundle-branch block

488

1.51

2.83

1.2

1.4

11.43

10.98

u/l

0.10

403

Postprocedural disorders of digestive system, not elsewhere classified

299

1.66

2.83

1.6

1.4

13.94

9.39

u/l

0.81

230

Dementia, including avohilmo

235

1995

0.80

2.82

1.4

11.17

12.19

u/l

0.50

180

1584

Other salmonella infections, including avohilmo

498

1.51

2.82

1.4

12.72

9.34

u/l

0.69

409

Other arthritis (FG)

516

4457

1.16

2.82

1.4

10.78

10.54

u/l

0.15

418

3563

Polymyalgia rheumatica

644

1.44

2.82

1.4

1.3

12.13

12.64

u/l

0.13

513

Cardiac murmurs and other cardiac sounds

211

1657

1.27

2.82

1.6

1.7

9.77

9.06

u/l

0.32

160

1249

Follicular adenocarcinoma of thyroid gland, including Hilmo

2.32

2.82

1.3

1.2

15.97

11.70

u/l

0.25

Benign neoplasm: Skin of eyelid, including canthus

163

1252

1.31

2.80

1.3

1.4

12.70

12.54

u/l

0.05

123

1012

Supervision of normal pregnancy

500

2447

1.17

2.80

1.2

1.4

13.73

12.79

u/l

0.66

417

1923

Monoplegia

152

1.95

2.80

1.3

1.2

16.12

9.88

u/l

0.94

122

Viral pneumonia (unknown virus, not influenza)

128

952

1.36

2.79

1.5

7.64

8.01

u/l

0.15

761

Primary gonarthrosis, bilateral

485

3484

1.17

2.79

1.3

11.76

13.50

u/l

1.87

396

2792

Sixth [abducent] nerve palsy

293

1.66

2.78

2.2

1.5

11.39

8.91

u/l

0.51

222

Other chromosome abnormalities, not elsewhere classified

113

2.20

2.77

3.0

2.3

7.89

7.17

u/l

0.06

Graves disease, strict definition

184

1441

1.29

2.77

1.5

1.3

11.20

12.24

u/l

0.46

151

1200

Necrosis of pulp, including avohilmo

1286

11598

1.10

2.76

1.4

9.73

9.78

u/l

0.04

1042

9427

Melanocytic naevi of other and unspecified parts of face

106

767

1.40

2.75

1.5

1.4

8.30

11.09

u/l

2.01

617

Perioral dermatitis

334

1.62

2.74

1.2

1.3

13.09

10.62

u/l

0.39

272

Other salmonella infections

365

1.58

2.73

1.5

1.4

12.35

9.00

u/l

0.57

297

Transitory endocrine and metabolic disorders specific to fetus and newborn

425

1.57

2.72

2.6

2.4

4.23

5.77

u/l

1.38

254

Mesial bite

206

1.82

2.72

1.8

7.56

8.07

u/l

0.14

165

Periodontitis

1871

11034

1.08

2.72

1.4

11.28

10.00

u/l

3.24

1518

8972

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

410

1.58

2.72

2.4

4.18

5.81

u/l

1.47

247

Impacted maxillary molar

245

1996

1.25

2.72

1.5

7.52

8.20

u/l

0.69

206

1613

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

266

1.71

2.71

1.5

1.6

7.14

7.77

u/l

0.24

220

105

731

1.41

2.70

2.4

2.3

5.77

5.91

u/l

0.06

464

Corneal ulcer

361

3044

1.19

2.70

1.5

1.4

10.73

9.22

u/l

1.19

298

2451

Disorders of acoustic nerve

212

1.77

2.70

1.8

1.3

12.41

10.02

u/l

0.31

172

Other bursal cyst

119

2.06

2.69

1.1

1.2

14.87

10.78

u/l

0.52

Malignant neoplasm of bone and articular cartilage of limbs

2.69

2.2

2.1

7.40

7.48

u/l

—

Ectopic testis

150

2.01

2.69

2.0

2.5

4.29

3.77

u/l

0.18

Injuries to the hip and thigh

713

5657

1.13

2.68

1.5

9.59

9.72

u/l

0.09

571

4520

Moderate visual impairment, binocular

190

1.81

2.68

2.6

1.6

6.99

9.67

u/l

0.88

150

Prurigo nodularis

183

1.83

2.68

1.8

1.3

12.56

10.99

u/l

0.23

142

Struck by thrown, projected or falling objec

124

926

1.36

2.68

1.3

1.5

5.94

7.32

u/l

1.72

107

744

Bruxism

282

1.67

2.67

1.6

1.3

14.66

10.50

u/l

0.73

228

Dermatographic urticaria

135

1020

1.34

2.67

1.7

1.3

11.67

10.70

u/l

0.30

112

829

Infective dermatitis

171

1333

1.29

2.67

1.4

10.12

9.89

u/l

0.09

138

1080

Carcinoma in situ, bladder

243

1.71

2.65

1.4

1.3

8.88

7.43

u/l

0.51

191

Disorder of external ear, unspecified

360

1.58

2.65

2.0

1.3

11.36

10.02

u/l

0.30

292

Impacted cerumen

139

1054

1.33

2.65

1.6

1.5

8.18

9.69

u/l

0.79

100

829

Suggestive for eosinophilic asthma

123

917

1.35

2.64

1.5

1.4

10.90

9.54

u/l

0.46

104

745

Diabetic nephropathy, excluding more controls

178

1837

0.78

2.63

1.3

1.4

10.50

8.09

u/l

1.55

135

1502

Maternal care for other conditions predominantly related to pregnancy

539

4583

1.15

2.63

1.2

1.3

11.12

11.75

u/l

0.52

454

3706

Anaemia in chronic diseases classified elsewhere

199

1.79

2.63

1.6

1.4

17.07

8.33

u/l

1.46

149

ILD, hospital admissions 1, main diag only

126

943

1.34

2.62

1.4

10.58

10.29

u/l

0.09

103

758

Benign neoplasm: Choroid

481

1.49

2.62

1.5

1.4

11.38

11.27

u/l

0.02

390

Other and unspecified paralytic syndromes

149

1.93

2.61

1.5

1.4

11.96

9.03

u/l

0.41

120

Leisure time condition

337

2835

1.20

2.60

1.4

1.5

9.83

9.11

u/l

0.49

275

2264

Other sexually transmitted chlamydial diseases, including avohilmo

405

3470

1.18

2.60

1.4

8.08

7.77

u/l

0.27

313

2830

Autoimmune diseases excluding thyroid diseases, strict definition

2131

10793

1.08

2.60

1.4

10.07

8.92

u/l

3.57

1735

8625

L02BB Anti-androgens

618

0.59

2.60

2.4

1.3

8.59

8.20

u/l

0.08

495

Paraplegia, diplegia of upper limbs

215

1.75

2.60

1.5

10.36

8.84

u/l

0.31

171

Abnormal spermatozoa

155

1198

1.30

2.59

1.4

8.65

6.90

u/l

0.80

115

958

Toxic effects of substances chiefly nonmedicinal as to source

247

2020

1.23

2.58

1.5

9.26

8.30

u/l

0.52

196

1613

Other and unspecified injuries of abdomen, lower back and pelvis

239

1.72

2.57

1.4

1.5

8.77

9.15

u/l

0.07

197

Oral leukoplakia, including avohilmo

238

1.71

2.57

1.4

13.07

8.21

u/l

0.94

190

Acute alcohol intoxication, ICD10

415

3557

1.17

2.57

1.4

1.5

8.94

7.72

u/l

1.34

313

2873

Open wound of head

1005

8543

1.11

2.57

1.5

8.35

8.60

u/l

0.29

769

6787

Personal history of risk-factors, not elsewhere classified

255

1.70

2.57

1.6

1.5

5.76

7.66

u/l

1.62

201

Emphysema

475

1.48

2.56

1.3

1.4

9.11

9.03

u/l

0.02

379

Osteomyelitis

650

1.41

2.56

1.6

1.5

10.91

7.86

u/l

1.42

521

Carcinoma in situ of skin

467

1.49

2.56

1.4

1.3

10.74

11.42

u/l

0.15

368

Radial styloid tenosynovitis [de Quervain]

101

735

1.39

2.56

1.3

11.52

11.61

u/l

0.02

596

Fibrosis and cirrhosis of liver

650

1.41

2.55

1.5

1.4

12.01

10.07

u/l

0.44

522

Defects in the complement system

102

2.15

2.55

1.3

1.5

9.93

10.74

u/l

0.10

Chondropathies

304

2540

1.21

2.55

1.5

8.75

9.29

u/l

0.35

239

2051

Drug-induced hypopituitarism

4.39

2.55

3.5

2.0

8.50

5.06

u/l

—

Vertigo of central origin

108

2.07

2.54

1.2

1.1

11.63

10.47

u/l

0.14

Other disorders of conjunctiva

157

1219

1.30

2.53

1.5

1.4

13.74

11.17

u/l

1.10

137

985

Colorectal cancer, including Hilmo

213

1596

1.25

2.53

1.4

1.3

14.68

9.63

u/l

3.82

167

1244

Unspecified privation

179

1415

1.28

2.53

1.3

1.4

8.54

9.05

u/l

0.23

133

1139

Glomerulonephritis

154

1195

1.30

2.52

1.6

1.5

12.73

8.54

u/l

2.25

133

940

Asthma mixed form (mode)

560

1.44

2.52

1.7

1.4

9.44

8.77

u/l

0.19

445

Speech disturbances, not elsewhere classified

106

779

1.37

2.51

1.5

1.4

10.26

10.05

u/l

0.06

637

Anxious personality disorder

383

1.55

2.51

1.4

6.67

8.43

u/l

0.93

315

Crohn's disease NAS

140

1075

1.32

2.51

1.5

8.96

8.45

u/l

0.20

116

850

Benign neoplasm of breast

138

1055

1.32

2.51

1.4

1.3

17.16

15.57

u/l

0.47

112

864

Injuries to unspecified part of trunk, limb or body region

179

1417

1.27

2.50

1.6

1.5

8.43

8.99

u/l

0.29

136

1124

Colectomy operation

180

1424

1.27

2.50

1.4

12.60

9.91

u/l

1.26

146

1147

Bacterial pneumonia, not elsewhere classified

575

4430

1.14

2.50

1.5

1.4

10.10

9.34

u/l

0.75

473

3550

Other meningitis

218

1.74

2.50

2.1

1.4

12.23

9.52

u/l

0.36

184

Renal tubulo-interstitial diseases

1661

11263

1.08

2.49

1.5

1.4

11.59

10.15

u/l

3.20

1330

9070

Malignant neoplasm of colon, including Hilmo

141

1076

1.31

2.49

1.3

14.60

9.53

u/l

2.76

113

837

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

217

1.72

2.49

1.2

1.3

8.71

8.58

u/l

0.02

174

Additional codes for the location of defect, injury or illness

705

1.39

2.49

1.5

10.35

9.47

u/l

0.28

565

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

882

6890

1.11

2.48

1.2

1.3

12.35

13.12

u/l

0.58

760

5654

Overexertion and strenuous or repetitive movements

187

1491

1.27

2.48

1.4

8.11

8.59

u/l

0.25

150

1187

Fasciculation

167

1.85

2.47

1.5

1.3

9.97

9.87

u/l

0.01

138

Spondyloarthritis

317

2666

1.20

2.46

1.4

10.44

9.48

u/l

0.56

261

2167

Superficial injury of shoulder and upper arm

219

1778

1.24

2.46

1.6

1.4

9.97

9.13

u/l

0.47

185

1423

Conductive hearing loss, unspecified

130

990

1.32

2.45

1.6

1.5

9.78

9.74

u/l

0.01

105

788

Benign neoplasm: Skin of other and unspecified parts of face

119

894

1.34

2.45

1.6

1.4

10.81

11.10

u/l

0.08

729

Gluteal tendinitis

335

1.57

2.45

1.2

1.3

14.62

13.84

u/l

0.14

267

Family history of other conditions

282

1.64

2.44

1.6

1.5

7.93

8.89

u/l

0.21

227

Melanoma in situ of trunk

117

2.01

2.44

1.3

1.2

8.34

9.21

u/l

0.16

Disorders resulting from impaired renal tubular function

376

1.54

2.43

1.9

1.6

12.01

8.37

u/l

0.99

295

Bilateral sagittal split ramus osteotomy operation

566

1.44

2.43

1.3

1.4

11.80

10.39

u/l

0.35

463

Nystagmus and other irregular eye movements

205

1.75

2.43

2.3

1.8

9.17

8.36

u/l

0.10

151

Foreign body in respiratory tract

700

1.39

2.43

1.8

1.6

12.28

9.03

u/l

1.31

542

Malignant neoplasm of digestive organs, including Hilmo

395

2480

1.17

2.43

1.4

1.3

13.61

9.31

u/l

5.90

314

1934

Colon adenocarcinoma

622

1.40

2.42

1.3

15.82

9.07

u/l

3.16

483

Persistent delusional disorders

107

794

1.36

2.41

1.4

9.89

8.97

u/l

0.26

642

Right bundle-branch block

297

1.60

2.41

1.4

10.19

8.94

u/l

0.31

247

Allergic urticaria

172

1364

1.27

2.40

1.6

1.5

10.59

9.91

u/l

0.26

141

1068

Ulcerative ileocolitis

626

1.41

2.40

1.7

1.4

8.79

8.60

u/l

0.05

514

Crowding of teeth, including avohilmo

334

2345

1.19

2.40

2.1

1.7

7.43

7.89

u/l

0.37

251

1789

Other or ill-defined heart diseases

634

1.40

2.38

1.4

1.5

8.78

7.81

u/l

0.28

525

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

2.32

2.38

1.8

1.2

9.01

7.59

u/l

0.14

Superficial injury of thorax

251

2074

1.22

2.38

1.4

8.11

8.87

u/l

0.58

191

1671

Striae atrophicae

162

1.84

2.37

1.3

12.69

10.15

u/l

0.35

129

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

2.15

2.37

2.1

1.8

14.69

6.96

u/l

0.91

Hyperkinetic disorders (excl. ADHD)

547

1.45

2.36

1.5

2.1

6.21

6.33

u/l

0.04

379

Giant cell arteritis

198

1.73

2.36

1.1

1.3

10.90

10.21

u/l

0.12

152

Diseases of peritoneum

121

917

1.33

2.36

1.3

1.4

12.67

10.87

u/l

0.51

101

744

Type 1 diabetes, wide definition

487

4251

1.15

2.36

1.4

1.6

8.99

8.14

u/l

0.76

382

3352

Carcinoma in situ of breast, intraductal

394

1.51

2.36

1.1

1.3

22.94

21.93

u/l

0.15

319

Asthma mixed form (mode), excluding more controls

568

1.42

2.35

1.6

1.4

9.44

8.94

u/l

0.13

449

Lichen simplex chronicus

307

1.58

2.35

1.4

14.84

9.54

u/l

1.18

240

Open wound of ankle and foot

212

1726

1.24

2.35

1.3

1.5

9.29

7.78

u/l

0.92

171

1356

5-aminosalicylic acid

445

3865

1.16

2.35

1.5

8.82

8.61

u/l

0.15

367

3125

Intermittent heterotropia

162

1280

1.28

2.34

2.3

1.7

6.28

8.00

u/l

1.87

121

953

Open bite that required surgery (Lefort1 or BSSO)

201

1.76

2.34

1.5

1.4

9.08

9.36

u/l

0.05

165

Social disorders starting during childhood or adolescence

241

1.70

2.33

2.2

1.9

4.92

7.04

u/l

1.30

169

Procedures for purposes other than remedying health state

230

1.68

2.33

1.2

1.3

15.04

13.47

u/l

0.19

181

Pregnancy hypertension

837

6750

1.11

2.32

1.2

1.3

12.48

12.90

u/l

0.26

720

5537

Chondrosarcoma, including Hilmo

3.06

2.32

1.5

1.4

10.80

8.50

u/l

—

Dependent personality disorder

200

1.73

2.32

1.3

8.44

10.19

u/l

0.43

162

Dislocation, sprain and strain of joints and ligaments of thorax

471

1.46

2.32

1.4

1.5

8.02

8.50

u/l

0.17

381

Kidney transplant status

103

767

1.36

2.31

1.9

1.6

11.32

7.25

u/l

1.69

593

Acute and subacute iridocyclitis

305

2574

1.19

2.31

1.4

11.55

9.86

u/l

1.12

245

2077

Other articular cartilage disorders

200

1.73

2.31

1.4

7.86

9.22

u/l

0.32

160

Alcohol abuse, main dg

320

2714

1.19

2.31

1.5

8.83

7.72

u/l

0.89

243

2183

Somnolence

186

1.77

2.30

1.3

1.4

7.38

8.88

u/l

0.38

150

Other and unspecified injuries of ankle and foot

109

820

1.35

2.30

1.4

1.6

9.97

8.35

u/l

0.69

635

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

406

2354

1.17

2.30

1.4

1.3

13.25

10.60

u/l

2.72

323

1840

Assault by hanging, strangulation and suffocation

2.60

2.30

1.3

1.5

14.35

8.97

u/l

—

Osteosarcoma

3.10

2.30

2.3

2.5

6.86

4.84

u/l

—

Giant cell arteritis with polymyalgia rheumatica

170

1.78

2.29

1.1

1.2

11.47

10.66

u/l

0.13

130

Inflammation of lacrimal passages (acute and unspecified)

156

1.83

2.29

1.5

1.3

10.28

11.34

u/l

0.20

130

Foreign body in alimentary tract

691

1.38

2.28

1.7

1.6

10.14

8.46

u/l

0.45

543

Parkinson's disease, strict definition, excluding more controls

539

1.41

2.28

1.3

10.24

11.89

u/l

0.75

447

Cholangitis (primary sclerosing, PSC)

614

1.40

2.28

1.3

1.5

8.82

8.50

u/l

0.06

481

Autoimmune hyperthyroidism

734

1.36

2.27

1.5

1.4

11.76

12.30

u/l

0.14

607

Contact with other sharp object(s)

175

1404

1.26

2.26

1.4

1.5

7.00

7.95

u/l

0.67

139

1114

Temporal arteritis

171

1.77

2.25

1.1

1.2

11.47

10.51

u/l

0.16

130

Finngen Rheumatological endpoints

2225

11848

1.07

2.25

1.4

10.07

9.39

u/l

1.54

1807

9543

Maxillary retrognathism

402

1.51

2.25

1.8

1.9

9.61

7.56

u/l

0.52

302

Dialysis

474

1.45

2.25

1.7

13.99

7.60

u/l

1.41

375

conjunctival haemorrhage

573

1.41

2.25

1.5

1.4

15.97

10.60

u/l

1.74

462

Anisometropia and aniseikonia

384

1.51

2.24

1.6

9.12

9.66

u/l

0.13

279

Maxillary hypoplasia

2.45

2.23

2.7

1.8

10.59

6.98

u/l

—

Other congenital malformations of circulatory system

296

1.58

2.23

2.1

1.3

12.01

9.24

u/l

0.42

235

Other infectious diseases, including avohilmo

126

970

1.31

2.23

1.3

1.4

11.49

9.47

u/l

0.82

785

Fitting and adjustment of external prosthetic device

3.49

2.22

1.0

1.2

11.22

8.49

u/l

—

Other acute viral hepatitis

204

1.72

2.21

1.6

1.4

11.69

8.34

u/l

0.54

168

Decubitus ulcer and pressure area

417

1.47

2.20

1.2

1.4

10.79

8.15

u/l

1.05

332

Other diseases of gallbladder

312

1.55

2.20

1.3

10.93

10.37

u/l

0.11

247

Unspecified visual impairment (binocular)

166

1.78

2.19

2.1

1.7

9.70

8.64

u/l

0.14

125

Other vitreous opacities

345

1.52

2.18

1.4

1.3

16.00

9.86

u/l

1.23

272

Malignant neoplasm of colon

113

858

1.32

2.18

1.3

1.4

15.93

9.51

u/l

2.93

671

Acute appendicitis, no complications

1206

11046

1.09

2.18

1.5

1.4

9.33

9.71

u/l

0.47

1000

8971

Motorcycle rider injured in other and unspecified transport accidents

158

1260

1.27

2.17

1.5

1.6

6.11

6.71

u/l

0.48

129

1002

Bursitis of shoulder

227

1.65

2.17

1.4

1.3

9.12

9.47

u/l

0.08

182

Chronic pancreatitis

164

1310

1.26

2.17

1.3

1.4

9.99

7.90

u/l

1.41

131

1044

Injury of nerves and spinal cord at neck level

243

1.63

2.17

1.5

7.51

7.15

u/l

0.09

193

Haemangioma, any site

131

1019

1.30

2.16

1.4

9.61

10.83

u/l

0.49

105

820

Post-traumatic wound infection, not elsewhere classified

355

1.52

2.16

1.6

1.5

8.27

7.83

u/l

0.09

294

Whooping cough, including avohilmo

324

1.55

2.15

1.4

9.69

9.18

u/l

0.08

252

Hydronephrosis

142

1116

1.28

2.15

1.6

1.4

15.23

9.76

u/l

2.48

127

903

Ascites

553

1.40

2.14

1.4

15.82

9.77

u/l

2.47

444

Personal history of certain other diseases

431

1.47

2.14

1.7

1.4

7.99

8.55

u/l

0.18

345

Acanthosis nigricans

2.70

2.14

1.4

1.5

9.30

7.05

u/l

0.17

Other and unspecified mononeuropathies of lower limb

197

1.70

2.14

1.5

1.2

12.05

12.42

u/l

0.03

159

Oral lichen planus, including avohilmo , including avohilmo

562

1.40

2.14

1.3

1.4

13.08

13.17

u/l

0.02

461

Other immunodeficiencies

153

1.82

2.13

1.5

12.09

10.73

u/l

0.17

106

Malignant neoplasm of eye and adnexa, including Hilmo

2.08

2.13

1.7

1.4

11.07

8.47

u/l

0.21

Benign neoplasm of bone and articular cartilage

149

1181

1.27

2.13

1.4

9.53

10.05

u/l

0.19

125

973

Helminthiases, including avohilmo

107

814

1.33

2.12

1.2

1.5

10.16

9.13

u/l

0.31

630

Other orthopaedic follow-up care

580

1.39

2.12

1.6

1.4

11.06

9.81

u/l

0.30

471

Thyrotoxicosis with toxic single thyroid nodule

2.19

2.12

1.4

1.2

16.72

13.81

u/l

0.32

Benign neoplasm: Descending colon

504

1.42

2.12

1.5

1.3

13.20

10.21

u/l

0.67

407

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

163

1307

1.26

2.11

1.3

1.4

8.71

9.75

u/l

0.54

131

1063

Other disorders of prostate

244

1.61

2.11

1.5

1.3

5.54

6.62

u/l

0.56

206

Postpartum haemorrhage due to retained placenta

332

2851

1.17

2.11

1.2

10.96

11.74

u/l

0.55

295

2408

Episcleritis

658

1.37

2.11

1.4

11.96

10.75

u/l

0.22

535

Tooth eruption problems

544

4669

1.13

2.10

1.8

1.5

8.12

7.75

u/l

0.17

420

3716

Other benign neoplasms of connective and other soft tissue

137

1076

1.28

2.10

1.5

1.4

8.62

11.03

u/l

1.69

120

876

Bronchiectasis

438

1.45

2.10

1.3

1.4

12.22

11.70

u/l

0.08

352

Atopic conjunctivitis

101

763

1.34

2.10

1.6

1.5

12.18

9.14

u/l

0.88

605

Covid-19 suspected case

493

4353

1.14

2.09

1.4

11.31

9.41

u/l

1.93

395

3518

Other congenital malformations of brain

104

2.03

2.09

2.4

2.0

7.35

7.59

u/l

0.04

Spondylopathies (FG)

273

2307

1.19

2.09

1.4

9.91

9.47

u/l

0.20

227

1880

Polyarthritis, unspecified

349

1.51

2.09

1.3

1.4

12.70

10.13

u/l

0.58

279

Retinal breaks without detachment

177

1433

1.24

2.08

1.4

11.88

11.70

u/l

0.05

141

1158

Delirium, not induced by alcohol and other psychoactive substances

108

820

1.32

2.08

1.3

1.4

10.87

9.25

u/l

0.61

663

STROKE

776

4716

1.11

2.08

1.4

11.28

10.97

u/l

0.22

609

3814

Sacroiliitis, not elsewhere classified

113

869

1.32

2.07

1.6

1.4

9.37

8.91

u/l

0.14

702

Other secondary gonarthrosis

415

1.46

2.07

1.3

1.4

13.48

10.98

u/l

0.63

337

Noninfective disorders of pinna

3.28

2.07

1.1

1.2

5.59

5.37

u/l

—

Fracture of femur

239

1795

1.20

2.07

1.5

11.50

10.11

u/l

0.70

192

1424

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

208

1.68

2.06

1.7

1.5

10.82

9.05

u/l

0.20

174

Other diseases of spinal cord

302

1.54

2.06

1.5

8.55

8.96

u/l

0.10

246

Other and unspecified psoriasis

695

1.35

2.05

1.5

1.4

13.19

9.93

u/l

1.10

554

Residual foreign body in soft tissue

739

1.34

2.05

1.4

1.5

7.05

7.76

u/l

0.39

592

Other malignant neoplasms of skin (=non-melanoma skin cancer)

373

2184

1.16

2.05

1.3

13.17

10.59

u/l

2.51

298

1701

Acquired absence of limb

2.15

2.05

1.3

1.2

8.64

6.23

u/l

—

Benign neoplasm: Appendix

2.15

2.05

1.1

1.2

10.22

8.42

u/l

—

Bacterial, viral and other infectious agents, including avohilmo

194

1593

1.23

2.04

1.6

1.5

8.65

7.76

u/l

0.41

142

1267

ILD, hospital admissions

135

1062

1.28

2.03

1.4

10.51

10.21

u/l

0.10

108

845

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

883

5063

1.10

2.03

1.4

12.07

10.63

u/l

1.95

721

4147

Childhood allergy (age < 16)

654

4853

1.12

2.03

1.7

1.6

6.67

7.38

u/l

1.84

507

3826

Assault by unspecified means

436

1.45

2.03

1.4

1.5

8.59

7.13

u/l

0.46

359

Vascular dementia

303

0.51

2.02

1.1

1.3

16.15

10.62

u/l

0.46

230

Type 1 diabetes, strict definition

177

2154

0.81

2.02

1.4

1.7

7.15

7.17

u/l

0.00

131

1648

Scleritis and episcleritis

102

776

1.33

2.01

1.4

11.42

11.09

u/l

0.06

629

Benign neoplasm: Cranial nerves

232

1.62

2.01

1.7

1.3

12.70

10.23

u/l

0.31

188

Maternal care for known or suspected malpresentation of fetus

565

3591

1.13

2.01

1.2

1.3

11.04

11.67

u/l

0.52

494

2866

Other specified/unspecified systemic involvement of connective tissue

544

1.39

2.00

1.3

1.4

12.54

11.77

u/l

0.18

442

Hereditary spherocytosis

2.73

2.00

1.1

1.4

13.52

5.75

u/l

—

Deficiency of other B group vitamins

148

1.78

2.00

1.3

1.2

11.30

10.73

u/l

0.08

116

Other and unspecified injuries of lower leg

166

1344

1.25

2.00

1.4

1.5

9.05

9.06

u/l

0.00

140

1068

Injury of unspecified body region

127

996

1.29

1.99

1.5

8.72

9.09

u/l

0.14

780

Other interstitial pulmonary diseases

136

1074

1.27

1.99

1.4

10.46

10.23

u/l

0.07

109

856

Interstitial lung disease

136

1074

1.27

1.99

1.4

10.46

10.23

u/l

0.07

109

856

Interstitial lung disease endpoints

136

1074

1.27

1.99

1.4

10.46

10.23

u/l

0.07

109

856

Other disorders of veins

528

4617

1.13

1.99

1.3

13.20

13.25

u/l

0.02

409

3762

COPD, hospital admissions 3, with asthma pneumonia sepsis

232

1658

1.20

1.99

1.3

1.4

10.88

10.06

u/l

0.41

176

1322

Tooth agenesis EXCLUDE clefts and syndromes

137

1089

1.28

1.97

2.1

1.7

6.34

7.91

u/l

1.78

105

823

Nephrotic syndrome

429

1.44

1.97

1.7

11.48

7.46

u/l

0.95

323

Cardiovascular disorders originating in the perinatal period

122

1.95

1.97

2.0

2.6

9.63

5.24

u/l

0.51

Other dialysis

371

1.48

1.97

1.7

12.54

7.90

u/l

0.76

288

Disorders of optic nerve, not elsewhere classified

164

1.73

1.97

2.0

1.3

24.34

8.82

u/l

1.23

126

Congenital malformations of eyelid, lacrimal apparatus and orbit, including avohilmo

212

1.66

1.96

1.9

2.2

6.46

7.02

u/l

0.18

150

therapeutic use

187

1.67

1.95

1.4

1.3

10.43

11.24

u/l

0.11

145

Malignant neoplasm of renal pelvis

2.79

1.95

1.1

1.3

20.28

5.97

u/l

—

Flatulence and related conditions

113

1.90

1.95

1.6

1.7

8.09

8.81

u/l

0.09

Infliximab

448

1.44

1.95

1.3

1.5

8.46

7.28

u/l

0.26

367

Eustachian salpingitis and obstruction

206

1712

1.22

1.95

1.5

1.4

8.66

8.32

u/l

0.14

159

1384

Diseases of arteries, arterioles and capillaries

812

5412

1.10

1.94

1.4

11.22

9.98

u/l

1.51

639

4357

Nonsuppurative otitis media

725

5701

1.11

1.94

1.7

1.5

7.75

7.97

u/l

0.25

568

4517

Mumps

315

1.52

1.94

1.2

1.4

14.11

8.75

u/l

0.75

256

Other disorders of binocular movement

398

1.46

1.94

1.4

1.5

16.07

9.34

u/l

0.44

317

Other predominantly sexually transmitted diseases, not elsewhere classified

444

3920

1.14

1.93

1.4

9.68

9.31

u/l

0.21

346

3227

Impetigo

115

897

1.30

1.93

1.9

1.5

9.70

8.10

u/l

0.60

671

Pneumonia due to Streptococcus pneumoniae

464

1.42

1.92

1.4

1.5

10.55

7.94

u/l

0.84

378

Haemangioma and lymphangioma, any site

141

1126

1.26

1.92

1.4

1.5

9.66

10.54

u/l

0.33

115

903

Xerosis cutis

143

1.78

1.91

1.5

1.2

10.92

7.72

u/l

0.60

106

Accessory breast

100

1.97

1.91

1.4

1.2

8.64

12.84

u/l

0.79

Myocardial infarction, unclassifiable

1152

0.77

1.91

1.3

1.4

14.66

9.64

u/l

1.39

904

Parkinson's disease, excluding more controls

582

1.35

1.90

1.3

10.12

12.25

u/l

1.11

479

Vitamin B12 deficiency anaemia

617

1.35

1.90

1.5

1.3

16.03

11.10

u/l

1.87

492

Puerperal sepsis

135

1073

1.26

1.90

1.3

15.35

16.29

u/l

0.28

115

889

Asthma/COPD (KELA code 203)

2067

13020

1.06

1.90

1.4

10.06

9.54

u/l

0.97

1669

10471

Degeneration of macula and posterior pole

372

2497

1.15

1.89

1.3

1.4

13.24

12.20

u/l

0.51

278

2007

Anterior Iridocyclitis

317

2736

1.16

1.89

1.4

11.55

9.95

u/l

1.05

253

2198

Other osteochondropathies

132

1049

1.27

1.89

1.6

1.5

8.87

8.92

u/l

0.02

102

851

Other and unspecified epidermal thickening

325

1.50

1.89

1.6

1.4

10.98

8.16

u/l

0.51

255

Tubulo-interstitial nephritis, not specified as acute or chronic

627

1.35

1.89

1.3

1.4

10.98

11.09

u/l

0.03

494

Postinfectious hypothyroidism

2.93

1.88

1.8

1.2

30.98

11.66

u/l

—

Volvulus

197

1.64

1.88

1.8

1.3

10.47

11.21

u/l

0.12

161

Vertical strabismus

408

1.44

1.88

1.7

1.4

10.67

9.55

u/l

0.19

320

Other infectious diseases

732

1.32

1.87

1.4

11.84

9.06

u/l

1.06

590

Von Willebrand disease

175

1.70

1.87

1.8

1.4

13.60

10.99

u/l

0.22

138

Chalazion

191

1581

1.22

1.87

1.6

1.4

9.04

9.80

u/l

0.35

145

1274

Other noninfective disorders of lymphatic vessels and lymph nodes

342

1.48

1.86

1.4

1.3

12.60

10.32

u/l

0.52

274

SLE (Finngen)

326

1.49

1.85

1.5

1.4

10.57

10.99

u/l

0.06

260

Psoriasis

448

3966

1.13

1.85

1.4

9.82

9.91

u/l

0.05

352

3160

Hereditary factor VIII deficiency

2.50

1.85

1.3

1.6

10.28

7.64

u/l

—

Degenerative macular diseases

707

1.32

1.84

1.5

1.4

12.03

11.27

u/l

0.15

572

Benign neoplasm: Skin of scalp and neck

270

1.54

1.84

1.6

1.4

11.26

9.86

u/l

0.23

212

Chronic lymphocytic leukaemia, helper endpoint

137

1.77

1.84

1.3

16.29

6.60

u/l

2.30

109

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

137

1.77

1.84

1.3

16.29

6.60

u/l

2.30

109

Chronic lymphocytic leukaemia

137

1.77

1.84

1.3

16.29

6.60

u/l

2.30

109

Assault by other specified means

192

1.66

1.84

1.3

1.4

9.57

7.61

u/l

0.48

156

Other other unspecified disorders of the circulatory system

270

1.53

1.83

1.4

16.13

11.51

u/l

0.85

203

Myeloproliferative diseases (CML excluded)

528

1.37

1.82

1.5

1.3

12.84

9.93

u/l

1.27

423

Type 1 diabetes, strict definition, subgroup 1

172

2073

0.82

1.81

1.4

1.7

7.18

7.05

u/l

0.05

127

1590

Early syphilis

177

1.68

1.81

1.5

6.30

6.16

u/l

0.03

148

Other superficial mycoses

362

1.46

1.81

1.6

1.4

8.96

8.36

u/l

0.13

293

Intracranial and intraspinal abscess and granuloma

109

1.87

1.80

1.6

1.3

6.12

8.74

u/l

0.82

Primary biliary cholangitis, wide definition

161

1.70

1.80

1.3

1.5

13.99

10.15

u/l

0.29

123

Previous suicide attempt

217

1.61

1.80

1.7

1.6

5.99

8.52

u/l

1.64

177

Assault by blunt object

273

1.54

1.79

1.5

7.99

6.70

u/l

0.35

222

Gonarthrosis, primary, with knee surgery

515

3576

1.12

1.79

1.3

11.58

13.40

u/l

2.16

418

2847

Superficial injuries involving multiple body regions

396

1.44

1.79

1.3

1.4

9.08

8.20

u/l

0.18

316

Inflammatory bowel disease

645

5844

1.11

1.79

1.5

9.22

9.01

u/l

0.18

528

4698

Hypertrophy of breast

257

2194

1.18

1.78

1.2

1.3

14.36

15.33

u/l

0.43

214

1790

Idiopathic gout

764

1.30

1.78

1.5

1.4

8.05

7.51

u/l

0.18

608

Excessive earwax

991

8285

1.09

1.78

1.5

9.24

9.85

u/l

0.78

782

6595

Peroneal tendinitis

193

1.63

1.77

1.2

1.3

9.56

11.29

u/l

0.34

155

Ulcerative colitis, NAS

276

2373

1.17

1.77

1.4

1.5

9.21

8.94

u/l

0.14

224

1894

Helminthiases

209

1.61

1.77

1.2

1.6

11.68

9.30

u/l

0.44

168

Open wound of forearm

186

1546

1.21

1.77

1.4

1.5

9.72

8.15

u/l

0.97

138

1230

Hepatic failure, not elsewhere classified

338

1.46

1.77

1.5

1.4

9.24

9.02

u/l

0.04

274

Other factor of the environment

155

1.72

1.76

1.3

1.2

9.17

10.26

u/l

0.19

126

Hordeolum and other deep inflammation of eyelid

109

855

1.29

1.76

1.8

1.5

10.33

9.53

u/l

0.19

671

Coxarthrosis

559

3234

1.12

1.75

1.4

1.3

11.04

12.33

u/l

1.37

455

2587

Lichen sclerosus et atrophicus

115

907

1.27

1.75

1.3

1.4

12.25

14.47

u/l

0.87

753

Other congenital malformations of nervous system

235

1.58

1.75

1.3

1.8

7.90

9.36

u/l

0.34

178

Benign neoplasm of urinary organs

330

1.47

1.75

1.4

1.3

11.42

11.04

u/l

0.05

263

Mumps, including avohilmo

323

1.48

1.74

1.2

1.4

14.11

8.90

u/l

0.72

263

Attention to artificial openings

314

1.48

1.74

2.0

1.4

16.91

9.14

u/l

1.66

247

647

1.34

1.74

2.5

2.3

5.98

6.02

u/l

0.02

400

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

234

1958

1.19

1.74

1.7

1.6

8.51

7.87

u/l

0.38

182

1460

Fracture of neck

585

1.34

1.73

1.4

8.65

8.02

u/l

0.19

467

Conduct disorder

528

1.37

1.73

1.5

1.8

8.75

6.81

u/l

0.72

402

Alzheimer’s disease (Late onset), excluding more controls

371

0.66

1.72

1.3

12.90

15.18

u/l

0.41

300

Glomerular disorders in diseases classified elsewhere

167

1378

1.22

1.71

1.5

11.70

8.18

u/l

2.21

124

1118

Melanocytic naevi of scalp and neck

358

1.45

1.71

1.5

1.4

9.55

8.95

u/l

0.12

295

Other specified/unspecified necrotizing vasculopathies

111

1.83

1.71

1.2

14.32

10.27

u/l

0.34

Disorders of breast

805

6494

1.09

1.70

1.3

14.67

13.58

u/l

1.11

684

5324

Chondrocostal junction syndrome [Tietze]

425

1.40

1.70

1.4

11.24

10.18

u/l

0.25

339

Aortic aneurysm

239

1997

1.18

1.69

1.4

9.99

8.11

u/l

1.26

188

1588

Transient global amnesia

501

1.36

1.69

1.5

1.3

9.43

12.74

u/l

1.58

400

Chronic hepatitis, not elsewhere classified

350

1.44

1.69

1.5

1.4

9.88

9.89

u/l

0.00

279

Other specified and unspecified retinal disorders

292

1.49

1.68

1.7

1.5

10.44

9.01

u/l

0.18

228

Burns and corrosions

293

2543

1.16

1.68

1.4

1.5

9.09

7.95

u/l

1.07

225

2021

Effects of other external causes

573

1.35

1.68

1.5

7.82

7.17

u/l

0.23

467

Other and unspecified acne

294

1.50

1.68

1.8

1.6

7.65

7.54

u/l

0.03

243

Transient ischemic attack

507

3617

1.12

1.68

1.3

1.4

11.54

11.61

u/l

0.04

391

2910

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

367

1.43

1.68

1.3

1.4

9.89

8.83

u/l

0.21

293

Toxic liver disease

165

1.67

1.5

1.2

14.05

8.92

u/l

0.81

131

Benign leiomyoma with endometriosis

125

1002

1.25

1.67

1.2

19.46

18.50

u/l

0.23

107

818

Open wound of hip and thigh

573

1.34

1.67

1.5

7.19

7.43

u/l

0.10

459

Other respiratory diseases principally affecting the interstitium

159

1308

1.22

1.67

1.5

1.4

11.37

10.63

u/l

0.25

131

1040

Perforation of oesophagus

2.52

1.67

1.2

15.97

6.63

u/l

—

Crohn's disease of large intestine

104

819

1.28

1.65

1.6

1.4

8.27

8.59

u/l

0.11

661

Other fall from one level to another

484

4340

1.12

1.65

1.6

1.5

8.81

8.24

u/l

0.51

380

3393

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

182

1.63

1.65

1.2

16.65

12.26

u/l

0.51

149

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

596

5412

1.11

1.64

1.4

9.20

8.81

u/l

0.30

464

4457

Congenital malformations of eyelid, lacrimal apparatus and orbit

183

1.64

1.63

1.8

2.2

6.75

6.95

u/l

0.05

136

Myelodysplastic syndrome, including Hilmo

135

1.72

1.63

1.3

1.4

17.20

7.77

u/l

1.21

111

Other and unspecified injuries of shoulder and upper arm

429

1.39

1.63

1.5

1.4

7.84

8.39

u/l

0.13

349

Eosinophilic disease (BM)

128

1.75

1.62

1.5

1.4

9.78

7.04

u/l

0.26

Dermatitis due to ingested food

132

1028

1.25

1.61

2.1

2.0

6.47

6.84

u/l

0.26

721

Hypoplasia of dental enamel, prenatal , including avohilmo

146

1.75

1.61

2.9

2.6

5.21

5.46

u/l

0.06

Superficial injury of hip and thigh

198

1670

1.19

1.61

1.4

10.13

9.43

u/l

0.34

161

1343

Acute peritonitis

593

1.32

1.60

1.4

1.5

13.41

8.85

u/l

1.18

479

Other specified disorders of muscle

304

1.46

1.60

1.6

1.4

13.79

7.47

u/l

1.38

247

Other benign neoplasm of uterus: Corpus uteri

2.37

1.60

1.1

1.2

11.66

14.80

u/l

—

Coeliac disease

211

1793

1.18

1.60

1.6

1.5

11.24

9.97

u/l

0.55

164

1407

112

831

1.26

1.59

1.3

15.28

13.18

u/l

0.59

648

IgA nephropathy (IgA glomerulonephritis)

330

1.45

1.59

1.8

1.4

10.35

7.84

u/l

0.60

267

Other lesions of median nerve

167

1.63

1.59

1.5

1.2

10.88

11.12

u/l

0.02

132

Other and unspecified haemorrhagic conditions

152

1.67

1.59

1.2

1.4

13.35

9.90

u/l

0.62

121

Acute inflammation of orbit

1.94

1.59

1.6

1.5

10.50

7.66

u/l

—

Calculus of lower urinary tract

431

1.38

1.57

1.4

11.47

8.41

u/l

1.12

349

Other and unspecified primary disorders of muscles

100

1.86

1.57

1.7

12.28

8.51

u/l

0.36

Other disorders of amniotic fluid and membranes

378

3241

1.13

1.56

1.2

1.3

11.11

10.92

u/l

0.06

326

2588

Artificial joint operation, meniscal resection

1329

7959

1.07

1.56

1.4

10.12

10.76

u/l

1.01

1092

6411

Unspecified dementia

347

0.62

1.56

1.5

1.3

8.82

10.75

u/l

0.31

266

Use of other anti-dementia drugs

900

0.78

1.56

1.3

10.51

12.92

u/l

0.94

704

Use of memantine

900

0.78

1.56

1.3

10.51

12.92

u/l

0.94

704

Pedal cyclist injured in transport accident

459

4123

1.12

1.55

1.5

8.72

8.67

u/l

0.03

372

3313

Congenital malformations of eye, ear, face and neck

162

1351

1.21

1.55

1.8

1.6

8.85

8.39

u/l

0.16

126

1040

Benign neoplasm: Skin of trunk

485

1.35

1.54

1.8

1.4

15.30

9.48

u/l

1.44

388

Behavioural disorders

548

1.34

1.54

1.5

1.7

8.73

7.00

u/l

0.64

418

Scabies

784

1.28

1.53

1.8

1.5

8.62

8.18

u/l

0.15

624

Other diseases of arteries and capillaries

102

809

1.27

1.53

1.4

13.63

10.13

u/l

1.12

657

Recurrent dislocation and subluxation of joint

144

1188

1.22

1.53

1.3

1.4

8.20

9.67

u/l

0.86

115

964

Desensitization to allergens

160

1336

1.21

1.53

1.5

7.34

8.66

u/l

1.09

123

1066

Listeriosis, including avohilmo

2.65

1.53

1.9

1.0

13.56

10.54

u/l

—

Postpartum haemorrhage due to anatomy

342

3028

1.14

1.52

1.3

1.2

10.22

10.11

u/l

0.06

298

2564

Malignant neoplasm of digestive organs

335

2253

1.14

1.52

1.4

1.3

14.78

9.19

u/l

7.31

266

1761

Injury of eye and orbit

303

2658

1.15

1.52

1.4

1.5

8.93

7.89

u/l

0.67

252

2127

Mental retardation, wide definition

107

850

1.26

1.52

2.8

1.9

7.22

6.84

u/l

0.16

590

Crohn disease (strict definition, require KELA)

143

1181

1.22

1.51

1.5

6.90

8.36

u/l

1.14

118

954

Abdominal aortic aneurysm (AAA)

541

1.32

1.51

1.4

1.3

10.26

8.90

u/l

0.39

433

Varicose veins

529

4411

0.90

1.51

1.4

1.3

14.27

14.09

u/l

0.09

436

3577

Retinoschisis and retinal cysts

154

1.64

1.51

1.3

13.78

8.26

u/l

0.87

115

Ulcer of lower limb, not elsewhere classified

141

1161

1.22

1.50

1.3

1.4

10.87

9.03

u/l

0.94

940

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

376

3250

1.13

1.50

1.9

1.6

9.40

8.30

u/l

0.71

287

2494

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

175

1472

1.19

1.50

1.4

10.98

8.18

u/l

1.49

129

1176

Primary Sclerosing Cholangitis, IBD and UDCA required

343

1.42

1.50

1.4

1.6

8.85

7.20

u/l

0.24

264

Mental and behavioural disorders associated with the puerperium

187

1.59

1.50

1.2

16.65

12.22

u/l

0.52

154

Benign neoplasm: Other and unspecified parts of mouth

292

1.45

1.50

1.5

12.63

9.79

u/l

0.70

233

Crohn disease (strict definition, require KELA, min 2 HDR)

141

1165

1.22

1.49

1.5

6.96

8.27

u/l

0.97

116

939

Disorders of eyelid in diseases classified elsewhere

351

1.41

1.49

1.3

1.5

12.89

10.04

u/l

0.69

283

Retinal detachments and breaks

363

3223

1.13

1.49

1.3

1.4

12.83

11.17

u/l

0.96

280

2611

Mixed disorders of conduct and emotions

710

1.29

1.49

1.6

1.8

5.86

6.76

u/l

0.76

545

Other and unspecified intracranial injuries

360

1.40

1.48

1.4

10.63

8.16

u/l

0.56

286

Acute otitis externa, noninfective

171

1.60

1.48

1.5

1.4

12.59

10.38

u/l

0.30

132

Colorectal cancer

179

1447

1.19

1.48

1.3

16.19

9.60

u/l

4.60

139

1132

Anogenital herpesviral [herpes simplex] infection

169

1423

1.20

1.47

1.5

1.4

7.88

9.47

u/l

1.25

130

1178

Arthropod-borne viral fevers and viral haemorrhagic fevers

137

1129

1.22

1.47

1.5

1.4

11.49

8.74

u/l

1.41

116

915

Obstructed labour due to malposition and malpresentation of fetus

507

4252

1.11

1.47

1.2

1.3

12.43

12.85

u/l

0.22

442

3416

Lifestyle-related condition

148

1.66

1.47

1.3

1.2

9.66

10.15

u/l

0.07

121

Lactose intolerance

438

1.36

1.46

1.4

1.5

8.34

8.73

u/l

0.09

338

Acute gastritis

637

1.29

1.46

1.2

1.4

10.76

9.90

u/l

0.17

520

Other disorders of Eustachian tube

353

1.40

1.45

1.6

1.3

7.12

10.09

u/l

1.81

289

Exophthalmic conditions

1.82

1.45

1.7

1.3

7.95

8.96

u/l

—

Psoriasis vulgaris

289

2539

1.14

1.43

1.5

1.4

9.61

9.53

u/l

0.04

226

2027

Complications of genitourinary prosthetic devices, implants and grafts

221

1.51

1.42

1.2

1.3

10.91

11.28

u/l

0.06

178

Viral pneumonia (known virus, not influenza)

304

1.43

1.42

1.4

1.6

10.87

8.60

u/l

0.41

233

Other sexually transmitted chlamydial diseases

231

2006

1.16

1.41

1.3

1.4

8.28

7.84

u/l

0.27

179

1632

Arnold-Chiari syndrome

207

1.54

1.41

1.4

1.7

7.21

9.55

u/l

0.91

161

Mental retardation

104

832

1.25

1.40

2.8

1.9

6.90

6.77

u/l

0.05

575

Later onset COPD

173

1172

1.19

1.40

1.2

1.4

11.79

11.66

u/l

0.04

127

911

Malignant neoplasm of oesophagus, including Hilmo

222

1.50

1.39

1.3

10.78

6.38

u/l

1.78

179

Lesion of plantar nerve

347

1.39

1.2

1.3

11.66

15.50

u/l

1.08

288

Burn and corrosion confined to eye and adnexa

383

1.38

1.6

1.5

7.50

7.82

u/l

0.12

319

Allergic contact dermatitis

232

2014

1.16

1.38

1.3

12.04

11.75

u/l

0.10

190

1637

Other congenital malformations of limb(s)

192

1.56

1.38

1.6

2.0

7.50

7.79

u/l

0.05

141

Rheumatoid arthritis

304

3042

0.88

1.38

1.3

15.08

12.57

u/l

1.83

256

2438

Other inflammation of vagina/vulva

654

1.28

1.37

1.2

1.3

10.69

11.47

u/l

0.23

546

Mandibular hypoplasia

105

1.77

1.37

1.4

1.5

9.15

8.83

u/l

0.04

Benign neoplasm of thyroid gland

256

1.46

1.37

1.3

1.2

14.99

11.99

u/l

0.53

206

Glaucoma secondary to drugs

2.23

1.37

1.0

1.5

7.07

8.00

u/l

—

Keratoconus

375

1.38

1.37

1.4

8.14

7.20

u/l

0.30

312

Other Crohn's disease

148

1241

1.20

1.37

1.4

1.5

9.49

8.38

u/l

0.46

126

1002

Contusion of toe(s) without damage to nail

479

1.33

1.36

1.5

9.92

8.48

u/l

0.52

377

Ankylosing spondylitis

140

1167

1.21

1.36

1.4

8.54

8.89

u/l

0.13

113

947

Background retinopathy and retinal vascular changes

191

1.54

1.36

1.6

1.3

7.72

8.75

u/l

0.18

151

Other and unspecified injuries of neck

160

1.61

1.36

1.5

9.76

9.43

u/l

0.05

133

ILD-related respiratory insufficiency

199

1.52

1.35

1.4

1.3

12.24

8.61

u/l

0.90

149

Other congenital malformations of the digestive system

103

828

1.25

1.35

1.8

2.0

8.24

7.70

u/l

0.17

571

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

282

2484

1.14

1.35

1.6

1.5

10.70

9.25

u/l

0.92

218

1962

Malignant neoplasm of stomach, including Hilmo

315

1.40

1.35

1.5

1.4

14.47

8.47

u/l

1.80

252

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Lutropin [Units/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS